Himmelfarb Health Sciences Library, The George Washington University

Health Sciences Research Commons
Health Policy and Management Issue Briefs

Health Policy and Management

3-2010

Strengthening Science in Government: Advancing Science in the
Public's Interest
Susan F. Wood PhD
George Washington University SPH, sfwood@gwu.edu

Ruth W. Long MA, MPH
George Washington University SPH

Liz Borkowski
George Washington University SPH, borkowsk@gwu.edu

David Michaels PhD, MPH
George Washington University SPH

Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/sphhs_policy_briefs
Part of the Public Health Commons

Recommended Citation
Wood, Susan F. PhD; Long, Ruth W. MA, MPH; Borkowski, Liz; and Michaels, David PhD, MPH,
"Strengthening Science in Government: Advancing Science in the Public's Interest" (2010). Health Policy
and Management Issue Briefs. Paper 58.
https://hsrc.himmelfarb.gwu.edu/sphhs_policy_briefs/58

This Report is brought to you for free and open access by the Health Policy and Management at Health Sciences
Research Commons. It has been accepted for inclusion in Health Policy and Management Issue Briefs by an
authorized administrator of Health Sciences Research Commons. For more information, please contact
hsrc@gwu.edu.

The Scientists in Government Project • March 2010

Strengthening Science in Government:
Advancing Science in the Public’s Interest
The Project on Scientific Knowledge and Public Policy
at The George Washington University
School of Public Health and Health Services

Authors:

Thanks:

Susan F. Wood, PhD

We also greatly appreciate the suggestions and contributions

Ruth W. Long, MA, MPH

of the following organizations:

Liz Borkowski

Federation of American Scientists

David Michaels, PhD, MPH *
Government Accountability Project
Acknowledgments:
The Project on Scientific Knowledge and Public Policy
(SKAPP) gratefully acknowledges the input and contributions of our advisory panel:
James Curran, MD, MPH, Dean, Rollins School of Public
Health, Emory University; former Director of the Centers

Scientists & Engineers for America
Union of Concerned Scientists
Several individuals assisted with the research and writing
of this report: Andrew Dubowitz, Karyn Feiden, Kristen
Perosino, and Lindsey Realmuto

for Disease Control and Prevention’s Division of HIV/AIDS

SKAPP would like to thank the Open Society Institute for

Prevention

the generous grant that made this work possible.

Paul Gilman, PhD, former Assistant Administrator for
Research and Development and Science Advisor at the
U.S. Environmental Protection Agency

Note:
The opinions expressed in this report do not necessarily
reflect those of the foundations that supported this work,

Lynn Goldman, MD, MPH, Professor, Bloomberg School of

or of the individuals who reviewed and commented on it.

Public Heath, Johns Hopkins University; former Assistant

Both the opinions and the information contained herein

Administrator for Toxic Substances at the US Environmental

are the sole responsibility of the authors.

Protection Agency
Neal Lane, PhD, Professor, James A. Baker III Institute for
Public Policy, Rice University; former Assistant to the
President for Science and Technology and Director of the
White House Office of Science and Technology Policy;
former Director of the National Science Foundation
Albert H. Teich, PhD, Director, Science & Policy Programs,
American Association for the Advancement of Science

* DM contributed to this research project until November 2009, when he
was confirmed as Assistant Secretary of Labor for Occupational Safety
and Health.

Table of Contents
Tables..........................................................................................................................................................iii
Acronyms.................................................................................................................................................iv
Executive Summary ......................................................................................................................... 1
Introduction ............................................................................................................................................ 1
Pressures on Scientists ...................................................................................................................... 2
Scientists in Government Project: Shaping the Debate .............................................................. 4
Findings and Recommendations ..................................................................................................... 5
Overarching Recommendation:
Ensuring Policy Consistency and Clear Communication ...................................................... 5
Morale................................................................................................................................................... 5
Management ....................................................................................................................................... 7
Feedback Mechanisms ...................................................................................................................... 8
Approving Proposed Research ........................................................................................................ 8
Disseminating Scientific Work ......................................................................................................... 9
Communicating with the Public ...................................................................................................12
Professional Development .............................................................................................................13
Inter-agency Data Sharing and Communication .......................................................................14
Influence ............................................................................................................................................14
Follow-up Survey..............................................................................................................................16
Conclusion ............................................................................................................................................ 17
Methodology ....................................................................................................................................... 18

Introduction ........................................................................................................................................ 21
Pressures on Scientists ..................................................................................................................... 21
Government Scientists’ Unique Role ............................................................................................22
Scientists in Government Project: Shaping the Debate ........................................................ 22
Non-Partisan Efforts to Protect and Advance Government Science ................................. 23
Recent Executive-branch Actions ................................................................................................. 23

Methodology...................................................................................................................................... 25
Interview Guide .................................................................................................................................. 25
Participant Recruitment................................................................................................................... 25
Interview Participants ...................................................................................................................... 26
Interview Data Analysis ................................................................................................................... 26
Additional Research: Policy Review ............................................................................................. 27
Follow-up Survey................................................................................................................................ 27

Agency Background ..................................................................................................................... 28
Other Key Executive-branch Offices............................................................................................. 29
Political Appointees and Career Civil Servants ........................................................................ 30

Research Participant Characteristics .............................................................................. 31

Findings .................................................................................................................................................. 35
Morale .................................................................................................................................................... 35
Changing Priorities ..........................................................................................................................36
Bureaucratic Processes ....................................................................................................................36
Inadequate Resources .....................................................................................................................36
Principles Under Threat ...................................................................................................................36
Recruitment and Retention ............................................................................................................37
Management........................................................................................................................................ 38
Public Health Service (PHS) and Civil Service .............................................................................39
Feedback Mechanisms ..................................................................................................................... 39
Setting Priorities and Approving Research ............................................................................... 40
IRB Approval and OMB Clearance .................................................................................................41
Research Approval Processes.........................................................................................................42
Scientific Dispute Resolution ......................................................................................................... 44
Disseminating Scientific Work ....................................................................................................... 46
Agency Approaches to Clearance .................................................................................................46
Scientists’ Views of Clearance Processes ......................................................................................47
One Agency Example of Clearance Process ................................................................................47
Other Federal-agency Clearance Processes ................................................................................48
Review for Quality and Editorial Standards.................................................................................51
Additional Requirements for “Influential Scientific Information”............................................51
Scientists’ Concerns about Clearance Processes ........................................................................52
Timelines ............................................................................................................................................54
Scientific Information Involving Policy or Sensitive Subjects ..................................................55
The Impact of Anticipated Reactions on Clearance Decisions ................................................57
Reviewers’ Credentials .....................................................................................................................57
Benefits of the Process ....................................................................................................................58
The Use of Disclaimers ....................................................................................................................59
Authorship .........................................................................................................................................60
Communicating with the Public .................................................................................................... 61
A Government-wide Policy of Scientific Openness ...................................................................61
Communicating with the Media: Official Agency Policies .......................................................62
Communicating with the Media: What Scientists Say...............................................................63
Little Awareness of Formal Policies...............................................................................................65
Varying Attitudes Toward Agency Oversight..............................................................................68
Agency Commitments to Sharing Data .......................................................................................69
Inter-agency Data Sharing and Communication ..................................................................... 70
Committee Participation.................................................................................................................72
Professional Development .............................................................................................................. 72
Influences on Government Science .............................................................................................. 74
Widespread Influence......................................................................................................................75
Congressional Influence on Research Priorities .........................................................................75
Congressional Budget Threats .......................................................................................................77
Executive-branch Influence............................................................................................................77
Public-sector Influence....................................................................................................................78
Private-sector Influence ..................................................................................................................80
Working in an Atmosphere of Influence ......................................................................................82
The Importance of Supportive Management .............................................................................83
Follow-up Survey Results ................................................................................................................ 83
Leadership .........................................................................................................................................84
Management .....................................................................................................................................85
Funding ..............................................................................................................................................85

ii • The Scientists in Government Project

Recommendations ......................................................................................................................... 86
Overarching Recommendation:
Ensuring Policy Consistency and Clear Communication ....................................................86
Management........................................................................................................................................ 86
Feedback ............................................................................................................................................... 87
Approving Proposed Research ...................................................................................................... 87
Disseminating Scientific Work ....................................................................................................... 87
Communicating with the Public .................................................................................................... 88
Inter-agency Data Sharing and Communication ..................................................................... 89
Professional Development .............................................................................................................. 89
Influence................................................................................................................................................ 90

Conclusion ............................................................................................................................................ 91
Endnotes ................................................................................................................................................ 92
Appendix A: Interview Guide ................................................................................................ 96
Appendix B: Synopsis of Institutional Review Board (IRB)
Approved Application .............................................................................................................. 100

Tables
Table ES-1: Number of Interviewees with Experience at Various Federal Agencies ...................20
Table 1: Political Appointees and Career Civil Servants ...........................................................................30
Table 2: Number of Interviewees with Experience at Various Federal Agencies...........................31
Table 3: Sex of Interview Participants and Professional Federal Workers ..........................................32
Table 4: Race of Interview Participants and Professional Federal Workers ........................................33
Table 5: Age of Interview Participants and Federal Workers ..................................................................33
Table 6: Interview Participants’ Length of Government Service ...........................................................34
Table 7: Advanced Academic Degrees Held by Participants ..................................................................34
Table 8: Results of Follow-up Survey ..............................................................................................................84

The Scientists in Government Project • iii

Acronyms
ARS – Agricultural Research Service
ATSDR – Agency for Toxic Substances and Disease Registry
CDC – Centers for Disease Control and Prevention
CDER – Center for Drug Evaluation and Research
CPSC – US Consumer Product Safety Commission
DOD – US Department of Defense
DOI – US Department of the Interior
EPA – US Environmental Protection Agency
FDA – US Food and Drug Administration
FSIS – Food Safety and Inspection Service
HHS – US Department of Health and Human Services
HUD – US Department of Housing and Urban Development
IHS – Indian Health Service
NCTR – National Center for Toxicological Research
NIH – National Institutes of Health
NIOSH – National Institute for Occupational Safety and Health
NIST – National Institute of Standards and Technology
OMB – Office of Management and Budget
OPM – Office of Personnel Management
OSHA – Occupational Safety and Health Administration
OSTP – Office of Science and Technology Policy
PHS – US Public Health Service Commissioned Corps
SAMHSA – Substance Abuse and Mental Health Services Administration
USDA – US Department of Agriculture
USGS – US Geological Survey
VHA – Veterans Health Administration

iv • The Scientists in Government Project

The search for truth, Albert Einstein has said, also implies a duty:
“One must not conceal any part of what one has recognized to be true.” 1

Executive Summary
Introduction

T

he statement above serves not only as a guiding

sound decision-making and the public policies that
strengthen our nation.

principle of good science, but as a framework for

Beyond the merits of advancing science, the open ex-

effective, science-based policy-making. The best

change of ideas is also cherished because it is concordant

public policies are built on a foundation of rigorous data

with the ideals of a democratic society. Freedom of infor-

and analyses, widely shared among scientists and the

mation is a core belief in the American system.

public. The fundamental obligations of a science-based
society—advancing the public health, protecting the

Despite these laudable goals, there is no such thing

workforce, safeguarding the environment, developing

as “pure” science, no isolated chamber where scientists

appropriate energy technologies, defending the nation,

can expect to carry out their research, announce their

and much more—depend on a full and open exchange of

findings, and assume they will be the sole consideration

ideas, methods, findings, and interpretations.

in addressing a real-world challenge.

New scientific knowledge constantly builds on existing

An analysis of the approach to science taken by the five

scientific knowledge. When information is readily

White House administrations that preceded that of Presi-

shared, new findings can be analyzed and new hypotheses

dent Barack Obama explains, “It is naïve to believe that

vetted in an ongoing process that continually gener-

scientific findings are the sole determinant of policy …

ates opportunities for further study and analysis. Science

Much of the funding, direction and use of American sci-

flourishes when scientific ideas are given a fair hearing

ence is determined by the federal government and the

by colleagues, debated on their merits, tested through

political biases of the dominant party invariably influence

replication and further research, and revised in light of

the decisions that get made.” 2

new understanding.

Policy decisions may be based on science, but they are

In all that, there is a direct public benefit. Safety and effec-

not purely scientific. Preferences and political consider-

tiveness studies are essential to drug approval decisions,

ations shape decisions about regulation, research pri-

laboratory and animal studies provide standard-setting

orities, service delivery, and program development and

data for chemical exposures in the workplace, and under-

evaluation. Nonetheless, the integrity of the science and

standing the cycle of carbon emissions helps shape the

the validity of the data that informs these decisions must

response to global climate change. Strong science drives

be preserved.
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PRESSURES ON SCIENTISTS

once it is complete and results are ready to be disseminat-

The pressures and constraints facing scientists within

ed through articles and presentations. Procedures differ

government differ considerably from those present in

from agency to agency, and there are often notable differ-

academic settings. For the most part, the nation’s univer-

ences between the approach spelled out in formal guid-

sities have embraced the concept of scientific freedom,

ance documents, if they exist, and what actually happens

granting their faculty the unfettered right to publish

on the ground.

their findings.

Many factors may shape research priorities and the review

Corporate control of scientific studies is a continuing issue

process, including the topic, the agency, the managerial

of concern in academia, however, especially over the past

style of those in charge, and the sensitivities of the mo-

decade as reports surfaced that research sponsors blocked

ment. Clearance procedures are generally more complex

the publication of findings detrimental to their commercial

when the work has significant policy and/or economic im-

interests on a number of occasions. 3 Such was the level of

plications, and political appointees often have an influen-

distress that the editors of thirteen of the world’s leading

tial voice in the review and approval process, whether or

biomedical journals, including The New England Journal

not they have scientific expertise. The Union of Concerned

of Medicine and The Journal of the American Medical

Scientists reported in 2008, “New and excessive analytical

Association, declared in 2001 that they would not publish

requirements have provided opportunities for industry

studies where research sponsors had the ability to control

groups to highlight uncertainty in agency science, and

presentation of the results. 4

have prevented federal agencies from responding promptly to urgent threats to public health and safety.” 5

Many universities have developed similar guidelines to
protect the independence of research, requiring faculty

Across most agencies, the many steps involved in clearance

members to retain full rights to disclose the information

often result in long delays before significant scientific find-

they gather, even if a commercial sponsor has funded

ings are widely shared. Along the way, interactions between

the work.

scientists and the media may be tightly controlled, and in
some instances the free exchange of data and results with

Scientists in government are less subject to overt com-

colleagues may be curtailed.

mercial pressures because they are on the public payroll,
but the principles and practice of open science have often

The lack of uniformity across agencies, and even among

butted against other agendas. Industry interests, interest-

offices and centers within a single agency, is striking and

group pressures, political ideology, and bureaucratic procedures all have considerable influence on the work they do.

highlights the need to explore and clarify the nature of the
rights and responsibilities accorded government scientists.
In the absence of clear policies, or in the presence of poli-

The unique challenge of government scientists is to bal-

cies that place significant restrictions on scientific freedom,

ance their work as researchers, regulators, and applied

these employees may be constrained in their ability to

scientists with their role as employees of structured, hier-

meet their obligations to the scientific community, and to

archical organizations. In particular, they may be expected

the public at large.

to represent and advocate for official agency positions,
regardless of their personal perspective on an issue. Conversely, they may be barred from presenting conclusions
or analyses that are inconsistent with an agency’s stance,
even if they are speaking as private citizens.

In the first decade of the 21st century, public concern about
political interference with science mounted. Events such as
the Food and Drug Administration’s long delay in approving emergency contraception for over-the-counter sale, 6 the
use of ideological criteria to select members of federal sci-

Government scientists are typically subject to some level

entific advisory committees, 7 and the suppression and dis-

of approval prior to launching a research project, and their

tortion of scientific findings on climate change called into

work often goes through several additional layers of review

question the integrity of government science. 8
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Under both the Bush and Obama administrations, the

aspects of the executive branch’s involvement with scien-

White House Office of Science and Technology Policy

tific and technological processes” (see box below).23

(OSTP) has taken steps to advance the openness and
integrity of scientific agencies. In May 2008, as directed

Several independent, non-partisan organizations have also

by the America COMPETES Act, OSTP released a set of

focused in recent years on scientific integrity, conflicts of in-

principles directing federal agencies to pursue “robust

terest, and the politicization of science. These organizations

In

include the American Association for the Advancement of

March 2009, in response to a Memorandum on Scientific

Science, the Government Accountability Project, the Insti-

Integrity from President Obama, OSTP began develop-

tute of Medicine, the Science and Engineering Workforce

ing a plan to “ensure the highest level of integrity in all

Project, and the Union of Concerned Scientists.

and open communication of scientific information.”

22

President Obama’s Memorandum on Scientific Integrity
In March 2009, the Obama Administration issued a Memorandum on Scientific Integrity that appeared to acknowledge
many of the concerns that have been expressed in recent years about the limitations of information dissemination and the
bias towards political considerations over scientific rigor. Specifically, the memo declared:
The public must be able to trust the science and scientific process informing public policy decisions. Political
officials should not suppress or alter scientific or technological findings and conclusions. If scientific and technological information is developed and used by the Federal Government, it should ordinarily be made available
to the public. To the extent permitted by law, there should be transparency in the preparation, identification,
and use of scientific and technological information in policymaking. The selection of scientists and technology professionals for positions in the executive branch should be based on their scientific and technological
knowledge, credentials, experience, and integrity. 23
To build on those objectives, the memo called for the Office of Science and Technology Policy (OSTP) to develop a plan to
ensure integrity in all aspects of government science, based on the following principles:
(a) The selection and retention of candidates for science and
technology positions in the executive branch should be
based on the candidate’s knowledge, credentials, experience, and integrity;

with statute, regulation, Executive Order, or Presidential Memorandum, each agency should make available
to the public the scientific or technological findings or
conclusions considered or relied on in policy decisions;

(b) Each agency should have appropriate rules and procedures to ensure the integrity of the scientific process
within the agency;

(e) Each agency should have in place procedures to identify
and address instances in which the scientific process or
the integrity of scientific and technological information
may be compromised; and

(c) When scientific or technological information is considered
in policy decisions, the information should be subject to
well-established scientific processes, including peer review
where appropriate, and each agency should appropriately
and accurately reflect that information in complying with
and applying relevant statutory standards;
(d) Except for information that is properly restricted from
disclosure under procedures established in accordance

(f ) Each agency should adopt such additional procedures,
including any appropriate whistleblower protections,
as are necessary to ensure the integrity of scientific and
technological information and processes on which the
agency relies in its decisionmaking or otherwise uses
or prepares. 23

OSTP called for public comments to inform its work, and the Project on Scientific Knowledge and Public Policy submitted
recommendations based on the preliminary results of this research. 24 OSTP did not issue a plan in mid-2009 as anticipated,
but was expected to do so in 2010.
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SCIENTISTS IN GOVERNMENT PROJECT:
SHAPING THE DEBATE

current and former federal scientists at health and envi-

The federal government must ensure that its scientists are

agency policies regarding agency research, and a litera-

able to function effectively, both so that agencies can pro-

ture review. Qualitative research is “a broad approach to

duce top-quality science to answer important questions
and so that they can attract and retain scientific talent.
Agencies must also demonstrate to the public that their

ronmental agencies, a review of publicly available online

the study of social phenomena … [drawing] on multiple
methods of inquiry,” such as structured interviews and
analysis of documents and materials. 25

scientists are working in the public’s interests and that

This study considers the barriers and opportunities for

agency management is facilitating (rather than suppress-

scientists as they set their research agendas, endeavor

ing or interfering with) the production and dissemination

to speak freely with one another, disseminate their con-

of knowledge. The public’s confidence in government sci-

clusions and the data that support them, and provide a

ence—and in the government as a whole—is at stake.

firm grounding for science-based policies and practices. It
also examines the internal and external influences on the

The Scientists in Government project was launched as
part of a larger effort to ensure that government uses
the best science to protect and promote the health and

research activities of government scientists, and includes
recommendations to enhance transparency, minimize interference, and ensure timely access to findings.

well-being of Americans. It operates under the umbrella
of the Project on Scientific Knowledge and Public Policy

The scientists who participated in this research spoke

(SKAPP) at The George Washington University School of

eloquently about their frustrations with a political and

Public Health and Health Services.

bureaucratic climate that sometimes impedes their best
work, and offered insights about the policies and practic-

With support from the Open Society Institute, the Scien-

es that can be strengthened or changed to improve their

tists in Government Project seeks to provoke and influ-

situations. Their voices are a reminder that an open ex-

ence the public discussion about federal scientists’ rights

change of information is essential to the conduct of good

and responsibilities. This report presents the results of a

science, the advancement of knowledge, and ultimately

qualitative research study that included interviews with

the strengthening of the nation’s health.

Research Questions
In exploring the role and functioning of government scientists through qualitative interviews and a review of publicly available
online agency policies, Scientists in Government researchers sought answers to the following questions:

• To what extent do agencies foster environments that
support scientific work in fulfillment of agency missions?

• What policies exist regarding research, publication, and
communication by scientists working at science-based
agencies within the federal government?

• How well do agencies facilitate the processes of conducting scientific work and disseminating results?

4 • The Scientists in Government Project

• What is the nature of agency review of scientific publications?
• Do government scientists retain their autonomy to publish
and communicate their scientific findings and conclusions?

• What is the nature of influence affecting federal scientists
and their work? How do agencies address this influence?

• Do accessible and useful feedback and dispute-resolution
mechanisms exist for federal scientists?

ings from interviews with scientists and a re-

OVERARCHING RECOMMENDATION:
ENSURING POLICY CONSISTENCY
AND CLEAR COMMUNICATION

view of several agencies’ written policies. Each

The White House OSTP and Office of Management and

recommendation section includes an overarching

Budget (OMB) should ensure that agencies adopt the

principle as well as specific recommendations to ad-

policies described in this report’s recommendations, and

dress the issues raised.

that the policies are generally consistent across agencies

Findings and Recommendations

T

he following sections describe some key find-

The recommendations address the issues around which

and appropriate within each agency’s mission and scope.

scientists expressed the most need for change. Address-

These policies should be clearly and actively communi-

ing scientists’ concerns can improve morale at federal

cated to agency leadership, scientific managers, and the

agencies, which will in turn improve scientists’ produc-

federal scientific workforce.

tivity and lead to better government. The recommendations below are often restatements of suggestions made
by multiple scientists about how to ensure that their

When OPM policies (for instance, those regarding hiring
and promotion) conflict with the recommendations in this

work proceeds efficiently and can be translated quickly

report, OPM should revise its policies to allow agencies to

into public benefits.

follow the recommendations.

While the majority of the recommendations apply to
agencies, White House offices and the Office of Personnel

MORALE

Management (OPM) also have a role to play in ensuring

Scientists’ morale affects their agencies’ productivity, as

that recommended policies are adopted. This leads to the

well as recruitment and retention. Many of the scien-

first overarching recommendation pertaining to all other

tists interviewed characterized their own morale, and

recommendations in this report.

often that of their colleagues, as being low or eroding.

Research Participants’ Agency Affiliations
Interviews were conducted with individuals who work for, or had previously worked for, the following agencies (some interviewees had work experience at more than one agency):
Agencies of the Department of Health and

Other agencies:

Human Services:

• US Consumer Product Safety Commission (CPSC)
• US Department of Agriculture (USDA)
• US Department of Commerce, including the National

• Centers for Disease Control and Prevention (CDC), including the National Institute for Occupational Safety and
Health (NIOSH) and the Agency for Toxic Substances and
Disease Registry (ATSDR)

• Food and Drug Administration (FDA), including the Center
for Drug Evaluation and Research (CDER) and the National
Center for Toxicological Research (NCTR)

• National Institutes of Health (NIH)
• Indian Health Service (IHS)
• Substance Abuse and Mental Health Services Administration
(SAMHSA)

Institute of Standards and Technology (NIST)

• US Department of Defense (DoD)
• US Department of Housing and Urban Development
(HUD)

• US Department of Labor, including the Occupational
Safety and Health Administration (OSHA)

• US Department of Veterans Affairs, including the Veterans
Health Administration (VHA)

• US Environmental Protection Agency (EPA)
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Their comments demonstrate the need to improve sev-

administrative functions, but these steps can also have

eral aspects of work at science-based federal agencies.

the result of taking scientists’ time away from their primary responsibilities.

Scientists cited their strong desire to work for the public good as a factor that drew them to government em-

•

Principles Under Threat: Of all the concerns raised in

ployment. When scientists feel that agencies are failing

the interviews, one of the most destructive to morale

to advance their missions as effectively as they should,

was an agency’s perceived relinquishment of principles.

morale suffers.

Several scientists described situations in which they or
their colleagues had taken a principled stand—e.g., ad-

During interviews, scientists described the following

vocating for a particular research agenda or project, or

issues as affecting morale at their agencies:

arguing against hiring an unqualified job candidate—

•

only to experience negative consequences. Agencies

Changing Priorities: Because each change in administration brings new personnel and priorities to
federal agencies, scientists often face abrupt changes
in research directions. Although such changes are
understandable, the effects on scientists can be harsh.
A National Institute for Occupational Safety and Health
(NIOSH) scientist described spending seven years
working on a high-profile topic, only to be told when
a new administration entered that the project was no

•

their work. If managers stand up for scientific integrity
in such cases, scientists can feel supported; however, if
managers in turn pressure scientists to abandon a line
of research or downplay certain results due to potential controversy, the scientists can fear that the agency
has lost its integrity or is failing to live up to the mission that attracted them to the job in the first place.

longer a priority and funding for it was no longer avail-

Some scientists expressed concern that eroding mo-

able. Others reported working as much as 10 or 15

rale is harming agencies’ abilities to recruit and retain

years on projects, only to have them halted before the

top scientific talent. In some cases, scientists feared

research was completed.

that while many of their agencies’ best scientists were

Bureaucratic Processes: Many scientists felt they were
spending too much time on internal processes—such

•

often face outside pressure to change the course of

leaving, others who were not serving the agency well
and should retire were staying.

as getting research proposals approved or seeking

Among the scientists who described problems with low

clearance to publish articles—and were left with too

morale, some had already retired or changed jobs. Among

little time for actually conducting scientific work. Some

those still at an agency, some stated that they remained

scientists said they also had to spend an inordinate

in their jobs because of practical considerations, such as

amount of time dealing with office politics.

impending retirements or children in need of college tu-

Inadequate Resources: Because federal employee
salaries and annual pay increases are set by the federal
government and have been rising steadily, many agencies find that an increasing share of their program and

ition. Others noted that despite problems, they appreciated the opportunity to do important work on interesting
topics that would not be available to them in academia or
the private sector.

research budgets must go to personnel costs. This

Not all scientists spoke about these problems at their

leaves scientists competing for a shrinking pool of

agencies; some praised their managers and expressed ap-

money to fund research, and they may have to pro-

preciation for the research opportunities they enjoy. Also,

duce lengthy proposals in order to get relatively small

some who described bureaucratic or budgetary frustra-

amounts of research funding. Some agencies try to

tions considered these to be acceptable trade-offs given

stretch their dollars by using fewer staff people to ac-

the stability, career development opportunities, and other

complish the same amount of work or by outsourcing

benefits that government careers provide.

6 • The Scientists in Government Project

Several interviewees recommended that scientists con-

One theme that arose during the interviews was that sci-

sidering federal-agency positions understand and accept

entists do not necessarily make good managers. Some

the constraints that will necessarily accompany govern-

scientists may seek promotion to a managerial position

ment employment. They suggested that agency scientists

for which they feel little inclination because it is the only

cultivate patience and thick skins.

way they can continue up the career ladder to higher pay
and greater responsibility. A few scientists suggested that

MANAGEMENT

scientists should have career advancement options that

One of the prominent themes that emerged from inter-

do not include managerial duties.

views was the importance of effective managers. While
some scientists praised their managers, most felt that
those above them were not doing all they could to ensure
productivity and top-quality scientific achievements.

One issue that managers may need to address is the tension that can arise between federal civil service employees and members of the Public Health Service (PHS) Commissioned Corps. In the interviews, several scientists—civil

Many of the scientists interviewed expressed strong

servants and PHS members alike—noted that tensions

views about the qualifications and roles of those whose

can arise around the different promotion and advance-

jobs involve managing scientists. Scientists from several

ment requirements the two types of employees face, and

agencies stated that managers should have enough of

these tensions can harm morale.

a background in science to understand what the scientists they supervise are doing and why. Managers should
also be able to explain work conducted by scientists to

RECOMMENDATIONS: MANAGEMENT

non-scientists, including other agency officials and the

PRINCIPLE: Agencies should hire and promote managers

lawmakers who determine agency budgets and shape

who have the training and skills necessary to facilitate sci-

research priorities.

entists’ ability to conduct and disseminate research.
Recommendation: Agencies should recruit and train man-

“We need supervisors who have the
courage to speak up for the science.”

agers who will buffer scientists against undue influence and

– CDC branch chief

Recommendation: Agencies should hire managers who

ensure that the agency pursues its scientific mission.

have enough scientific training to translate between scientists and upper management and policymakers.
It appears that managers need a combination of political
skills and toughness to perform what many scientists see
as a crucial role: standing up for science and buffering sci-

Recommendation: Agencies should provide management training to those who will be managing scientists.

entists from political pressures. Some scientists expressed

Recommendation: Agencies should not require scientists

disappointment and frustration with managers who they

to become managers in order to advance in their profes-

felt were too quick to yield to pressure to avoid or mini-

sional careers.

mize controversial topics or findings. Others expressed
appreciation for managers who resisted such pressure

Recommendation: Agencies should evaluate and address

and defended scientific integrity.

perceived and real inconsistencies in the treatment of scientists on different career pathways (e.g., PHS vs. civil servants).

Managers may also need to resist pressure from agency
leadership to create additional administrative tasks for

Recommendation: Agencies should minimize adminis-

scientist that will detract from their scientific work with-

trative duties that detract from scientists’ ability to con-

out adding commensurate value to the agency.

duct their work.
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“We are all scientists and we want to give our input, and we feel neglected or
dismissed if we are not asked our opinion.”
– NIOSH medical officer

FEEDBACK MECHANISMS

Recommendation: Provide a formal and anonymous

Managers at all levels could benefit from hearings sci-

means by which scientists can provide feedback to rel-

entists’ concerns and suggestions, but interviews sug-

evant colleagues, including upper management, without

gested many agencies’ current mechanisms for collect-

fear of retaliation.

ing feedback are insufficient.

Recommendation: Provide regular and follow-up train-

Many scientists felt that their observations and sugges-

ing to ensure that all managers and supervisors are prop-

tions could be useful in improving agency policies and

erly trained to understand employees’ rights and to com-

practices, but were frustrated by a lack of opportunities

ply with the procedures that protect whistleblowers.

to provide feedback in a meaningful way. A few scientists provided examples of existing feedback mecha-

APPROVING PROPOSED RESEARCH

nisms they considered to be effective, but many others

Science-based agencies have a limited amount of fund-

stated that the mechanisms either did not exist or were

ing to devote to specific research projects, so they often

not useful, either because scientists would not use them

develop processes by which scientists essentially apply to

for fear of retribution or because those who could ben-

their own agencies for intramural funding. Publicly avail-

efit from the feedback would ignore the results.

able online policies governing the selection or approval

Scientists from several agencies stressed that feedback
mechanisms must allow for anonymity, since many employees fear that stating criticisms openly could pro-

of such intramural research projects are markedly less formal than those in place for extramural research (in which
outside entities apply to an agency for research funding).

voke retaliation. Several scientists feared that criticiz-

At the intramural level, the most consistent policy state-

ing agency management could lead to losing funding

ment across agencies is that proposed, and sometimes

or other project support, being transferred to a less

ongoing, intramural research studies will be reviewed

desirable location or position, and facing even more

by experts. The Centers for Disease Control and Preven-

obstacles to getting research done. Some scientists

tion (CDC) and NIOSH’s Mining Program specifically note

had either experienced such retaliation or witnessed a

that those reviews are undertaken by “external” experts.

colleague experiencing it.

NIOSH’s Mining Program specifies that the reviewers

The Whistleblower Protection Act is designed to protect

must be “technical experts in their fields,” 64 while CDC

those “evidencing illegal or improper government activi-

refers to “subject matter experts”; 65 both agencies’ poli-

ties”; however, a few scientists reported either acting as

cies state that these external reviewers should be free

whistleblowers or witnessing a colleague’s whistleblow-

from conflicts of interest. At the National Institutes of

ing, and they stated that these protections were inade-

Health (NIH), research program priorities are shaped, in

quate to prevent retaliation.

part, through “professional hiring and promotion decisions” and resource allocation decisions. 66

RECOMMENDATIONS: FEEDBACK MECHANISMS

At the research planning stage, none of the publicly

PRINCIPLE: Agencies should encourage honest feedback

available online policies reviewed for this study describe

from scientists, and use it to inform decisions about poli-

additional procedures for evaluating confidential or sen-

cies and practices.

sitive topics.

8 • The Scientists in Government Project

The relatively brief descriptions contained in publicly

DISSEMINATING SCIENTIFIC WORK

available online agency policies related to intramural re-

In general, scientists throughout the federal science in-

search contrast with the complicated review processes

frastructure feel a strong obligation to disseminate their

described by scientists at NIOSH, other CDC agencies, and

findings to other scientists, and to the general public, in

elsewhere. In particular, interviewees note that the lag

a timely manner. A number of government employees

between a proposed idea and approval to move forward

commented that they work for the public, and the public

is often long. Agencies may require detailed applications

has a right to see their results, “since it is their tax dollars

and extensive review processes even when the amount

that are paying for the research in the first place.”

of funding being sought is small. Several NIOSH interviewees raised concerns about this issue, and their experience is described in the box on the next page.

Likewise, federal agencies typically consider it part of
their mission to disseminate scientific information to the
public, and encourage their employees to do so. In agen-

Federal scientists conducting surveys must also receive

cy policies publicly available online, some agencies state

clearance from OMB. The Paperwork Reduction Act, first

that all information products must be cleared before be-

passed in 1980 and amended in 1995, established a pro-

ing published or released. Others allow their centers to set

cedure for federal agencies to follow before initiating a
collection of information (e.g., a survey) from 10 or more

their own requirements, and do not specify that all information products must be reviewed.

people. The agency must provide a 60-day notice of its
proposed information collection in the Federal Register

Clearance

and solicit comments to “evaluate whether the proposed

Most federal scientists must submit scientific materials for

collection of information is necessary for the proper per-

clearance before disseminating them or submitting to a

formance of the functions of the agency” and to “mini-

journal. This process may involve review by several people

mize the burden of the collection of information on

at different levels within the agency.

those who are to respond.”

67

Although OMB has made

some improvements to the process by which it evaluates requests to collect information, some scientists still
considered the process to be excessively burdensome.

Agencies generally require internal review in addition to
peer review required by the journals to which scientists
submit manuscripts. The review will usually address the
science, and it may also determine whether the information product has policy implications and demonstrates a

RECOMMENDATIONS:
APPROVING PROPOSED RESEARCH

high standard of editorial quality. Policies at the Depart-

PRINCIPLE: Agencies should limit the time and effort

logical Survey (USGS) require that products be well con-

required by scientists proposing research to what is

structed or well written in order to be cleared.

necessary to ensure that the agency is supporting highquality research.

ment of the Interior (DOI) and DOI’s United States Geo-

At many agencies, the nature of the information product will influence the nature of the review process. The

Recommendation: Agencies should streamline intramu-

review process for research with policy implications

ral proposal processes to the extent possible.

typically involves more layers and takes longer to complete—something that scientists say can restrict the

Recommendation: Agencies should make the time and

publication of research that challenges the status quo.

effort required to propose research commensurate with

Under the Information Quality Act of 2001, higher stan-

the amount of funding being sought.

dards are in place for “influential” scientific information

Recommendation: OMB should streamline the process

as defined by the OMB.

for approving information collections subject to its over-

Scientists described clearance processes that often

sight, and facilitate the process for the scientists involved.

included review by multiple individuals and entailed
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NIOSH Scientists Describe Their Agency’s Research Approval Process
At NIOSH, research projects must be determined to fit within the agency’s National Occupational Research Agenda (NORA),
which includes 21 priority research areas.
During interviews, NIOSH scientists described a lengthy process for seeking NORA funding. Researchers now submit a onepage letter of intent that includes a list of collaborators, a budget, preliminary data, and the NORA sector goals it is designed
to meet. If the idea is of interest, researchers are asked for a full proposal that uses a format and instructions similar to that
of a full extramural NIH proposal; it may be 100-200 pages in length. Far more proposals are invited than are ultimately
funded – one interviewee recalled that in one funding round, 18 of the original 100 letters of intent were funded. Reflecting
the commitment to move research into practice, a relatively recent requirement is to provide in the proposal a description
of how study results will be used.
The proposal then moves through a lengthy approval process that begins with an internal review that typically involves the
team leader, branch chief, and a number of people in the researcher’s division, including the associate director of science. It is
also reviewed by the Institutional Review Board, and by a person at CDC who is intimately familiar with OMB regulations.
According to scientists, the proposal may also go to OMB, which can request changes and require that the scientist revise
and resubmit the proposal. Following OMB review, it may have to be returned to the IRB for approval of a revised research
strategy before data collection can begin.
Scientists reported that full approval can take up to 2-1/2 years, which can be problematic. One scientist commented, “The
relevance and collaborators can change during this time.”
A NIOSH research chemist called the process “extremely onerous,” especially for projects that do not have a lot of money
at stake (there is no distinction in the process by funding level). “It takes up huge blocks of time . . . I put together a 50-page
proposal, single-spaced, for a project that was giving me $15,000 a year . . . Does that make sense?”
The process can also create “a negative work environment,” noted the research chemist. “If you spend a lot of time competing for funding and you never get any, what work are you then hired to do?”
On the other hand, some scientists said they appreciated the NORA process because once they are funded, they are not likely
to be asked for further information from their supervisors. Whether this outcome occurs seems to depend on the individual’s
managers and the division in which the scientist is located.

multiple requests for revisions or responses from au-

policies. This seemed to be a problem for scientists at

thors. A number of scientists stated that they could un-

the Food and Drug Administration (FDA) in particular.

derstand the need for the process and had benefited
from reviewers’ feedback. Others found the benefits of
the process to be outweighed by problems.

Several interviewees suggested that an individual’s experience with the clearance process depends in part on
his or her rank.

Scientists expressed frustration about a lack of clarity

The issue of reviewers’ qualifications also arose in sev-

and consistency regarding the clearance process. Some

eral interviews. Scientists repeatedly stressed that a

were concerned about a lack of consensus about what

scientific review should be conducted by scientists.

constitutes policy; a number felt their agencies only

They also noted that the requirement to respond to all

wanted results that supported their predetermined

reviewers’ comments can place significant demands on

10 • The Scientists in Government Project

scientists’ time, although not all comments are neces-

Concerns about information products becoming bogged

sarily useful or relevant.

down in lengthy clearance processes prompted Congress
to specify a firm timeline for clearance of FDA publica-

Scientists mentioned a number of incidents in which
the clearance process appears to have been used to
delay or prevent the publication of research because of
industry concerns or agency fears about the publication igniting controversy.
Delays
Many scientists expressed frustration about the timeconsuming nature of their agencies’ clearance processes.
Some stated that lengthy, complicated processes discourage some of their colleagues from publishing. Others reported that agency scientists will remove their
names from papers co-authored with others outside the

tions in the FDA Amendments Act of 2007. The legislation
requires an FDA policy that gives reviewing officials 30
days to provide written clearance. If the deadline is not
met, authors can submit the article for publication with
the appropriate disclaimer.
Disclaimers
The use of disclaimers on information products can provide an opportunity for scientists to disseminate their
work without going through an agency approval process.
It is common for agencies to require that employees publishing or presenting scientific work relevant to their jobs
but not cleared by the agency include a statement indi-

agency in order to spare their colleagues the agency’s

cating the work is the product of an individual scientist

lengthy review process.

and does not represent the views of the agency.

Scientists report a range of typical approval times. In some

The use of disclaimers can be problematic, however, if

agencies, scientists say it might take three to four weeks;

they are required even when the research has been

for others, three to four months is typical. Delays of a year

reviewed and cleared by agency officials. Interviewees

or even two were also reported. In some instances, delays

reported that NIOSH and the Environmental Protection

reflect the complexities of research or proprietary and

Agency (EPA) National Center for Environmental Assess-

confidentiality concerns, but comments from scientists

ment require that all publications and presentations in-

suggest that research with significant policy implications

clude a disclaimer. This seemed counterintuitive to many

is particularly likely to be delayed.

scientists, who wondered why an agency would fund the

At NIOSH, scientists say papers are subject to a “tripartite

research and then not attach its name to the findings.

review” by the affected industry, labor, and government

The NIH policy states that the clearance process normally

agencies (in addition to internal staff ), which can take an

eliminates the need for a disclaimer, but one may still be

additional 3-6 months.

required to make clear that the work does not necessarily

Some agencies’ policies acknowledge potential problems

represent the NIH view.

with lengthy clearance processes and urge those respon-

The issue of scientific publications produced on scien-

sible for developing and implementing the processes to

tists’ personal time also arose during the interviews. Even

make review times as short as possible. Some agencies

though such publications usually include a disclaimer

have policies specifying the time frame in which the clear-

stating that the work represents only the view of the au-

ance is to be completed, although they differ consider-

thor and not that of the agency where the author is em-

ably in the extent to which they cover all of the required

ployed, a few agencies still require scientists to submit

clearance steps.

these publications for agency clearance.

CDC’s policy calls for clearance standards that “balance
that should generally not exceed one month (unless the

RECOMMENDATIONS:
DISSEMINATING SCIENTIFIC WORK

author is asked to make revisions). 74 In practice, scientists

PRINCIPLE: Agencies should disseminate scientific work

report that delays in the clearance process are common.

in a timely fashion, and the clearance process should not

the concerns of quality and timeliness,” and a timeline
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be a tool for slowing down the dissemination of scientific

public, subject to classification restrictions and consis-

information that may be deemed unfavorable.

tent with existing laws and regulations, scientific and
technical ideas, approaches, findings, and conclusions

Recommendation: All agencies should have clear poli-

based on their official work.” 22

cies on review and clearance, and apply them consistently
and in a timely fashion.

Agency policies publicly available online are not entirely
supportive of such free and open discussion. The policies

Recommendation: Agencies assigning reviewers to re-

tend to require, or strongly encourage, employees to

view the content of scientific output should ensure that

seek prior approval before being interviewed. However,

the reviewers have expertise in a relevant field.

many agencies appear to offer little or no guidance

Recommendation: Agencies should encourage expeditious and focused reviews.

on the subject, and the perception among scientists
at most agencies is that some sort of preapproval is
required to speak with the media.

Recommendation: Agencies should have processes for
expedited clearance of time-sensitive materials.

In interviews, a picture emerged of a common agency
practice requiring that all media inquiries be routed

Recommendation: Agencies should allow scientific work

through a central office. This prevents scientists from

conducted on agency time but not approved by the

speaking directly to reporters until the media office

agency within a reasonable timeframe to be published

determines which agency employee should respond.

with a disclaimer that it represents only the views of the
author(s) rather than the agency.

In some scientists’ view, this practice is a necessary
step to ensuring that the agency speaks to the pub-

Recommendation: Agencies should allow scientists to

lic with a single voice. Others questioned the appro-

disseminate scientific work done on their own time, pro-

priateness of having a manager or political appointee

vided they attach any necessary disclaimers, without re-

answer questions about scientific work they may not

ceiving agency approval. Scientists should not face retri-

fully understand, and some expressed frustration that

bution if they exercise this right.

they may devote a great deal of time to a project but
not be the one speaking about it.

COMMUNICATING WITH THE PUBLIC

Some scientists appreciate having a media office to

The primary method by which scientists communi-

handle press calls when they do not view themselves

cate their findings to the public is through the media,

as having the necessary skills to respond. Scientists

and the policies governing scientists’ interactions with

noted the complexity of interacting with the media,

reporters have come under scrutiny in recent years. In

and those working on potentially controversial topics

2008, OSTP instructed agencies to develop and update

were particularly concerned about saying the wrong

policies regarding employee interactions with the pub-

thing in a media interaction. According to the scien-

lic and press. The policies should be designed to ensure

tists, some agencies offered strong media training but

that “employees may freely and openly discuss with the

others did not.

“We are still arguing about disclaimers … If they’re saying we don’t speak for
the agency, why can’t we just say anything we want? Instead, it still has to be
cleared.”
– CDC branch chief

12 • The Scientists in Government Project

“I would prefer to provide the information to the media … Otherwise information
gets lost in translation.”
– VHA health systems specialist

In addition to deciding who should respond to press

relationships, receive feedback on projects, and learn

inquiries, some agency media officials also make a

about new developments in their fields. Nonetheless,

practice of being on the line or in the room with any

many scientists felt their agencies did not fully appreci-

scientist being interviewed. Although not all of the

ate the benefits of attending scientific meetings.

scientists who described this practice found it to be
intrusive, some see it as potentially having a chilling
effect on what scientists say.

While some agencies actively encourage their scientists
to attend outside meetings and conferences, others are
reluctant to do so. Scientists reported that in recent years,

RECOMMENDATIONS:
COMMUNICATING WITH THE PUBLIC

funding restrictions have reduced the number of meetings
they can attend. Most scientists interviewed indicated they
could attend one or two professional meetings or confer-

PRINCIPLE: As directed by the OSTP principles, agencies

ences a year; however, a few scientists mentioned that they

should develop policies that “provide for the widest prac-

had not attended a meeting in recent years and did not

ticable and appropriate dissemination of factual informa-

know when their next chance would arise.

tion concerning agency scientific activities and their results” and ensure free and open discussion.

CDC and NIOSH scientists explained that restrictions have
recently been placed on the number of employees of their

Recommendation: Agencies should have clear policies

agencies who could attend any single conference. This

on scientists’ communication with the media and the

caused particular frustration in the case of the industrial

public, and ensure that they are understood and consis-

hygienists’ annual conference. One scientist reported that

tently enforced.

approximately 90 NIOSH employees had customarily at-

Recommendation: Agencies’ default policy should be

tended this event (since NIOSH employs more industrial

to allow scientists to handle media inquiries directly and

hygienists than any other federal agency), but a CDC offi-

interact with reporters without the presence of media

cial had decided that only 12 should attend.

office representatives; under certain circumstances (e.g.,
when the topic is a policy rather than technical issue)
it may be necessary for the media office to play a more
central role.

Participation is sometimes contingent on presentation
of a paper at the meeting the scientist wishes to attend.
Scientists working on multi-year projects, or those whose
agencies have lengthy clearance processes for presenta-

Recommendation: Agencies should not require scientists

tions, may find this a difficult requirement to meet. NIOSH

to speak with the media; those who wish to do so should

scientists indicated that conference participation is not

be offered media training or be allowed to shift inquiries

supported until a scientist is ready to submit a manuscript

to the media office.

to a journal for publication.
Scientists at higher levels within some agencies seem to

PROFESSIONAL DEVELOPMENT

have an easier time securing money and time for travel,

Interactions with colleagues from scientists’ disciplines

which can frustrate their lower-ranking counterparts.

are crucial for professional development. For many

Lower-ranking scientists commented that those who were

scientists, attendance at professional meetings is the

allowed to attend the most meetings tended to be those

most important way for them to build professional

who were the most trustworthy in the eyes of the agency.
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Several scientists reported that they will pay for their own

about issues that both agencies study. One FDA scientist

attendance at professional events if their agencies will

stated that contacts with colleagues at other agencies to

not cover the costs, and may even use vacation time to

discuss scientific topics are prohibited.

attend conferences and meetings.

RECOMMENDATIONS:
PROFESSIONAL DEVELOPMENT
PRINCIPLE: Scientists should be encouraged to main-

RECOMMENDATIONS: INTER-AGENCY DATA
SHARING AND COMMUNICATION
PRINCIPLE: Scientists should be able to communicate and
share data freely and efficiently across federal agencies.

tain their professional standing and pursue professional
development through engagement with their sci-

Recommendation: Agencies should develop and commu-

entific colleagues, to the extent possible given their

nicate clear policies on data sharing.

agencies’ resources.

Recommendation: Agencies should end explicit or perceived prohibitions on inter-agency communications.

“There should be a commitment to
professional development … there
should be resources to do that. Managers should recognize that is part of
their job, to get those resources.”
– HUD manager

Recommendation: Agencies should examine the need for
establishing MOUs with other agencies before data sharing
occurs; when MOUs are deemed necessary, they should be
developed quickly and in a straightforward manner.
Recommendation: Agencies should identify ease of
data sharing as a priority when making decisions about
data systems.

Recommendation: Agencies should ensure that requirements determining which scientists are eligible for sup-

INFLUENCE

port to attend professional meetings and conferences are

Federal-agency science is subject to influence from the

flexible, appropriate, and applied consistently.

public, private, and political arenas, particularly with regards to which topics are researched and how scientific

Recommendation: Agencies should allow all scientists for

information is disseminated. Most scientists found these

whom attendance at a particular meeting is appropriate to

influences burdensome, especially when they were asked

attend without imposing arbitrary limits on the total num-

to redirect their work based on what one scientist re-

ber of employee attendees.

ferred to as “political whims.” At the same time, some interviewees noted that such influences are inescapable for

INTER-AGENCY DATA SHARING
AND COMMUNICATION

scientists employed by the federal government, and that

Some scientists also noted the importance of interact-

ate and may be beneficial.

ing with colleagues from other federal agencies on topics
of common interest. Accessing data from other agencies
can be difficult due to both technological and bureaucratic hurdles; incompatible data systems and restrictive Memoranda of Understanding (MOUs) between
agencies were two of the problems raised.

a certain amount of input from stakeholders is appropri-

Many governmental processes are designed to allow for
input from groups who are affected by government action
or inaction on a particular issue. Scientists noted that it is
often appropriate for private- and public-sector groups to
communicate with federal agencies to share their experiences and expertise on particular issues that an agency

A few scientists also stated that they were discouraged

may be studying. They differentiated between such ap-

from contacting colleagues at other agencies directly

propriate activities and what they considered to be undue
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influence—for instance, asking an agency to deviate from

influenced by the private sector. In general, scientists

standard scientific procedures. Most scientists expressed

expressed more concern about private-sector influence

concerns about undue influence compromising scientific

than public-sector influence, but not all of the scientists

integrity in some specific instances at their agencies, and

interviewed felt that industry groups exerted inappropri-

a few considered it a systemic problem.

ate or outsized influence.

Political Influence

Multiple scientists gave examples of particular reports

Many interviewees cited examples of Congress exercis-

or data that they were instructed not to release because

ing influence over agencies’ work. Often, members of

the information was unfavorable to an industry. A few

Congress will direct an agency to study a health issue

scientists stated that when they or a colleague released

that is of concern to a member’s constituents—even

such unfavorable information despite warnings, harmful

if that requirement comes without additional fund-

career repercussions followed. A scientist from US De-

ing and may draw resources from work that scientists

partment of Agriculture (USDA) and another from FDA

see as more important for the public’s health. Fears of

felt that private-sector influence was so pervasive that

Congressional disapproval, which may lead to reduced

their agencies were now doing more to serve regulated

funding or greater restrictions for an agency, can also

industries than the public.

discourage agencies from addressing controversial
topics or releasing complete research results.

navigate, and about additional reviews from lawyers

“I used to think that politics had
nothing to do with what we do here,
when I was very new … [But] politics
are more important than I thought
… They influence what the agency
chooses to pursue to research.”

and policy specialists that scientists find unhelpful to

– NIOSH team leader

Influence from government players can also operate
subtly. Changes in agency leadership often spell new
scientific priorities and management styles, which can
subject scientific work to new research directions and
requirements. Several scientists expressed concerns
about additional layers of bureaucracy that they must

advancing agencies’ scientific goals.
Several scientists also brought up the difficulty of get-

Scientists did not seem to fear that public-sector groups

ting their work cleared by OMB, which often raises

exert undue influence over agency decisions about dis-

questions about particular elements of scientific infor-

seminating scientific work, although a few interviewees

mation products; one scientist reported that OMB had

expressed frustration about what they saw as unfounded

insisted that a large amount of exposure information

criticism from advocacy groups about agency science be-

be deleted from a report, and the agency felt it had no

ing slanted in favor of industry. Scientists noted that pres-

choice but to comply. Since agencies must continue

sure from advocacy groups—particularly those focused on

working with the same OMB staff members, they have

specific diseases—can influence research priorities. Such

an incentive to maintain harmonious relationships and

influence may not be problematic if it keeps an important

may tailor their work based on expectations of what

health issue on Congressional or agency priority lists.

that office will object to.
Groups’ ability to influence agency science can fluctuate
Private- and Public-sector Influence

over time. Scientists who worked with tribal groups noted

During interviews, scientists provided numerous exam-

that American Indians have historically had little say in

ples of cases in which they felt that members of Con-

research conducted in and around their tribes, but new

gress and agency leadership were exerting influence

mechanisms for soliciting tribal input are helping to ad-

on scientists because these officials were themselves

dress this shortfall. By contrast, NIOSH scientists reported
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decreased participation from affected workers in agency
research about workplace hazards.

“The primary concern at USDA is
industry, not public health.”

RECOMMENDATIONS: INFLUENCE

– USDA division director

PRINCIPLE: Agencies should protect scientific work from
inappropriate influence.
Recommendation: Agencies should adopt policies and
training programs for both managers and scientists that

A majority of respondents reported that there had been

affirm agency commitment to scientific integrity and help

no change in the areas of access to data, research review

employees distinguish between appropriate and inap-

processes, publication/review clearance processes, scien-

propriate influence on scientific work.

tists’ communication with the media and the public, and

Recommendation: Agencies should have policies in place

scientists’ ability to attend meetings and conferences.

to ensure transparency regarding input from political actors

In three other areas, responses indicated that some

as well as private- and public-sector stakeholders.

scientists perceive improvements. Although 50% of
respondents believed there to be no change in the

FOLLOW-UP SURVEY

agency providing a supportive workplace, 20% of the

To investigate effects that a new administration might be

respondents did report a change for the better. To the

having on scientists’ views of the topics covered during

question about scientists’ ability and willingness to

the interviews, we conducted an online follow-up survey

provide feedback, 33% reported improvement. And, ac-

during July and August 2009, approximately six months

cording to 30% of respondents, the overall work environ-

after the Obama administration began. The research team

ment has changed for the better.

used the online survey service Zoomerang 28 to disseminate, collect, and analyze the anonymous survey.

Despite indications that some scientists perceive improvements at their agencies, comments reflected a belief that

Of the 30 scientists who responded, 18 are currently

change comes slowly, if at all, to federal agencies. Some

employed by the federal government at one of the fol-

scientists felt that entrenched managers and civil-service

lowing agencies: Veterans Health Administration (VHA),

leadership would hamper improvements, and several

Indian Health Service (IHS), CDC (including NIOSH),

noted that funding concerns have not abated and may

USDA, or EPA.

worsen further.
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“[I don’t anticipate much change] because the bureaucratic system in place during
the previous administration is now ensconced in our agency.”
– Scientist responding to follow-up survey

Conclusion

T

•

ate new research and to allow for publication or oth-

he roles and responsibilities of scientists who

er dissemination of research results, with or without

work for the federal government in science-based

disclaimers;

agencies cannot be simplified into a sound bite

or single issue. This study and the recommendations

Minimizing the bureaucratic maze needed to initi-

•

that have emerged from it call for ensuring a balance

Providing the opportunity for scientists to communicate with the public, while also providing any support

that will protect the fundamental principles of scientific

or training that scientists need to improve their skills in

method, integrity, freedom of inquiry, and dissemination

public communication;

of results as well as one that will achieve the missions
and goals of the scientific agencies as established by our

•

elected representatives.

other agencies and with the larger scientific community, including sharing of data and professional op-

The commitment and pride of scientists who work in fed-

portunities; and

eral agencies is remarkable. Their dedication to the public
mission of our health and environmental agencies was

Promoting engagement with federal scientists at

•

Minimizing the impact of inappropriate influence

demonstrated repeatedly throughout this study. Individual

from non-scientific directions, while recognizing the

scientists within federal agencies, their managers, agency

appropriate roles of elected officials and the public

leaders, the relevant offices at the White House, and Congress all play critical roles in creating a work environment
that promotes the morale and productivity of the scientific
workforce that ultimately benefits the public.
The principles that are outlined in this report start with
valuing the scientific workforce and establishing policies
that are consistent across the federal government while
being tailored appropriately for the mission and scope of

in shaping the missions, scientific work, and policies
of the agencies.
Concerns about scientific integrity and the politicization
of science have been raised across several administrations, and peaked during the first decade of the 21st century over issues ranging from climate-change research
and reproductive-health issues to regulatory standards.

each agency. Transparency, consistency, and accountabil-

It is notable that in follow-up research conducted after

ity must be key elements in these policies.

the 2009 inauguration, several scientists who participated in this research did not anticipate that the change

The OSTP, along with the OMB, should bring agencies’

in administration would significantly alter their agen-

leadership together to establish common policy ap-

cies’ approach to science. Change in large agencies with

proaches. Specific policies should address

hierarchical structures is difficult and takes time. This

• Improving

management training and overall man-

presents a challenge to both the new leadership and the

agement approaches for scientific projects and staff,

existing career scientists to initiate and maintain new

including promoting opportunities for honest feed-

strategies and approaches for improving and sustaining

back without fear of retaliation;

the scientific workforce.
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Methodology

T

he Scientists in Government Project, launched
by the Project on Scientific Knowledge and Public Policy (SKAPP) with support from the Open

Society Institute, seeks to contribute to the public discussion about federal scientists’ rights and responsi-

From May 2008 through January 2009, 37 structured,
in-depth, confidential interviews were conducted by a
researcher trained in qualitative research methods with
individuals who work for, or had previously worked for,
the following agencies (some interviewees had work experience at more than one agency):

bilities. This report presents the results of a qualitative

Agencies of the Department of Health and

research study that included:

Human Services:

•

•

•

Structured, in-depth interviews with current and for-

Centers for Disease Control and Prevention (CDC),

mer federal-agency scientists, which were transcribed

including the National Institute for Occupational

and coded using themes derived from Grounded

Safety and Health (NIOSH) and the Agency for Toxic

Theory;

Substances and Disease Registry (ATSDR)

a review of publicly available online agency policies

•

Food and Drug Administration (FDA), including the
Center for Drug Evaluation and Research (CDER) and

regarding agency research; and

the National Center for Toxicological Research (NCTR)

•

a literature review.

•

National Institutes of Health (NIH)

•

Indian Health Service (IHS)

•

Substance Abuse and Mental Health Services Admin-

The report considers the barriers and opportunities for
scientists as they set their research agendas, endeavor to
speak freely with one another, disseminate their conclusions and the data that support them, and provide a firm

istration (SAMHSA)

grounding for science-based policies and practices. It also
examines the internal and external influences on the re-

Other agencies:

search activities of government scientists, and concludes

•

US Consumer Product Safety Commission (CPSC)

interference, and ensure timely access to findings.

•

US Department of Agriculture (USDA)

An advisory committee composed of five scientists ex-

•

US Department of Commerce, including the National

with recommendations to enhance transparency, minimize

Institute of Standards and Technology (NIST)

perienced in working with federal-agency scientists provided advice and input to assist with the development of
an interview guide and research-participant recruitment.
Two informational interviews with experts in the field val-

•

US Department of Defense (DoD)

•

US Department of Housing and Urban Development

idated the interview guide. A literature review provided a

(HUD)

foundation and rationale for the interviewing process.

•
The research team recruited interview participants who

US Department of Labor (DOL), including the Occupational Safety and Health Administration (OSHA)

held advanced degrees and had at least five years of experience working in a scientific capacity for a federal agency

•

Veterans Health Administration (VHA)

that focuses on health or the environment. The criterion of
working for a health or environment agency was broadened to include persons who may not have been working

US Department of Veterans Affairs, including the

•

US Environmental Protection Agency (EPA)

specifically at this type of agency, but whose work was re-

The term “agency” when used in this report refers

lated to health or the environment.

not only to agencies but to departments (e.g., the US
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Department of Agriculture) and to offices, institutions,

for research, publication, and communication with the me-

or bureaus (e.g., the National Institute for Occupational

dia and the public by scientists employed at federal agen-

Safety and Health)—in short, to any organization that

cies. We found relevant policies regarding at least one of

derives its authority from federal law.

these activities from the following agencies and centers:

To investigate effects that a new administration might be

•

the interviews, an online follow-up survey was conducted
(using the online survey tool Zoomerang) 28 during July

Agricultural Research Service (an agency of the US
Department of Agriculture)

having on scientists’ views of the topics covered during

•

Center for Drug Evaluation and Research (a center of
the Food and Drug Administration)

and August 2009, approximately six months after the
Obama administration began.

•

Centers for Disease Control and Prevention

The 37 participants had experience working for 13 dif-

•

Environmental Protection Agency

•

Food Safety and Inspection Service (an agency of the US

ferent agencies, for a total of 55 agency work experiences (see Table ES-1). It is noteworthy that 12 of the par-

Department of Agriculture)

ticipants have experience working for NIOSH, which is
part of CDC. In addition, five participants were members

•

of the Public Health Service (PHS) Commissioned Corps;

National Institute for Occupational Safety and Health (an
institute of the Centers for Disease Control and Prevention)

members of the PHS work for a variety of agencies with-

•

National Institutes of Health

while serving in the Commissioned Corps.

•

US Department of Agriculture

Information about participants’ sex, race, and age was

•

US Department of Interior

•

US Geological Survey (a bureau of the Department

in the Department of Health and Human Services (HHS)

compared to corresponding information from the US
Office of Personnel Management (OPM) Demographic
Report of 2006

62

regarding government employees in

the “professional” category, whose description matched
the study’s recruitment criteria most closely. Compared
to government employees in the “professional” category,
the group of study participants included more males,
more employees older than age 45, and fewer employees
who identify as belonging to a minority group.

of Interior)
Qualitative research is “a broad approach to the study
of social phenomena … [drawing on] multiple methods of inquiry,” including structured interviews and
analysis of documents and materials. Qualitative research also has limitations. 25 One of these is funding,
which determines the amount of time a researcher can

Because the OPM report does not calculate average

devote to a project. Ultimately, qualitative researchers

length of government service for the professional catego-

aim to reach the point of data saturation; however, a

ry alone, we used the average number of years of service

researcher is never absolutely certain that it has been

for all federal employees, which is 14.6 years. Our partici-

attained. Qualitative research does not employ nor as-

pants had a longer average length of service, 16.9 years.

pire to have a representative sample; rather, validity
and reliability are achieved by rigorous application of

The team then searched online for policies from health-

field methods and analysis, especially recruitment for

and environment-focused agencies regarding procedures

the characteristics being researched.
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Table ES-1: Number of Interviewees with Experience at Various Federal Agencies
Agency

Number of Participants

US Department of Health & Human Services (HHS) ......................................................................................................................................34
Centers for Disease Control & Prevention (CDC), including the Agency for Toxic Substances
& Disease Registry (ATSDR) and National Institute for Occupational Safety & Health (NIOSH) ................20
Food & Drug Administration (FDA), including the Center for Drug Evaluation &
Research (CDER) and the National Center for Toxicological Research (NCTR) ................................................ 6
Indian Health Service (IHS) ................................................................................................................................................ 3
National Institutes of Health (NIH) .................................................................................................................................. 4
Substance Abuse & Mental Health Services Administration (SAMHSA) ........................................................... 1
US Consumer Product Safety Commission (CPSC) ............................................................................................................................................1
US Department of Agriculture (USDA) ..................................................................................................................................................................3
US Department of Commerce, including the National Institute of Standards &
Technology (NIST) .........................................................................................................................................................................................................1
US Department of Defense (DoD) ...........................................................................................................................................................................4
US Department of Housing & Urban Development (HUD) ............................................................................................................................1
US Department of Labor, including the Occupational Safety & Health Administration (OSHA) ......................................................1
US Department of Veterans Affairs, including the Veterans Health Administration (VHA) ................................................................2
US Environmental Protection Agency (EPA) ........................................................................................................................................................8
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Introduction

T

he search for truth, Albert Einstein has said, also

An analysis of the approach to science taken by the five

implies a duty: “One must not conceal any part of

White House administrations that preceded that of Presi-

1

what one has recognized to be true.”

This statement serves not only as a guiding principle of
good science, but as a framework for effective, science-based
policy-making. The best public policies are built on a foundation of rigorous data and analyses, widely shared among
scientists and the public. The fundamental obligations of a

dent Barack Obama explains, “It is naïve to believe that
scientific findings are the sole determinant of policy …
Much of the funding, direction and use of American science is determined by the federal government and the
political biases of the dominant party invariably influence
the decisions that get made.”2

science-based society—advancing the public health, pro-

Policy decisions may be based on science, but they are

tecting the workforce, safeguarding the environment, devel-

not purely scientific. Preferences and political consider-

oping appropriate energy technologies, defending the na-

ations shape decisions about regulation, research pri-

tion, and much more—depend on a full and open exchange

orities, service delivery, and program development and

of ideas, methods, findings, and interpretations.

evaluation. Nonetheless, the integrity of the science and

New scientific knowledge constantly builds on existing

the validity of the data that inform these decisions must

scientific knowledge. When information is readily shared,

be preserved.

new findings can be analyzed and new hypotheses vetted in an ongoing process that continually generates
opportunities for further study and analysis. Science
flourishes when scientific ideas are given a fair hearing
by colleagues, debated on their merits, tested through

Pressures on Scientists

T

he pressures and constraints facing scientists
within government differ considerably from those
present in academic settings. For the most part, the

replication and further research, and revised in light of

nation’s universities have embraced the concept of scien-

new understanding.

tific freedom, granting their faculty the unfettered right to

In all that, there is a direct public benefit. Safety and effec-

publish their findings.

tiveness studies are essential to drug approval decisions,

Corporate control of scientific studies is a continuing is-

laboratory and animal studies provide standard-setting

sue of concern in academia, however, especially over the

data for chemical exposures in the workplace, and under-

past decade as reports surfaced that research sponsors

standing the cycle of carbon emissions helps shape the
response to global climate change. Strong science drives
sound decision-making and the public policies that
strengthen our nation.

blocked the publication of findings detrimental to their
commercial interests on a number of occasions.3 Such
was the level of distress that the editors of thirteen of the
world’s leading biomedical journals, including The New

Beyond the merits of advancing science, the open ex-

England Journal of Medicine and The Journal of the Ameri-

change of ideas is also cherished because it is concordant

can Medical Association, declared in 2001 that they would

with the ideals of a democratic society. Freedom of infor-

not publish studies where research sponsors had the abil-

mation is a core belief in the American system.

ity to control presentation of the results.4

Despite these laudable goals, there is no such thing

Many universities have developed similar guidelines to

as “pure” science, no isolated chamber where scientists

protect the independence of research, requiring faculty

can expect to carry out their research, announce their

members to retain full rights to disclose the information

findings, and assume they will be the sole consideration

they gather, even if a commercial sponsor has funded

in addressing a real-world challenge.

the work.
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Scientists in government are less subject to overt com-

between scientists and the media may be tightly con-

mercial pressures because they are on the public pay-

trolled, and in some instances the free exchange of data

roll, but the principles and practice of open science have

and results with colleagues may be curtailed.

often butted against other agendas. Industry interests,
interest-group pressures, political ideology, and bureau-

The lack of uniformity across agencies, and even among

cratic procedures all have considerable influence on the

offices and centers within a single agency, is striking and

work they do.

highlights the need to explore and clarify the nature of
the rights and responsibilities accorded government sci-

GOVERNMENT SCIENTISTS’ UNIQUE ROLE
The unique challenge of government scientists is to balance their work as researchers, regulators, and applied
scientists with their role as employees of structured, hierarchical organizations. In particular, they may be expected

entists. In the absence of clear policies, or in the presence
of policies that place significant restrictions on scientific
freedom, these employees may be constrained in their
ability to meet their obligations to the scientific community and to the public at large.

to represent and advocate for official agency positions,

In the first decade of the 21st century, public concern

regardless of their personal perspectives on issues. Con-

about political interference with science mounted. Events

versely, they may be barred from presenting conclusions

such as the Food and Drug Administration’s (FDA’s) long

or analyses that are inconsistent with an agency’s stance,

delay in approving emergency contraception for over-

even if they are speaking as private citizens.

the-counter sale,6 the use of ideological criteria to select

Government scientists are typically subject to some level
of approval prior to launching a research project, and
their work often goes through several additional layers
of review once it is complete and results are ready to be
disseminated through articles and presentations. Procedures differ from agency to agency, and there are often
notable differences between the approach spelled out in
formal guidance documents, if they exist, and what actually happens on the ground.
Many factors may shape research priorities and the review

members of federal scientific advisory committees,7 and
the suppression and distortion of scientific findings on
climate change8 called into question the integrity of government science.

Scientists in Government Project:
Shaping the Debate

T

he federal government must ensure that its scientists are able to function effectively, both so that
agencies can produce top-quality science to an-

process, including the topic, the agency, the managerial

swer important questions and so that they can attract and

style of those in charge, and the sensitivities of the mo-

retain scientific talent. Agencies must also demonstrate

ment. Clearance procedures are generally more complex

to the public that their scientists are working in the pub-

when the work has significant policy and/or economic im-

lic’s interests and that agency management is facilitating

plications, and political appointees often have an influen-

(rather than suppressing or interfering with) the produc-

tial voice in the review and approval process, whether or

tion and dissemination of knowledge. The public’s confi-

not they have scientific expertise. The Union of Concerned

dence in government science—and in the government as

Scientists reported in 2008, “New and excessive analytical

a whole—is at stake.

requirements have provided opportunities for industry
groups to highlight uncertainty in agency science, and
have prevented federal agencies from responding promptly to urgent threats to public health and safety.”5

The Scientists in Government project was launched as
part of a larger effort to ensure that government uses
the best science to protect and promote the health and
well-being of Americans. It operates under the umbrella

Across most agencies, the many steps involved in clear-

of the Project on Scientific Knowledge and Public Policy

ance often result in long delays before significant scientif-

(SKAPP) at the George Washington University School of

ic findings are widely shared. Along the way, interactions

Public Health and Health Services.
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With support from the Open Society Institute, the Scien-

member of Professionals for the Public Interest, a coali-

tists in Government Project seeks to provoke and influ-

tion formed to defend members against external pres-

ence the public discussion about federal scientists’ rights

sures that challenge the integrity of their work.11

and responsibilities. This report presents the results of a
qualitative research study that included interviews with

•

The

Government Accountability Project pro-

duced “ABCs of Drug Safety: Accountability, Balance

current and former federal scientists at health and envi-

and Citizen Empowerment,”12 focused on the ap-

ronmental agencies, a review of publicly available online

proval process for new drugs and conflicts of interest

agency policies regarding agency research, and a litera-

at the FDA. It has also investigated external pressures

ture review. Qualitative research is “a broad approach to

on climate scientists, collaborating with the Union of

the study of social phenomena … [drawing] on multiple

Concerned Scientists on a report about political in-

methods of inquiry,” such as structured interviews and

terference in climate science and producing its own

analysis of documents and materials.9

report, “Redacting the Science of Climate Change: An
Investigative and Synthesis Report.”13

This study considers the barriers and opportunities for
scientists as they set their research agendas, endeavor
to speak freely with one another, disseminate their con-

•

based on the premise that “reliance on science that is

clusions and the data that support them, and provide a

free of political interference provides the foundation

firm grounding for science-based policies and practices. It

for public trust in government decision making.”14 Its

also examines the internal and external influences on the

reports include an independent evaluation of the Food

research activities of government scientists, and includes

and Drug Administration, with recommendations in

recommendations to enhance transparency, minimize in-

the areas of organizational culture, scientific expertise,

terference, and ensure timely access to findings.
The scientists who participated in this research spoke
eloquently about their frustrations with a political and

The Institute of Medicine has undertaken research

and advisory committees.15

•

The Science and Engineering Workforce Project, a
project of Harvard University’s Labor and Worklife Pro-

bureaucratic climate that sometimes impedes their best

gram and the National Bureau of Economic Research,

work, and offered insights about the policies and practic-

supported by the Alfred P. Sloan Foundation, produces

es that can be strengthened or changed to improve their

publications and events focusing on the state of the

situations. Their voices are a reminder that an open ex-

science and engineering workforce.16

change of information is essential to the conduct of good
science, the advancement of knowledge, and ultimately

•

The Union of Concerned Scientists has conducted a
series of surveys with government-agency scientists,

the strengthening of the nation’s health.

and has documented a wide array of what it calls “abus-

Non-Partisan Efforts to Protect and
Advance Government Science

A

es of science.”17 Publications include “Voices of Federal
Scientists: Americans’ Health and Safety Depends on
Independent Science,”18 “Atmosphere of Pressure: Po-

number of other independent, non-partisan or-

litical Interference in Federal Climate Science,”19 “The

ganizations have also focused in recent years on

A to Z Guide to Political Interference in Science,”20

scientific integrity, conflicts of interest, and the

and “Federal Science and the Public Good.”21

politicization of science. Among activities of interest:

•

The American Association for the Advancement of
Science, through its Program on Scientific Freedom,
Responsibility & Law, examines the ethical, legal, and
social issues associated with the conduct of research
10

and advances in science and technology. AAAS is a

Recent Executive-branch Actions

U

nder both the Bush and Obama administrations,
the White House Office of Science and Technology Policy (OSTP) has taken steps to advance the

openness and integrity of scientific agencies. In May 2008,
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OSTP released a set of principles for federal agencies’

considerations over scientific rigor.23 Specifically, the

communication of scientific research results, as required by

memorandum declared:

the 2007 America COMPETES Act. The document states:

The public must be able to trust the science and sci-

Robust and open communication of scientific infor-

entific process informing public policy decisions. Po-

mation is critical not only for advancing science, but

litical officials should not suppress or alter scientific or

also for ensuring that society is informed and provided

technological findings and conclusions. If scientific and

with objective and factual information to make sound

technological information is developed and used by the

decisions. Accordingly, the Federal government is

Federal Government, it should ordinarily be made avail-

committed to a culture of scientific openness that fos-

able to the public. To the extent permitted by law, there

ters and protects the open exchange of ideas, data and

should be transparency in the preparation, identifica-

information to the scientific community, policymakers,

tion, and use of scientific and technological information

and the public.22

in policymaking. The selection of scientists and technology professionals for positions in the executive branch

OSTP Director John Marburger sent the principles to

should be based on their scientific and technological

agency heads along with a memo directing them to de-

knowledge, credentials, experience, and integrity.23

velop and update “clear guidelines regarding processes
for sharing research data and results generated by Fed-

To build on those objectives, the memorandum called for

eral scientists.” 22

OSTP to develop a plan to ensure integrity in all aspects of
government science. OSTP called for public comments to

In March 2009, the Obama administration issued a

inform its work, and the Project on Scientific Knowledge

Memorandum on Scientific Integrity that appeared

and Public Policy submitted recommendations based on

to acknowledge many of the concerns that have been

the preliminary results of this research.24 OSTP did not is-

expressed in recent years about the limitations of in-

sue a plan in mid-2009 as anticipated, but is expected to

formation dissemination and the bias towards political

do so in 2010.

Research Questions
In exploring the role and functioning of government scientists through qualitative interviews and a review of publicly available online agency policies, Scientists in Government researchers sought answers to the following questions:

• To what extent do agencies foster environments that
support scientific work in fulfillment of agency missions?

• What policies exist regarding research, publication, and
communication by scientists working at science-based
agencies within the federal government?

• How well do agencies facilitate the processes of conducting scientific work and disseminating results?

• What is the nature of agency review of scientific
publications?
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• Do government scientists retain their autonomy to
publish and communicate their scientific findings and
conclusions?

• What is the nature of influence affecting federal scientists and their work? How do agencies address this
influence?

• Do accessible and useful feedback and dispute-resolution mechanisms exist for federal scientists?

Methodology

T

timeframe, 37 participants were secured for interviews.

views. All interviews were conducted by a qualita-

used to recruit interview participants. These strategies

tive Research Associate (RA1). A second Research Associ-

were Snowball or Chain, Criterion, Opportunistic, Combi-

ate (RA2) was present at each interview along with the

nation or Mixed, and Convenience.25

he study methodology is a qualitatively-based
design using semi-structured, key-informant inter-

Five sampling strategies from qualitative inquiry were

RA1. The Principal Investigator (PI) provided oversight
of the methodology to ensure its accuracy. The RA1 was
trained in qualitative methodologies and has utilized
these skills in domestic and international settings while
adhering to all Institutional Review Board (IRB) standards.

Interview recruitment began once IRB approval was received in May 2008, and continued through November
2008. (See Appendix B for IRB approval information.) Pilot interviews were conducted in May 2008, and the remaining interviews began in June 2008 and continued

Literature and policy reviews were conducted. Reports,

through January 2009.

journal articles, newspaper articles, and various other
types of publications were collected and analyzed to
help provide a foundation and rationale on which the interviews were based. An advisory committee composed
of five experts with extensive experience working with
government scientists provided insights and guidance
to the project.

The research team recruited participants who held advanced degrees and had at least five years of experience
working in a scientific capacity for a federal agency that focuses on health or the environment. The criterion of working for a health or environment agency was broadened to
include persons whose agencies may not have this focus,
but whose work was related to health or the environment.

Interview Guide

A

For example, a participant from the Department of Housing and Urban Development (HUD) worked on lead and

n interview guide (see Appendix A) was devel-

asbestos exposures in federal housing. Therefore, it was a

oped and revised using feedback from the advi-

health and environment topic that was being addressed

sory committee members and two informational

even though the agency’s mission is not primarily health

interviews conducted with leaders in the field of science

or the environment. All participants met all of these cri-

and government. The RA1 used these interviews to dis-

teria, with the exception of three who had worked fewer

cuss the proposed research and the questions being developed for the semi-structured, key-informant interviews.
Feedback and advice from these interviews assisted with

than five years for the government. There were no inclusion or exclusion criteria based upon gender, race/ethnicity, age, risk factors, or prevalence/incidence.

the development of the interview guide.
Recruitment information was disseminated on numerous
Three pilot interviews were conducted using this interview guide in May 2008. Additional feedback from these
interviews helped refine the interview guide and provided the interviewer with a better understanding of what
was feasible and necessary to ask during each interview.

Participant Recruitment

H

listservs (American Public Health Association, environmental and occupational health, federal, universities, local,
etc.), and research team members distributed recruitment
flyers at several conferences (e.g., American Public Health
Association annual meeting and the Center for Science
in the Public Interest’s conference on scientific integrity.) Members of the research team also participated in

undreds of potential subjects were asked to par-

meetings to inform colleagues of the work and to recruit

ticipate in the study with the expectation that

participants, including meeting with the Department of

approximately 50 would be willing and able to

Professional Employees at AFL-CIO and presenting at

participate. Within the project’s available budget and

the “Representing Professionals in Science, Engineering,
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and Technology” conference at Harvard University Law

•

26

Institute of Standards and Technology (NIST)

School. After conducting 25 interviews, the assistance
of participants was solicited to recruit additional partici-

US Department of Commerce, including the National

pants, and this yielded an additional 12 interviews.

•

US Department of Defense (DOD)

Subjects were given the option to sign a consent form or

•

US Department of Housing and Urban Development
(HUD)

not, since such records could compromise confidentiality;
instead, interview participation was considered consent.

•

All research documents and audio tapes containing iden-

US Department of Labor, including the Occupational
Safety and Health Administration (OSHA)

tifiable information (e.g., agency name or subject title)
were kept in a secure location only accessible to the re-

•

ans Health Administration (VHA)

search team, and will be destroyed.

Interview Participants

F

rom May 2008 through January 2009, 37 in-depth,
semi-structured, key-informant interviews were
conducted with individuals who worked for, or

had previously worked for, 13 different federal agencies.
Several interviewees had work experience at multiple
agencies, which resulted in a total of 55 agency work
experiences. Participants described experiences at the
following agencies:
Agencies of the Department of Health and
Human Services:

•

•

US Department of Veterans Affairs, including the Veter-

•

US Environmental Protection Agency (EPA)

Several of these participants were members of the Public
Health Service (PHS) Commissioned Corps, and were also
able to comment on their experience of working for federal agencies while serving as PHS members.

Interview Data Analysis

D

ata was collected via audio tapes of interviews
and via handwritten/typed notes taken during
the interviews by RA2. After each interview was

conducted, field notes were typed and reviewed to identify any items in need of clarification. The audio tapes

Centers for Disease Control and Prevention (CDC), in-

were transcribed, and the transcribers signed confidenti-

cluding the National Institute for Occupational Safety

ality statements and adhered to all IRB regulations. Audio

and Health (NIOSH) and the Agency for Toxic Sub-

tapes, transcripts, and notes were used during the issue-

stances and Disease Registry (ATSDR)

focused,27 open-coding analysis, which provided a means

Food and Drug Administration (FDA), including the

by which to organize and interpret collected data.

Center for Drug Evaluation and Research (CDER) and

The analysis of the qualitative data involved creating

the National Center for Toxicological Research (NCTR)

data categories based on general themes and subcat-

•

National Institutes of Health (NIH)

•

Indian Health Service (IHS)

•

Substance Abuse and Mental Health Services Admin-

egories, also known as ‘codes,’ into which each piece of
data was assigned. In order to reduce the possibility of
bias when conducting the qualitative data analysis, the
research team worked together to code two interviews.

istration (SAMHSA)

Using the principle of Grounded Theory, under which the
data drives the analysis, the team read through the inter-

Other agencies:

views and identified the themes, or codes, that emerged.

•

US Consumer Product Safety Commission (CPSC)

Then, to determine the validity of the themes identified

•

US Department of Agriculture (USDA)

by the entire team, two of the team members conducted
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analysis separately and then compared their coded data

to determine whether two different researchers would

the media and the public by scientists employed at fed-

come to the same conclusions regarding code assign-

eral agencies. Relevant policies were found regarding at

ment. Based on this process, the team members deter-

least one of these activities from the following agencies

mined that the themes were accurate. Once this process

and centers:

was completed, RA1 conducted the analysis of the interviews, applying agreed-upon codes to every statement

•

made in the interviews, then sorting the statements into
theme-based documents, and finally synthesizing the
data to be used in writing the report.

•

inquiry,” including structured interviews and analysis of
documents and materials.9 Qualitative research also has

Centers for Disease Control and Prevention, including the National Institute for Occupational Safety
and Health

Qualitative research is “a broad approach to the study of
social phenomena … [drawing on] multiple methods of

Center for Drug Evaluation and Research (a center of
the US Food and Drug Administration)

•

National Institutes of Health

•

US Department of Agriculture, including Agricul-

limitations. One of these is funding, which determines the

tural Research Service and Food Safety and Inspec-

amount of time a researcher can devote to a project. Ul-

tion Service

timately, qualitative researchers aim to reach the point of
data saturation; however, a researcher is never absolutely

•

Geological Survey

certain that it has been attained. Qualitative research does
not employ nor aspire to have a representative sample;

US Department of the Interior, including the US

•

US Environmental Protection Agency

rather, validity and reliability are achieved by rigorous application of field methods and analysis, especially recruitment for the characteristics being researched.

Additional Research: Policy Review

T

Follow-up Survey

T

o investigate effects that a new administration
might be having on scientists’ views of the topics
covered during the interviews, an online follow-

o supplement the data collected through inter-

up survey was conducted during July and August 2009,

views, the research team also reviewed policies re-

approximately six months after the Obama administra-

garding the practice of science from science-based

tion began.

federal agencies that focus on health or the environment.
The team began by contacting health- and environment-

The questions addressed workplace supportiveness, ac-

focused agencies to request policies regarding the work

cess to data, research review process, publication/review

of agency scientists, and received a few responses refer-

clearance process, access to media, access to meetings/

encing online agency resources. In one case, a response

conferences, ability and willingness to provide feedback,

from the Department of Labor indicated that policies

and overall work environment.

from the Mine Safety and Health Administration (MSHA)
were posted on the agency’s intranet, but not on the website accessible to the public.

The research team utilized an online survey service
called Zoomerang28 to disseminate, collect, and analyze
the anonymous survey. Only the RA1 had access to the

The team then searched online for policies from health-

survey online, and results, once downloaded, became

and environment-focused agencies regarding proce-

available only to the research team. These results will

dures for research, publication, and communication with

also be destroyed.
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Agency Background

T

he term “agency” when used in this report refers

Use Sciences, Quantitative Sciences, Forest Manage-

not only to agencies but to departments (e.g., the

ment Sciences, and Environmental Sciences.34

US Department of Agriculture) and to offices, insti-

tutions, or bureaus (e.g., the National Institute for Occupational Safety and Health)—in short, to any organization
that derives its authority from federal law. The agencies

US Department of Commerce works to advance economic growth and job opportunities; it has responsibilities in the areas of trade, technology, and environmental

whose names appear in bold type below, in alphabetical

stewardship, among others.35 Its National Institute of

order, are those that are included in this report. An agency

Standards and Technology (NIST) provides technology,

may be included because one of its current or former sci-

measurements, and standards to “help U.S. industry in-

entists participated in an interview, or because its policies

vent and manufacture superior products reliably, provide

were reviewed as part of the research.

critical services, ensure a fair marketplace for consumers
and businesses, and promote acceptance of US products

US Consumer Product Safety Commission (CPSC)

in foreign markets.”36

monitors and researches hazards presented by consumer products; it uses both mandatory and voluntary stan-

US Department of Defense (DOD) is responsible for the

dards to reduce the risk of injury and death from con-

US military. Medical personnel serving in the military con-

sumer products, and may obtain the recall of products

duct research as well as providing care, and DOD spon-

when necessary. It is an independent regulatory agency

sors extramural research.

headed by three commissioners who are nominated by
the President and confirmed by the Senate to sevenyear terms.29

US Department of Health and Human Services “is the
United States government’s principal agency for protecting the health of all Americans and providing essential

US Department of Agriculture (USDA) addresses agri-

human services, especially for those who are least able

culture and food issues; its key activities include expand-

to help themselves.”37 The agencies and offices within it

ing markets for agricultural products and enhancing food

include the following:

safety.30 Its centers and services include:

•

is “dedicated to protecting health and promoting qual-

search in four areas: Nutrition, Food Safety/Quality; An-

ity of life through the prevention and control of dis-

imal Production and Protection; Natural Resources and

ease, injury, and disability.”38 Among its functions are

Sustainable Agricultural Systems; and Crop Production

disease surveillance and collection of statistics used by

and Protection.

health researchers. The agencies within it include:

Food Safety and Inspection Service (FSIS) is the reg-

•

Agency for Toxic Substances and Disease Regis-

ulatory agency responsible for the safety of commer-

try (ATSDR) functions include providing informa-

cial meat, poultry, and egg products; FSIS is required to

tion on toxic substances and conducting public

conduct carcass-by-carcass inspections at all federally

health assessments of Superfund sites.39

inspected slaughter facilities and verify that these facilities follow food safety regulations.32

•

Centers for Disease Control and Prevention (CDC)

Agricultural Research Service (ARS) conducts re-

31

•

•

•

National Institute for Occupational Safety and
Health (NIOSH) conducts research and makes rec-

Forest Service manages public lands in national for-

ommendations to prevent injuries and illnesses at

ests and grasslands;33 its research program focuses on

workplaces. Upon request, it will conduct Health

informing policy decisions in the areas of Resource

Hazard Evaluations of specific worksites.40
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•

Food and Drug Administration (FDA) is a regu-

US Department of Housing and Urban Development

latory agency that ensures “the safety of all food

(HUD) works to “increase homeownership, support commu-

except for meat, poultry and some egg prod-

nity development and increase access to affordable hous-

ucts” and “the safety and effectiveness of all drugs,

ing free from discrimination.”49 HUD programs and projects

biological products, medical devices, and animal

must comply with environmental review requirements.50

drugs and feed.” 41 The agency’s drug-related regulatory responsibilities, including the evaluation of
new drugs, are carried out by the Center for Drug
Evaluation and Research (CDER).42 The National
Center for Toxicological Research (NCTR)—in
participation with researchers from elsewhere in
the FDA, other government agencies, academia,
and industry—provides innovative technology,
methods development, vital scientific training, and
technical expertise. 43

•

Indian Health Service (IHS) provides health services
to American Indians and Alaska Natives.44

•

resources (including dams and reservoirs), works to preserve species of fish and wildlife, and conducts research
that helps land and resource managers with decisionmaking.51 Its bureaus include the US Geological Survey
(USGS), which “collects, monitors, analyzes, and provides
scientific understanding about natural resource conditions, issues, and problems.”52
US Department of Labor (DOL) administers federal laws on
several issues affecting workers, including the work environment, the minimum wage, work hours, and freedom from
employment discrimination.53 DOL’s Occupational Safety

federal agency for conducting and supporting medi-

and Health Administration (OSHA) is the regulatory agen-

cal research.”45 It is composed of multiple Institutes

cy that sets and enforces workplace health and safety stan-

and Centers that conduct intramural research and also

dards under the Occupational Safety and Health Act.54
US Department of Veterans Affairs (VA) provides veterans

The Office of Public Health and Science houses 12 of-

and their eligible family members with healthcare and

fices focusing on different aspects of public health,

other benefits.55 The Veterans Health Administration

including the Office of the Surgeon General. The Sur-

(VHA) is home to a healthcare system that consists of 153

geon General heads the Commissioned Corps of the

medical centers, numerous community-based outpatient

US Public Health Service (PHS),46 which is “dedicated

clinics, and other facilities;56 it also conducts and funds re-

to delivering the Nation’s public health promotion and

search at many of these facilities.

disease prevention programs and advancing public
health science.”47 The Commissioned Corps is one of

•

ety of surface lands (including national parks) and water

National Institutes of Health (NIH) “is the primary

sponsor extramural research.

•

US Department of the Interior (DOI) manages a vari-

US Environmental Protection Agency (EPA) is an independent regulatory agency that implements environ-

the country’s seven uniformed services; its members

mental laws, including the Clean Air Act and Clean Water

are eligible to be employed by any HHS agency, and

Act, and researches environmental problems.57 It includes

they receive benefits that often differ from those of-

several headquarters offices, 10 regional offices, and mul-

fered by the civil service.

tiple labs.58

Substance Abuse and Mental Health Services Administration (SAMHSA) funds and administers “grant
programs and contracts that support state and community efforts to expand and enhance prevention and
early intervention programs and to improve the quality, availability and range of substance abuse treatment,
mental health and recovery support services.”48

Other Key Executive-branch Offices

I

n addition to the federal agencies listed above, two
White House offices emerge from this research as having important effects on the work of scientists at fed-

eral agencies. The White House Office of Management
and Budget (OMB) assists the President in overseeing the
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federal budget, and as part of this role it “evaluates the effectiveness of agency programs, policies, and procedures,
assesses competing funding demands among agencies,
and sets funding priorities.”59 The White House Office of
Science and Technology Policy (OSTP) advises members
of the Executive Branch on “the effects of science and

Political Appointees and Career
Civil Servants

I

t is useful to note that the vast majority of the employees at the agencies listed above are civil servants, who
begin and advance through their careers in a manner

technology on domestic and international affairs” and is

standardized across the federal government. By contrast,

authorized to “lead interagency efforts to develop and

political appointees are selected by an individual admin-

implement sound science and technology policies.”60

istration for top positions at an agency, where they rarely
remain for more than a few years. In Getting to Know You:

The Office of Personnel Management (OPM) also plays an

Rules of Engagement for Political Appointees and Career

important role in establishing personnel policies (hiring,

Executives, Ferrara and Ross summarize the differences

promotion, etc.) and job descriptions that affect the roles

between the two types of employees in a table that high-

of federal scientists.

lights potential sources of friction (Table 1).61

Table 1: Political Appointees and Career Civil Servants
Factor

Political appointees

Careerists

Role perception

• “Determine the nation’s business”
• Focused on achieving policy outcomes

• “Determine the nation’s business”
• Focused on ensuring a fair, open, and
sound decision process

Partisanship

• Affiliated with a political party
• Serve a particular president

• Nonpartisan on the job
• Serve various presidents

Professional experience

• Often a mix of government, academic, and

• Government has been their main career

private sector
Tenure of service

• Come in and go out
• Average about two years in their positions,
about four years in their agency, and about
nine years of government service

Time perspective

• Tend to have a shorter-term outlook

Source: Ferrara & Ross, 2005
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• Senior executives average four years in
their positions, 19 years in their agency, and
more than 25 years of government service
• In for the long term

• Tend to have a longer-term outlook

Research Participant Characteristics

B

ased on discussions with advisory committee

It is noteworthy that 12 of the participants had experience

members and key informants, recruitment of study

working for the National Institute for Occupational Safety

participants focused primarily on environment-

and Health (NIOSH), which is part of the Centers for Dis-

and health-based agencies, but participants from other

ease Control and Prevention. In addition, five participants

agencies were not excluded. The 37 participants had ex-

were members of the Public Health Service (PHS) Com-

perience working for 13 different agencies (see Table 2);

missioned Corps; members of the PHS work for a variety

several interviewees had experience at multiple agencies,

of agencies within the Department of Health and Human

which resulted in a total of 55 agency work experiences.

Services (HHS) while serving in the PHS.

Table 2: Number of Interviewees with Experience at Various Federal Agencies
Agency

Number of Participants

US Department of Health & Human Services (HHS) ......................................................................................................................................34
Centers for Disease Control & Prevention (CDC), including the Agency for Toxic Substances
& Disease Registry (ATSDR) and National Institute for Occupational Safety & Health (NIOSH) ................20
Food & Drug Administration (FDA), including the Center for Drug Evaluation &
Research (CDER) and the National Center for Toxicological Research (NCTR) ................................................ 6
Indian Health Service (IHS) ................................................................................................................................................ 3
National Institutes of Health (NIH) .................................................................................................................................. 4
Substance Abuse & Mental Health Services Administration (SAMHSA) ........................................................... 1
US Consumer Product Safety Commission (CPSC) ............................................................................................................................................1
US Department of Agriculture (USDA) ..................................................................................................................................................................3
US Department of Commerce, including the National Institute of Standards &
Technology (NIST) .........................................................................................................................................................................................................1
US Department of Defense (DoD) ...........................................................................................................................................................................4
US Department of Housing & Urban Development (HUD) ............................................................................................................................1
US Department of Labor, including the Occupational Safety & Health Administration (OSHA) ......................................................1
US Department of Veterans Affairs, including the Veterans Health Administration (VHA) ................................................................2
US Environmental Protection Agency (EPA) ........................................................................................................................................................8

The Scientists in Government Project • 31

Participants were asked to provide the position titles of

Senior Advisor

all of the scientific positions they held at federal agencies.

Senior Economist

They provided the following titles:

Senior Epidemiologist
Senior Research Health Scientist

Activity Chief

Senior Research Scientist

Associate Director for [Topic Area]

Service Unit Sanitarian

Associate Director of Health

Statistician

Behavioral Scientist

Survey Statistician

Branch Chief

Team Leader

Clinical Associate

Veterinary Medical Officer

Commander
Director of [Topic Area] Health Program

Information about participants’ sex, race, and age was

Director of Policy

compared to corresponding information from the OPM’s

Division Director

Demographic Report of 200662 regarding government

Environmental Analyst

employees in the “professional” category, whose descrip-

Environmental Engineer

tion matched the study’s recruitment criteria most closely.

Epidemiologist

OPM defines professional occupations as follows:

Health Scientist

Occupations that require knowledge in a field of sci-

Health Scientist Administrator

ence or learning typically acquired through educa-

Health Statistician

tion or training pertinent to the specialized field, as

Health Systems Specialist

distinguished from general education. The work in

Industrial Hygienist
Institutional Environmental Health Officer
Mathematical Statistician

a professional occupation requires the exercise of
discretion, judgment, and personal responsibility for
the application of an organized body of knowledge

Medical Director

that is constantly studied to make discoveries and

Medical Epidemiologist

interpretations, and to improve the data, materials,

Medical Officer

and methods.”62

Project Officer
Research Biologist

Comparisons between the sex, race, and age of research

Research Chemist

participants and professional federal workers are detailed

Research Scientist

in Tables 3–5.

Table 3: Sex of Interview Participants and Professional Federal Workers
Sex

No. of Participants

% of Participants

% from 2006 OPM Report

Male

22

59.5%

56.9%

Female

15

40.5%

43.1%

TOTAL

37

100%

100%
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Table 4: Race of Interview Participants and Professional Federal Workers
Race

Participants

% of Participants

% from 2006 OPM Report

Non-Minority

37

100%

75.5%

Black

0

0%

9.4%

Hispanic

0

0%

4.9%

Asian/Pacific Islander

0

0%

8.8%

American Indian/Alaskan Native

0

0%

1.4%

TOTAL

37

100%

100%

Study participants were asked which of four age ranges they fell into. OPM uses different age ranges, and it reports age
distribution for the entire federal civilian non-postal executive-branch workforce, rather than just for workers falling into
the professional category. Table 5 describes the age distributions of the participant pool and the federal civilian nonpostal executive-branch workforce.

Table 5: Age of Interview Participants and Federal Workers
Age Range
for Participants

Age Range from

% from 2006

No. of Participants

% of Participants

2006 OPM Report

OPM Report

< 35 years

0

0%

< 31 years

11%

36-45 years

2

0.5%

31-40 years

18.8%

46-55 years

15

40.5%

41-44 years

11.8%

> 55 years

20

54.0%

45-49 years

16.8%

TOTAL

37

100%

50-54 years

18.1%

> 55 years

23.5%

TOTAL

100%
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Because the OPM report does not calculate average length of government service for the professional category alone,
the average number of years of service for all federal civilian non-postal executive-branch employees, which is 14.6
years,62 was used. The interview participants had a longer average length of service, 16.9 years. Table 6 describes the
years of service of research participants.

Table 6: Interview Participants’ Length of Government Service
Years of Service

No. of Participants

% of Participants

0-5 years

3

8%

6-10 years

10

27%

11-15 years

2

5%

16-20 years

7

19%

20+ years

15

41%

TOTAL

37

100%

Table 7 describes the advanced degrees held by participants (several held more than one). OPM reports that 43% of federal
civilian non-postal executive-branch employees hold at least a bachelor’s degree;63 this compares to 100% of research participants who have more than a bachelor’s degree, but that outcome is to be expected since having an advanced degree
was one of the study recruitment criteria.

Table 7: Advanced Academic Degrees Held by Participants
Advanced Academic Degrees

No. of Participants

% of Participants

MA

3

4.7%

MF

1

1.6%

MPH

14

22%

MS

10

15.6%

MD

13

20%

PhD

20

31.3%

DVM

1

1.6%

ScD

2

3.2%
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Findings

T

he following sections describe findings from in-

have differing views about the extent to which media

terviews with scientists and a review of several

offices should act as gatekeepers between reporters

agencies’ written policies. Key findings include

and scientists.

the following:

•

al meetings is crucial to scientists’ career development,

across multiple agencies. Scientists identified several

but agency restrictions on employees’ meeting atten-

factors that harm morale, including abrupt changes

dance have multiplied in recent years and made such

in agency priorities, lengthy and burdensome bu-

attendance increasingly difficult.

proval, inadequate resources, and relinquishment of
agency principles.

•

Influence—Policies and practices designed to protect scientific integrity from inappropriate influence
are not uniformly successful. Scientists expressed
concern about agencies steering research away from

scientists should include buffering those scientists

potentially controversial topics, to the detriment of

from political pressures that could compromise sci-

agency missions.

entific integrity. Some scientists also suggested that

All of these issues affect the morale of scientists at federal

although having a scientific background is impor-

agencies. The following section contains findings from sci-

tant for managing scientists, not all scientists make

entist interviews describing the issues that scientists found

good managers.

most critical for maintaining agency morale. Later sections

Feedback mechanisms—Agencies need functional
provide anonymous feedback that will be given con-

discuss these and other findings in greater detail.

Morale

plying for intramural research funding can require too

S

much time and effort relative to the amount of fund-

or eroding. Their comments demonstrate the need to

ing being sought.

improve several aspects of work at science-based fed-

sideration by managers and agency leadership.

•

•

Management—The role of managers in charge of

feedback mechanisms that encourage scientists to

•

Interacting with colleagues—Attending profession-

Morale—Low and eroding morale is a problem

reaucratic processes for research and publication ap-

•

•

Approving proposed research—The process of ap-

Disseminating scientific information—The process

cientists’ morale affects their agencies’ productivity, as well as recruitment and retention. Many of
the scientists interviewed characterized their own

morale, and often that of their colleagues, as being low

eral agencies.

of getting information products cleared for dissemi-

Several scientists cited a desire to work for the public

nation can be more lengthy and cumbersome than

good as a factor that drew them to government employ-

necessary to ensure the products’ quality. Concerns

ment. When scientists feel that their agencies are failing

exist about agency officials using the clearance pro-

to advance their missions as effectively as they should,

cess to delay or prevent the publication of information

their morale suffers.

products that may call into question previous agency
actions or affect the reputation of an industry or con-

Factors that scientists mentioned as harming morale in-

sumer product.

cluded frequent changes in agency priorities, often with
limited input from the scientists who will conduct the

•

Communicating with the public—The extent to which

research; onerous bureaucratic processes; insufficient

scientists are able to interact freely with the media and

resources; and a sense that an agency has relinquished

the public varies between agencies, and scientists

its principles.
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CHANGING PRIORITIES

INADEQUATE RESOURCES

Because each change in administration brings new per-

Because federal employee salaries and annual pay in-

sonnel and priorities to federal agencies, scientists often

creases are set by the federal government and have been

face abrupt changes in research directions. Although such

rising steadily, many agencies find that an increasing

changes are understandable, the effects on scientists can

share of their budgets must go to personnel costs. This

be harsh. One scientist described spending seven years

leaves scientists competing for a shrinking pool of money

working on a high-profile topic, only to be told when a

to fund research. Scientists from multiple agencies voiced

new administration came in that the project was no lon-

frustrations about resource constraints:

ger a priority and funding for it was no longer available.
Others reported working as much as 10 or 15 years on

•

People are often asked to take on additional tasks—

projects, only to have them halted before the research

even those outside the scope of their job descrip-

was completed. One mentioned coming upon a col-

tions—without receiving additional funding or re-

league crying in the bathroom, devastated by the order

sources, even if it will hinder their performance on

for a project’s abrupt termination.

other job duties. This is particularly frustrating when
scientists do not see the additional tasks as being valu-

Some scientists expressed a desire to have more input

able or necessary for the agency’s work.

into important decisions that affect their work. A CDC
branch chief noted that when scientists promote agen-

•

A NIOSH epidemiologist reported that some of the

das that do not coincide with upper management’s plans,

agency’s departments must devote nearly 90% of their

management may dismiss them as scientists’ attempts to

budgets to personnel costs—which means that some

bolster their own CVs.

scientists are writing grant proposals in order to cover
overhead costs such as paper and toner cartridges.

BUREAUCRATIC PROCESSES

•

Some agencies have reduced administrative staff and/

Scientists from several different agencies voiced concerns

or outsourced administrative functions like photo-

about lengthy and burdensome processes for getting re-

copying and making travel arrangements, but this of-

search projects or publications approved. “I can’t think of

ten leads to scientists taking on more of those tasks or

a bigger discouragement” to doing research or publish-

facing additional delays in having them performed.

ing than “to spend a year writing a report and then having
it show up under somebody’s desk,” commented a statistician from CPSC.

PRINCIPLES UNDER THREAT
Of all the concerns raised in the interviews, one of the

Some scientists also felt that they had to spend an in-

most destructive to morale was an agency’s perceived

ordinate amount of time dealing with office politics. An

relinquishment of principles. Examples offered by scien-

FDA senior manager commented, “You have to work like

tists included:

a demon and convince people on the inside that there is
a better way to do things … That takes years and years of
learning how to do that, and frankly by the time that I got
to that point … I was just too frustrated.”

•

Several scientists described situations in which they
or their colleagues had taken a principled stand—
e.g., advocating for a particular research agenda
or project, or arguing against hiring an unquali-

Overall, many scientists felt they were spending too much

fied job candidate—only to experience negative

time on internal processes and too little actually conduct-

consequences. Some also felt that their agencies as

ing science.

a whole were simply not doing the job they were
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•

supposed to be doing. “Whenever I have stuck to

were leaving, others who should have been retiring were

principle it has been a nasty price to pay,” said a VHA

staying. This has become a particular concern as many

health systems specialist.

older workers have suffered significant losses in their retirement portfolios and decided to keep working longer

Agencies often face outside pressure to change the
course of their work, and management’s response to
such pressure can determine the extent to which morale suffers. An OSHA manager commented that scientists may feel as if they are “fighting a noble battle with
support of their management,” or they can feel “abused

than they had initially planned. While many older workers
make valuable contributions, agencies may be reluctant
to invest in training those who they expect to be retiring in the near future. “Sometimes people stay just out
of inertia or laziness,” commented an OSHA manager, although “I think that is the minority.”

and disrespected by upper management.” The latter
situation is much more harmful to morale.

•

Some agencies have responded to budget concerns by hiring fellows—whose time at the agency is limited—rather

A veterinary medical officer at the USDA stated that although the agency claims to be working in the public’s
interest, “we are a fraud.”

Not all scientists spoke about these problems at their
agencies; some praised their managers and expressed
appreciation for the ability to research topics that would
be difficult to investigate in other jobs. Also, some who
described bureaucratic or budgetary frustrations considered these to be acceptable trade-offs given the stability,
career development opportunities, and other benefits
that government jobs promise.

than permanent employees. These positions may not be as
attractive to top candidates as permanent positions would
be, so recruitment becomes more challenging.
Scientists who described bleak conditions at their agencies were asked why they stayed, and several cited practical considerations, including impending retirement, a
need to get children through college, being geographically limited by a partner’s career, or lacking the up-todate credentials for securing another job. One VHA scientist stated that his mother is a veteran who would like to
be interred at Arlington, and the scientist thinks that stay-

Several interviewees recommended that scientists con-

ing in his job will help that to happen—but he will likely

sidering federal-agency employment understand and

leave shortly after his mother’s death.

accept the constraints that will necessarily accompany
a government job. These include extensive bureaucratic
processes and a requirement to pursue research directions chosen by management. One scientist suggested
that agency scientists cultivate patience and thick skins.

Practical considerations are not the only reason why scientists continue working in frustrating circumstances,
however; many also see unique opportunities and rewards in government service. An OSHA manager commented, “There is a lot of commitment and dedication
to public service. There are people who believe deeply in

RECRUITMENT AND RETENTION

the mission of their agency or the potential value of the

Among the scientists who described low morale at fed-

science they do. They operate at a great sense of public

eral agencies, several had already retired or changed jobs.

service and idealism … by and large the scientists who

Some scientists expressed concerns about the departure

are working for these agencies are very dedicated, com-

of talented scientists from agency positions and the dif-

mitted people.”

ficulty of recruiting other top scientists to replace them.
One NIOSH scientist could think of eight scientists who
had left within the last two years, explaining, “They felt
they weren’t being treated as full scientists.”

When asked why scientists remain at federal agencies
despite significant challenges, an FDA senior manager
replied, “The reason they do it is because they are getting to work on some of the most fascinating topics in

During the interviews, some scientists expressed con-

the world … what keeps you going is what you are do-

cerns that while many of their agencies’ best scientists

ing is very important.”
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Scientists who participated in this research volunteered

meetings,” noting that “decisions are not made in meet-

in order to contribute to an effort aimed at improving

ings, they are made in hallways before meetings.”

the situations that currently threaten scientists’ morale
at federal agencies. The following sections describe findings from this research in greater detail. They discuss
statements from both interviews and agencies’ written
policies; in-depth examples from individual agencies are
provided where relevant, along with summarized results
from multiple agencies.

Management

O

ne of the prominent themes that emerged from

It appears that managers need a combination of political skills and toughness to perform what many scientists
see as a crucial role: standing up for science and buffering
scientists from political pressures. Some scientists expressed disappointment and frustration with managers who they felt were too quick to yield to pressure to
avoid or minimize controversial topics or findings. Others
expressed appreciation for managers who resisted such
pressure and defended scientific integrity. Comments on
this issue included the following:

interviews was the importance of effective managers. While some scientists praised their man-

•

A CDC branch chief stated, “[What] I wish some of my

agers, most felt that those above them were not doing all

bosses could do was to speak the truth to their bosses.

they could to ensure productivity and top-quality scien-

A lot of people are frightened of their next position.
For example, instead of supporting the scientific work,

tific achievements.

they went along with the suppression of the data …
Many of the scientists interviewed expressed strong

We need supervisors who have the courage to speak

views about the qualifications and roles of those whose

up for the science.”

jobs involve managing scientists. Scientists from several
agencies—including CDC, EPA, HUD, NIH, NIOSH, and

•

be very tough … we see a dark correlation between

OSHA—stated that managers should have enough of a

good outcomes for scientists and the amount of push-

background in science to understand what the scientists

back that our managers give. So, being smart, being

they supervise are doing and why. Having a manager with

nimble enough to work well with your supervisors and

an insufficient understanding of science can frustrate sci-

yet able to withstand pressure appropriately is abso-

entists; an EPA/NIOSH epidemiologist stated, “You end up

lutely critical.”

spending all of your time explaining not only to your boss
who can’t seem to remember why what you do is impor-

•

tant, but to everyone [your boss reports to].”

An epidemiologist with experience at EPA and NIOSH
commented, “I have a supportive environment because I feel like the only thing saving me is my immedi-

In addition to understanding the work of the scientists

ate management and my division level management,

they supervise, managers should also be able to explain

and it’s been great resistance to that kind of pressure.”

that work to non-scientists, including other agency officials and the lawmakers who determine agency budgets

According to a NIOSH epidemiologist, “You’ve got to

•

A senior manager from FDA explained, “There’s a lot of

and shape research priorities. Some scientists suggested

political skills that you have to have, when you get to a

that the most effective managers are those who can com-

senior level, in order to protect the people under you

bine scientific knowledge with political skills; one senior

… Most people don’t realize that there is probably not

scientist with experience at CDC and NIOSH suggested

a nastier work environment on earth than being in a

managers need to understand how Congress, Congres-

bureaucracy, it is incredible … You have to be willing

sional committees, and cabinet departments work, “and

to be stabbed in the back a thousand times.”

they have to be pragmatic about it.”
In addition to these qualities, which are important for
An FDA senior manager recommended that manag-

managers of scientists operating in a political environ-

ers learn about bureaucratic infighting and “how to ‘do’

ment, scientists noted the importance of managerial
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skills that are useful in a variety of settings: listening skills,

servants may resent taking on their PHS colleagues’ du-

openness to questions and ideas from others, and ability

ties. The PHS members may also fear that non-PHS man-

to mentor the employees they supervise.

agers will view deployments unfavorably when making
promotion decisions.

When asked whether managers can acquire these and
other managerial skills through training, many scientists

One scientist also reported that PHS members are now

thought that training for managers would be useful. At

required to wear their uniforms to work (something that

the same time, several interviewees suggested that some

had been strongly recommended in 2003 and become

people are not well suited to becoming managers of sci-

compulsory in 2008), creating a more visible differentia-

entists and should not be hired into those positions.

tion between the two types of employees.

One theme that arose during the interviews was that sci-

Scientists pointed out several benefits and drawbacks to

entists do not necessarily make good managers. Some

each type of career path. The main difficulty of PHS service

scientists may seek promotion to a managerial position

is the requirement of working for 20 years in order to re-

for which they feel little inclination because it is the only

ceive retirement benefits. PHS members receive unlimit-

way they can continue up the career ladder to higher pay

ed sick leave and enjoy higher salaries and more vacation

and greater responsibility. A few scientists suggested that

time than their civil-service counterparts do, although

scientists should have career advancement options that

members of the civil service have the benefit of being eli-

do not include managerial duties.

gible for annual bonuses. It is easier for PHS members to
move between agencies, and the “points” they receive for

Management of scientists by non-career employees can
also cause friction. One NIOSH epidemiologist reported
an agency-wide push to fill division director positions
with people who are hired from outside the government
on what is understood to be a temporary basis. This epidemiologist raised the concern that these hires will be

deployment count towards promotion, in some cases taking the place of points that civil servants would earn by
publishing. One scientist also suggested that supervisors
may promote PHS members more often, because they
have different options for advancing in rank and pay scale
than civil servants do.

subject to political pressure, and that the practice is “a
way of getting potentially unqualified people, who might

One NIOSH senior epidemiologist and PHS member

come in from industry, who won’t come for federal salary

commented, “The Commissioned Corps has privileges

to be a career employee, but want to come for a few years

and civil servants have rights.” This scientist was con-

and manage or wreck a group and then leave.”

cerned that PHS members with complaints about workplace issues had nowhere to turn for assistance; this sci-

PUBLIC HEALTH SERVICE (PHS)
AND CIVIL SERVICE
One issue that managers may need to address is the tension that can arise between civil servants and members of
the Public Health Service (PHS) Commissioned Corps. In
the interviews, several scientists—civil servants and PHS
members alike—noted that tensions can arise around the
different requirements that the two types of employees
face and can harm morale.

entist noted that although the civil servants’ unions do
not seem to be used often to settle complaints, it is an
option for those employees.

Feedback Mechanisms

M

anagers at all levels could benefit from hearing scientists’ concerns and suggestions, but
interviews suggested many agencies’ current

mechanisms for collecting feedback are insufficient.

According to the scientists who spoke about these ten-

Many scientists felt that their observations and sugges-

sions, problems have arisen during the past several years

tions could be useful in improving agency policies and

as PHS members have been deployed more regularly for

practices, but were frustrated by a lack of opportunities

emergency response. During these deployments, civil

to provide feedback in a meaningful way. “We are all
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scientists and we want to give our input, and we feel ne-

feedback on ways to improve things, because the agency’s

glected or dismissed if we are not asked our opinion,” one

top-down management style does not allow for it.

NIOSH medical officer said.
Scientists from several agencies stressed that feedback
When asked how scientists could provide feedback on

mechanisms must allow for anonymity, since many em-

policies or practices they wanted to improve, some scien-

ployees fear that stating criticisms openly could provoke

tists provided examples of existing mechanisms. A VHA

retaliation. Despite whistleblower laws, several scientists

manager mentioned an annual survey on employee sat-

feared that criticizing agency management could lead

isfaction; a DOD scientist noted that scientists had been

to them losing funding or other project support, being

involved in a review process that revamped documents,

transferred to a less desirable location or position, and

tools, and training; and an EPA scientist reported that the

facing even more obstacles to getting research done.

agency’s twice-yearly formal review process—at which
scientists are asked what should be done differently and

A NIOSH epidemiologist suggested that retribution for

if anything additional is needed—has been effective for

speaking out could include “cutting your funding, putting

scientists on some issues.

you in a closet somewhere and giving you no personnel
to help you accomplish your research, coming down very

Other scientists indicated that mechanisms for giving

hard on your reviews, forcing you to go through endless

feedback exist, but may be ineffective because manage-

rounds of review on everything you do.” A NIOSH senior

ment will ignore scientists’ input or because scientists will

scientist put it even more bluntly: “You get siloed, you get

be reluctant to use them.

farmed out, you can get put somewhere and don’t get to

•

•

One NIOSH scientist noted that employees contributed input to a Total Quality Management overhaul

One USDA scientist stated that she had been forced out of

in the 1990s, but upper management seemed to have

her position because she had questioned the decision to

made its decisions without taking employee sugges-

hire a supervisor who was less qualified than other candi-

tions into account.

dates—and less qualified than the people that individual

CDC scientists noted that requests for feedback are
sometimes put out, but no results seem to come from
feedback that is provided.

•

A HUD manager expressed doubt that scientists from
that agency would approach internal management or
the Inspector General to complain about a process.

•

do anything meaningful.”

An EPA scientist suggested that employees could bring

was responsible for supervising.

Setting Priorities and
Approving Research

S

cientists hired by a federal agency have a general sense of what kind of research they can
expect to conduct, but decisions about specific

research projects will depend on agency funding and

concerns to the branch chief or to the Inspector Gen-

priorities, which change from year to year and with

eral, but that these mechanisms are used infrequently.

political administrations.

Another scientist suggested that going to the Inspector General would be a career-ending maneuver.

Because they are funded by taxpayers, agencies must
prioritize research that will best serve the public. Indi-

Other scientists did not see any evidence of feedback

vidual agencies have developed processes to identify

mechanisms existing at all. When asked about venues for

and support high-quality research projects that will help

feedback, an FDA senior manager responded, “Their venue

the agencies fulfill their Congressionally mandated mis-

was ‘accept it and be quiet about it, that’s it.’” Some CDC

sions. As a result, scientists employed by federal agen-

scientists stated that they lack a mechanism to provide

cies often find themselves proposing research projects
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that must compete with others for a share of limited

IRB APPROVAL AND OMB CLEARANCE

agency funding.

Like their colleagues in academia, federal scientists must

A review of online agency policies for setting priorities
and approving research found that policies regarding
intramural research (i.e., research conducted by agency

receive IRB approval for human subjects research. Unlike
their colleagues in other settings, federal scientists must
also receive clearance from the OMB before conducting

employees) were generally less detailed than those re-

surveys. The Paperwork Reduction Act, first passed in

garding extramural research (i.e., research conducted by

1980 and amended in 1995, established a procedure for

outside scientists who apply to agencies for funding).

federal agencies to follow before initiating a collection of
information (e.g., a survey) from 10 or more people. The

For example, EPA and NIOSH describe their evaluation

agency must provide a 60-day notice of its proposed in-

criteria in detail on each extramural research grant an-

formation collection in the Federal Register and solicit

nouncement, and NIH and CDC have developed docu-

comments to “evaluate whether the proposed collection

ments providing an overview of their evaluation approach

of information is necessary for the proper performance of

to extramural research proposals.

the functions of the agency” and to “minimize the burden

At the intramural level, the most consistent policy statement across agencies is that proposed, and sometimes
ongoing, intramural research studies will be reviewed by
experts. NIOSH’s Mining Program and CDC specifically
note that those reviews are undertaken by “external” experts. NIOSH’s Mining Program specifies that the review-

of the collection of information on those who are to respond.” The agency must also certify that the collection
of information meets ten specific criteria, including that
it “reduces to the extent practicable and appropriate the
burden” on the people providing the information and “has
been developed by an office that has planned and allo-

ers must be “technical experts in their fields,”64 while

cated resources for the efficient and effective manage-

CDC refers to “subject matter experts”;65 both agencies’

ment and use of the information to be collected.”67 This

policies state that these external reviewers should be free

certification and the proposed collection of information,

from conflicts of interest. At NIH, research program priori-

along with copies of pertinent statutory authority and

ties are shaped, in part, through “professional hiring and

other related materials, then go to the OMB for approval.

promotion decisions” and resource allocation decisions.66
At the research planning stage, none of the policies describe additional procedures for evaluating confidential
or sensitive topics.

The Director of the OMB’s Office of Information and Regulatory Affairs must allow at least 30 days for public comment prior to deciding whether to approve or disapprove
the proposed collection of information. Notification of

The relatively brief descriptions contained in online agen-

the decision must be provided within 60 days after re-

cy policies related to intramural research contrast with

ceipt of the proposed collection; if that notification does

the complicated review processes described by scientists

not occur, approval may be inferred, but the agency may

at NIOSH, other CDC agencies, and elsewhere. In particu-

collect the information for no more than one year. (When

lar, interviewees note that the lag between a proposed

the Director issues an approval, it may allow for collection

idea and approval to move forward is often long.

of information for a period of up to three years.) Independent regulatory agencies “administered by two or more

Conflicts can also arise regarding which scientists should

members of a commission, board, or similar body” may

conduct specific studies. Some scientists reported in

void the Director’s disapproval by a majority vote.67

the interviews that they had been told they were not
the “right” people to undertake certain types of research,

In a 2007 article in the journal Health Affairs, Berk, Schur,

even if they considered it to fit within their job descrip-

and Feldman state that in practice, this review process “of-

tions and capabilities.

ten involves layers of review that rarely result in much
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change to surveys yet may adversely affect the timeliness
68

According to interviews with scientists, researchers now

of the data collected.” They note that pre-testing of sur-

submit a one-page letter of intent that includes a list of

vey questions is often limited to only nine cases to avoid

collaborators, a budget, preliminary data, and the NORA

the OMB review requirement, and this low threshold hin-

sector goals it is designed to meet. If the idea is of interest,

ders the assessment of design features.

researchers are asked for a full proposal that uses a format
and instructions similar to a full NIH proposal and that

RESEARCH APPROVAL PROCESSES
During interviews, the procedures that scientists described for approving research processes varied by agency—but nearly every scientist felt that funding was insufficient to meet agency needs.

can be 100-200 pages in length. Far more proposals are
invited than are ultimately funded—one scientist stated
that in one funding round,18 of the original 100 letters
of intent were funded. (Scientists gave different figures
for proposal length and the percentage funded, which
may be due to different processes in different branches

Because the interviews included several participants from

or divisions or for different NORA sectors.) Reflecting the

NIOSH as well as other parts of the CDC, these agencies’

commitment to move research into practice, a relatively

practices are described in detail below.

recent requirement in the proposal is a description of
how study results will be used.

Research Approval at NIOSH*
The framework for occupational safety and health research at NIOSH is the National Occupational Research
Agenda (NORA), which was unveiled in 1996 and extended in 2006, and is slated to run through 2016. Approximately 500 organizations and individuals outside NIOSH
provided input into the development of the agenda,
which includes 21 priority research areas.69
The priority-setting process is informed by:

•

According to the scientists’ description of the process, the
proposal then moves through a lengthy approval process
that begins with an internal review that typically involves
a team leader, branch chief, and a number of people in the
researcher’s division, including the associate director of science. It may also be reviewed by the IRB and by a person at
CDC who is intimately familiar with OMB regulations.
According to scientists, the proposal may also go to OMB,
which can request changes and require that the scientist

The number of workers at risk for a particular injury

revise and resubmit the proposal. Following OMB review,

or illness.

it may have to be returned to the IRB for approval of a revised research strategy before data collection can begin.

•

The seriousness of the hazard or issue.

•

The probability that new information and approaches

years, which can be problematic. One scientist comment-

will make a difference.70

ed, “The relevance and collaborators can change during

Scientists reported that full approval can take up to 2-1/2

NIOSH has formed eight NORA Sector Councils focused

this time.”

on specific industries (such as construction, manufactur-

A NIOSH research chemist called the process “extremely

ing, mining, and healthcare and social assistance). Rep-

onerous,” especially for projects that do not have a lot of

resentatives from academia, industry, labor, and govern-

money at stake (there is no distinction in the process by

ment serve on these councils to draft goals, measures, and

funding level). “It takes up huge blocks of time … I put

implementation plans.71 NORA also has 15 cross-sector

together a 50-page proposal, single-spaced, for a project

programs and seven coordinated emphasis areas.69

that was giving me $15,000 a year … Does that make
sense?” In this particular department, discretionary funding reportedly dropped from $250,000 in 2002 to $5,000

* While NIOSH is part of the CDC, information about the agency is reported separately because one-third of the interviewees for this project
were current or former NIOSH employees.
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in 2008. Scientists were told that “things are bad all over
and there is nothing that can be done.”

The process can also create “a negative work environ-

Other NIOSH interviewees also stated that the memory of

ment,” noted the chemist. “If you spend a lot of time com-

this Congressional attack on NIOSH remains strong and

peting for funding and you never get any, what work are

continues to inform agency decisions about research.

you then hired to do?” A medical officer at NIOSH spoke
of an overarching result of limited funds: “We try to do
things as best as we can, with what we have … I feel a
little hesitant to do a really huge [study] … because we
are all going to be using that one pot of money and I don’t
want to blow the whole wad on my project.”

President George W. Bush’s Presidential Management
Agenda emphasized performance and showing impact.72
Scientists noted that this forced many agencies to switch
from disease and health research to outcome research.
An industrial hygienist stated, “We’ve not been able to get
anywhere with projects … that have to do with exposures,

Scientists reported that before NIOSH adopted the NORA

disease, or surveillance … only those injury-related” are

process, they only needed to convince their superiors that

awarded funds.

the research had merit for the division in order to secure
project funding. One scientist stated that it is still possible
to receive research money through a division’s discretionary funds instead of using the NORA process. To secure discretionary funds, scientists propose research ideas through
their management chains, and division leaders determine
allocations. However, discretionary budgets have been reduced, so these opportunities are still limited.

A NIOSH scientist noted that the agency is now focused
on safety research because it is easier to show impact
on areas for which surveillance data is available, such
as lost work days and fatalities. By contrast, cancer related to workplace exposures is challenging to study,
and may go unresearched despite its importance. The
scientist described NIOSH’s approach as “lamp-post
research,” in which the agency studies what it already

Scientists spoke of a drain of scientists from NIOSH due to

knows. (The term, the scientist explained, comes from a

a change in management style that has reduced scientists’

joke about the man who searched for his glasses under

ability to participate in setting research priorities. Accord-

a lamp post—not because that was where he had lost

ing to a senior scientist, “All research areas are dictated

them, but because that was where he could look for

from management and you must be limited to doing re-

them most easily.)

search in these specific areas … As a consequence, eight
people have left within the last two years alone. They felt
they weren’t being treated as full scientists.”

Research Approval at CDC
CDC policies state that major intramural studies conducted at CDC centers, institutes, and offices are to be

NIOSH’s work has the potential to identify a need for private

reviewed by external experts “for scientific and technical

industries to spend more money on worker-health protec-

quality” at inception and once every five years.65

tions, which can make it a target for politicians seeking to
reduce businesses’ costs. A NIOSH team leader spoke about
how the agency became a political target in the past and
now tries to avoid repeating that experience:

Interviews suggest the process is more complex than the
policies indicate. For research to move forward, scientists
say, an investigator must write a proposal that is approved
by the team lead, by branch chiefs, and ultimately by the

In 1995, there was a bill introduced in Congress to

center’s associate director and the division director. If the

eliminate NIOSH, and the justification for it, among the

goal is to publish in a high-profile journal, such as Journal

people who introduced it was, we don’t need what this

of the American Medical Association or the New England

agency does … The agency is now very careful to not

Journal of Medicine, it must go through additional clear-

get into something that is overly controversial, because

ance, including a review by the center’s associate director

we were one vote away from being totally eliminated

of science. Decisions as to whether the research should

… I feel the area of occupational health is inherently

proceed, and be conducted by the person who has pro-

more controversial than some other aspects of public

posed it, are sometimes made by individuals who are not

health because you are impinging on industry.

necessarily researchers themselves.
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Scientists reported that CDC used to allow each program

Scientists from all agencies expressed frustration, some

to set its own strategic plan, which would include re-

more than others, about the time-consuming processes

search priorities. More formal review processes now exist

of research proposal approval. Some scientists did ex-

for both extra- and intramural research programs.

press concern about agencies setting research priorities

Some researchers believe that winning reviewer approval to move forward requires them to lay out all of their
potential findings up front, yet procedures state that information-gathering should not proceed until research
is approved. According to one branch chief: “The easiest way to do this, and everyone’s figured it out by now,
is to do the entire analysis and basically write the paper.
At that point, it’s much easier to say what you are going

or approving projects based on a desire to avoid controversial topics.

Scientific Dispute Resolution

D

uring interviews, scientists were asked about how
their agencies resolve situations in which two scientists, or a scientist and a supervisor, disagree

about a scientific aspect of their work. Such disputes

to do. But it’s completely counterproductive because the

might include disagreements about how to collect or

idea is that you are not supposed to be working on things

analyze data or differing interpretations of study results.

that haven’t been approved.”
Such scientific disputes may be beneficial if they result in
Other Agencies’ Research Approval Policies

a productive dialogue and lead to improvements in re-

Scientists from other agencies described different pro-

search. Scientists’ comments suggest that some agencies

cesses in the interviews. In general, proposed research

attempt to work through such disputes and seek agree-

was considered in light of research priorities and strate-

ment between the parties involved, while others let the

gies set at a high level. Examples include:

most senior employee “win” the dispute.

•

•

•

A scientist from FDA’s NCTR explained that every

A DOD scientist described the following process when

research project begins with a concept paper that

data-interpretation questions arose: “Other scientists

is vetted throughout the agency and ultimately ap-

would then be brought in from the outside to assist

proved by the NCTR director. Approved concepts are

in evaluating the data and try to understand the dif-

then developed into a full proposal, which is consid-

ferences. If there was a significant disagreement, addi-

ered by a nine-member Science Advisory Board and

tional parties would be brought in until the situation

by peer reviewers.

was resolved. Often times it had to do with statistical
analysis and we would call university statisticians for

According to a DOD scientist, priorities were set by

input.”

scientific and medical people at the level of Assistant Secretary of Defense or the Navy Surgeon Gen-

•

A NIOSH scientist reported that decisions were “not

eral. “Whether or not I agreed with them, they were the

necessarily hierarchical … You have to have support-

right people to be setting the … priorities, and gen-

ing evidence and justification for your argument, and

erally I did agree with them except, of course, when it

science generally wins the debate.”

didn’t go my way … You have to trust that the chain of
command has priorities and pressure they know about

•

Speaking of a situation involving a fundamental disagreement with a supervisor’s decision, a CDC medical

and we don’t.”

epidemiologist stated, “I would go to somebody who

•

A CPSC statistician reported that an idea must be in

was an expert in the area and ask them” to help clarify

line with the current policymaker’s strategy in order

the situation.

to receive approval. “I’ve had ideas shot down verbally.
I’ve never put something in writing and had it denied
in the pre-approval stage.”
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•

A CPSC statistician suggested, “If the situation at hand
is kept at the same level (e.g., all statisticians), then it

•

is more likely that a consensus will be sought. No one

As an example of how agencies fail to settle scientific dis-

person can be an expert on everything.”

putes effectively, multiple scientists brought up the case
of Dr. David Lewis. Dr. Lewis was a microbiologist work-

According to a CDC branch chief, “The highest … managerial position wins … the supervisory person wins,
no matter … even if what they are saying is ridiculous
… you can’t do anything about it.”

ing at an EPA laboratory, and his findings from research
on sewage sludge led him to think that EPA’s sewage
sludge regulation was insufficiently protective. In testimony before the House of Representatives Committee on

Procedures for resolving scientific disputes seemed to vary

Natural Resources, Subcommittee on Energy and Mineral

depending on managers’ styles as well as agency policies.

Resources, Dr. Lewis stated that he had been forced out of

Although some scientists expressed dissatisfaction with

his EPA job for “publishing research unsupportive of EPA

procedures in which seniority decided a dispute’s out-

policies.” 73 The scientists who described this case consid-

come, others found it appropriate. “Management has the

ered it a demonstration of an agency’s inability to deal

right to make decisions that you don’t agree with,” one

appropriately with a scientific dispute—and suggested

NIOSH scientist said. A manager with experience at NIH

that the story makes other scientists think twice before

and FDA deemed it appropriate for scientific disputes to

pursuing a line of scientific work that could lead to a dis-

be resolved at the level of one or two supervisors: “You

agreement about current agency policy.

should not have to go up to the Commissioner for problems like this … that is a general pattern of problem solving in the bureaucracy as a whole.”

Several scientists with experience working at NIOSH
spoke about how that agency addresses scientific disputes. Each NIOSH division has an Associate Director for

Personality issues can also influence how disputes in a

Science (ADS), a scientist who has the responsibility for

particular office play out. One scientist described “turf

adjudicating on scientific issues. Despite having a scien-

wars” and commented, “Sometimes the problem is a

tist tasked with dispute resolution, some scientists voiced

personality conflict or long-standing perceptions about

concerns about the resolution of these disagreements.

who does what, what certain disciplines can and cannot
do.” Several scientists noted that egos and personalities
often get in the way of discussions about scientific issues.

Several NIOSH scientists felt that the majority of disputes
were not resolved on scientific merits, but, as one scientist
put it, “the most unpleasant person wins.” One scientist

Often, disagreement still exists among scientists even af-

suggested that the scientists filling the ADS positions lack

ter a dispute is resolved; in such situations, scientists re-

the skills to stand up to difficult personalties, and this oc-

ported it is not uncommon for an author to remove his or

curs because of the agency’s “poor habit of taking good

her name from a manuscript.

scientists and making them managers who don’t get
much training. Some of them shy away from conflict.”

In some cases, scientists reported that they might attempt
to work through disagreements one-on-one, and amiably

A NIOSH senior scientist also noted that important details

agree to disagree if they could not settle on an outcome

about scientific disagreements can be lost as information

that satisfied both parties. One scientist noted that under

travels through layers of management to the ADS. This

these circumstances, a scientist should “just document

scientist suggested that the agency “bring in an outside

your position so that it doesn’t come into question at a

person who is not allied with one group or the other …

later date.” If a supervisor disagrees with a scientist’s in-

bring everyone together … instead of the scientist ex-

terpretation of results, the scientist might still be able to

plaining something very complex to the first manager up

publish his or her interpretation provided it includes a dis-

who dumbs it down a little bit for the next manager up,

claimer stating that it represents the scientist’s individual

and so on throughout the various levels … I think it might

views and not those of the agency.

be better to have an ombudsman.”
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If scientists from multiple NIOSH divisions are involved

ways to get information into the public domain.” Posting

in a scientific dispute, the division directors and ADSs

data, manuscripts, and reports on a website, as CPSC does,

receive written summaries from the scientists involved

is another significant mechanism for dissemination.

and hold a meeting at which they determine how the issue will be resolved. They then bring the involved parties
together to hear the decision and finalize details about
moving forward. Although scientists did not express concerns about whether this process arrives at appropriate
outcomes, some felt that it takes too much time from senior staff and delays work.

Plans for dissemination begin early at some agencies.
At DOD, for example, planning begins when research is
initially proposed and emphasizes peer-reviewed journals. “We discouraged publication in what I would call
‘throwaway’ journals that had commercial interests or
did not represent mainstream science,” explained a DOD
medical scientist. The agency has a supportive process in

Disseminating Scientific Work

I

place to assist junior scientists throughout the research
and dissemination process—developing protocols, con-

n addition to getting approval to conduct research,

ducting research, writing up findings, and submitting

agency scientists must seek agency approval to pub-

to journals. Senior researchers also work with junior col-

lish an information product (e.g., a report or schol-

leagues to revise their submissions if they are turned

arly article) describing research findings. This clearance

down, this scientist explained.

process can strengthen publications and ensure that
agencies present unified messages, but it can also frustrate scientists.

AGENCY APPROACHES TO CLEARANCE
Online policies describe what needs to be reviewed, and

In general, scientists throughout the federal science in-

by whom, with varying degrees of specificity. Some fed-

frastructure feel a strong obligation to disseminate their

eral agencies state that all information products must

findings to other scientists, and to the general public, in

be cleared before being submitted for publication or re-

a timely manner. A number of government employees

leased. Others allow their centers to set their own require-

commented that they work for the public, they are paid

ments, and do not specify that all information products

by the public, and the public has a right to know “since it

must be reviewed. Some agencies also require scientists

is their tax dollars that are paying for the research in the

to seek approval for disseminating work done on their

first place.”

own time, especially if the author’s affiliation is identified.

In particular, many value publishing in peer-reviewed lit-

At many agencies, the nature of the information product

erature because it opens up a data-driven discussion in

will influence the nature of the review process. For exam-

which anyone can participate. “If the information gets into

ple, CDC policy states that the number and qualifications

the literature, it can be accessed by a larger body,” said

of persons responsible for clearance should be commen-

one interviewee. It is also the case that information—

surate with these characteristics of the product: “visibility

data, findings, etc.—generally cannot be discussed with

or breadth of dissemination; topic’s level of sensitivity;

anyone outside of the agency without approval. There-

originality of findings; scientific or technical complexity;

fore, it is imperative that the science be approved to allow

potential to impact CDC recommendations, policies, or

for open discussion.

programs; or urgency of need for dissemination.”74

Likewise, federal agencies typically consider it part of their

The review process for research that has policy implica-

mission to disseminate scientific information to the pub-

tions typically involves more layers and takes longer to

lic, and encourage their employees to do so. “NIH is push-

complete, and it sometimes raises sensitive questions

ing people to make data available to the general public,

about a political agenda. On the other hand, mecha-

whether through publication or other forms of dissemi-

nisms are in place for expedited clearance if information

nation,” said one scientist. “Some people look for creative

needs to be released promptly or if it is not deemed very
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sensitive; as an NIH scientist noted, “literature reviews

questions, including “Were the analytic methods used

are subject to less scrutiny and more likely to be pub-

in the ‘70s adequate for identifying mercury exposure

lished quickly.”

in the range of current interest?” Required reviews in-

Many review policies call for an assessment of the quality of the information product—both in terms of its scientific rigor and its editorial presentation—prior to the
article being submitted to a journal peer review process.
For example, USGS requires three types of review prior to
bureau approval:

•

Peer review, “which ensures the scientific quality of
USGS information.”

•

•

volved a peer review panel, a technical review process,
and input from OMB and FDA’s Science Advisory Board,
and took two years to be completed—and that, said
the scientist, was an “expedited” timeframe because of
a Congressional mandate.
Even when research is ultimately released and in theory
publicly available, it can be difficult to locate, say some
scientists. “Many reports are not put on agency websites
and are not disseminated by other means,” said one sci-

Policy review, “which ensures that all policies relevant

entist. “There should be greater efforts to publish govern-

to USGS Fundamental Science Practices are met and

ment reports in the peer-reviewed literature.” In some

identifies policy-sensitive issues.”

cases, documents are actually posted on websites, but
these sites may be poorly organized or difficult to search.

Editorial review, “which ensures appropriate Bureau
standards and quality assurance for accuracy and clar-

It is important to note, however, that comments about the

ity of expression are met.”75

review process were not uniformly negative—some scientists spoke positively about the effects of review on the

SCIENTISTS’ VIEWS OF CLEARANCE PROCESSES

quality of their papers.

Across the federal government, there are often significant differences between an agency’s written policies,

ONE AGENCY EXAMPLE OF CLEARANCE PROCESS

which are in general relatively brief, and the multi-step

The contrast that sometimes exists between official clear-

clearance process that scientists say actually occurs.

ance policies and the review process in the “real world” can

Interviews suggest that the review process sometimes

be illustrated by an overview of CDC’s approach.

hinders, rather than supports, scientists’ dissemination
efforts. Several scientists used the word “onerous” in

CDC requires the Office of the Director of each center

their comments and said clearance procedures some-

to “develop and document clearance procedures for their

times became burdensome enough to discourage them

respective units” and to identify appropriate staff to man-

from publishing. Common concerns included long de-

age the clearance process. Clearance standards “should

lays and inconsistent and time-consuming requirements

be appropriate for the type of information product under

that sometimes involve reviewers who lack expertise in

review, and should balance the concerns of quality and

the relevant scientific field.

timeliness.” Agency policy calls for a timeline that should
generally not exceed one month, although that can be

Where research or information products have policy im-

extended if the author is asked to make revisions. CDC

plications, agency guidelines often call for closer review

centers are also required to have an expedited clearance

and assurances that the product reflects current policies

process during public health emergencies or for informa-

accurately. In practice, say scientists, this often restricts the

tion products requiring immediate release.74

publication of research that challenges the status quo.
Each center is to develop and maintain a matrix on the
The complexity of the clearance process is illustrated by

CDC Intranet that:

a scientist’s description of the steps involved in clearing
a Congressionally mandated FDA report about mercury in food, which was designed to answer scientific

•

Identifies the information products produced by
the center.
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•

Notes whether clearance is required for that informa-

because no one wants to take on full responsibility

tion product and which officials, if any, must clear that

for anything. There is a level of fear that comes with

type of product.

that kind of power.”

•

Specifies the level of review required.

•

Displays timelines for clearance officials.74

•

“There is an overemphasis on minor matters which are
usually less about the science itself and more about
the presentation and how it is written,” said a CDC division director.

Each CDC center or office is supposed to “monitor and
evaluate its clearance process to ensure timeliness and
improve the process,” and to develop a mechanism for

•

One scientist commented, “At CDC everyone considers themselves a subject-matter expert and therefore

resolving any disputes that arise. If a dispute cannot be

feel that they are entitled to make comments, recom-

resolved at the center level, it should be taken to the

mendations, etc. on papers. Everyone has something

agency’s Office of the Chief Science Officer for final arbi-

to say.”

tration. 74 (Further discussion of scientific dispute resolution appears in the previous section of this report.)

•

“The process is over-extended and after a certain point
there is not much more to gain,” one scientist said.

According to interviews with CDC scientists, a paper must
be submitted for clearance first to the CDC branch chief,

There is somewhat more enthusiasm for the expedited

then to the associate director for science, and finally, if it

clearance process. “If there is a time-sensitive piece, such

deals with a sensitive topic, to the center associate direc-

as a letter to the editor, the people in the process can

tor. Each reviewer has 10 business days to respond to the

sometimes be understanding of that and will push the

request for clearance but can at any point send the paper

piece through faster,” said one scientist.

back to the scientist with comments or requests for clarification, which restarts the 10-day clock.

Efforts under the previous CDC director to standardize
the research review process and bring it more in line

Scientists reported that if anyone in the review process

with the NIH review process fell short, according to one

is away from the office, the clearance request is delayed.

interviewee. The standardization attempt was likely diffi-

Further delays may occur because an earlier reviewer

cult because the NIH model is largely conducted by aca-

can send back comments at a later stage in the process,

demic institutions, whereas CDC’s research may also be

forcing the scientist to revise the work, and restarting

conducted by state and local health departments and

all clearance steps. As a result, the one-month deadline

non-profit organizations.

for clearing research papers is often missed, according
to CDC scientists. “That timeframe doesn’t really mean
much,” commented one.

One scientist noted that if one CDC scientist’s work includes a critique (explicit or implicit) of another CDC scientist’s work, the scientist whose work is being criticized must

Although one interviewee suggested that as a scientist

still receive clearance before responding. For instance, that

becomes familiar with the process over the years, “the lay-

scientist may write a letter to the editor of the journal that

ers of review become fairly easy to navigate,” many others

published the other scientist’s work, and receive clearance

questioned the process:

for the letter before submitting it to the journal.

•

A CDC branch chief called it “a very onerous review
process” that is “essentially a form of hindrance … I
don’t think there’s any benefit of having all these people look at this. It’s just a huge waste of time.”

OTHER FEDERAL-AGENCY
CLEARANCE PROCESSES
At other agencies, the following requirements are in place
for clearing information products prior to dissemination.

•

“There doesn’t seem to be a clear objective to the

Unless otherwise indicated, they address the clearance

process,” commented one scientist. “Perhaps it is

process for submission to external journal publications.
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•

CPSC: The agency requires clearance for any “release

•

of information initiated by the Commission, includ-

fied as subject to review includes materials with policy

ing information disseminated on the agency’s web

implications targeted to specific audiences (such as

site.” Articles submitted for publication to outside

industry groups, community organizations, educators,

journals must also be cleared if the article concerns

consumers, and public officials), conference materials,

the agency or its activities in any way, and identifies

fact sheets, reports, speeches, and “technical docu-

the author’s affiliation. Clearance is required by each

ments with broad and direct policy, political, social or

assistant or associate executive director whose area

ethical implications, or those used to introduce a new

of responsibility is involved. (Publications or presen-

Agency policy or requirement.” In general, other types

tations that do not relate to CPSC policies, objectives,

of technical material are not subject to review.78

or operations are not subject to clearance procedures

EPA reminds authors that drafting materials for publi-

but “are still subject to regulation on employee stan-

cation “will often require frequent coordination among

dards of conduct.”)76

originators, product review officers, content coordinators and designated reviewers.”78

CPSC allows for emergency clearance when extenuating circumstances make it difficult to complete normal
clearance procedures in a timely manner. Those mea-

•

clearance requirements, the FDA Amendments Act

of the Executive Director, the Office of General Coun-

(HR 3580) directs the FDA to establish a policy on

sel, and the Office of Information of Public Affairs and

review and clearance of scientific articles published

do not replace the normal clearance measures. “Imme-

by FDA employees. The legislation specifies that if an

diately after written clearance by each of these offices,

employee is directed by the policy to submit an article

the originator will submit a copy of the published writ-

for review and clearance before seeking to publish it or

ing for appropriate full clearance procedure,” states

present it at a conference, the employee must do so at

the policy.76
DOI: DOI requires electronic or print publications to
be “cleared through the appropriate bureau publica-

least 30 days in advance.79

•

FDA/CDER: Within CDER there is a requirement that “all
communication materials concerning FDA programs,

tion approval process,” but states that the Office of

policies or activities” be cleared. When the topic affects

Communications (OCO) has overall responsibility for

only one division, division directors and office direc-

ensuring adherence to the agency’s policy. The policy

tors are the clearing officials, although office directors

specifies that “all materials that include any message

may designate the division director as the sole clear-

from the Secretary must be reviewed and approved by

ing official for certain communications. When material

OCO” and that “all articles for publication, letters to the

describes policy affecting more than one division, the

editor, and editorial replies written by employees of

chair of the relevant Coordinating Committee is gener-

the Department in their official capacities are subject

ally the clearing official.80

to prior review by OCO. Bureau public affairs offices
will determine when review is required.”77

•

FDA: Although the agency does not appear to have
a policy available online that describes agency-wide

sures require the direct written approval of the Office

•

EPA: The lengthy list of products specifically identi-

The clearing official may request greater detail on
some or all parts of the submission. Authors may ap-

DOI/USGS requires that all information products “must

peal the decision of the clearing official to the Co-

be reviewed and approved for official release and dis-

ordinating Committee chair for discipline-specific

semination, whether they are published by the USGS

requests, or to the clearing official’s supervisor for non-

or an outside entity, if the work has been funded, whole

discipline specific requests. 80

or in part, by the USGS or if USGS affiliation is identified
with the authorship.”75 A peer review, a policy review,
and an editorial review are required.

•

NIH: Each publication or audiovisual product prepared
at an NIH institute or center must be approved by the
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director of the originating component or by the di-

consent of that tribe, a requirement that recognizes

rector’s designee. Official publications must also be

tribal sovereignty as well as prior abuses.

approved by the editorial and public affairs offices—
specifically, the Office of Communications and Public
Liaison (OCPL) in the Office of the Director, and the
Office of the Assistant Secretary for Public Affairs in
DHHS. (This does not apply to articles written by NIH
authors for publication in outside journals.)81

Multiple NIOSH scientists provided a detailed picture of
the review process at that agency. Although the process
differs from division to division, it typically involves an
internal branch review (including the team leader and
branch chief ) and two or more external reviewers, who
are often academic subject-matter experts. “It’s best to

Any employee whose draft or presentation is denied

send it to those who you consider your ‘enemies,’ such

clearance may request that the deputy director for in-

as pro-industry people, as part of the external review, as

82

tramural research review that decision.

NIH dictates that the OCPL associate and deputy as-

well as to academics, who can anticipate potential criticisms,” said a senior scientist.

sociate directors formally review the agency’s clear-

Scientists must respond to reviewer comments, and

ance policies on an annual basis, and make appropri-

then return the information product to the team leader

ate changes as needed, based in part on user input

and branch chief for approval. (If the piece has policy

submitted via emails, telephone calls, meetings, and

implications, additional review beyond these levels

memoranda. Specific contact information is provided

may be necessary.)

to encourage feedback.

81

If the authors include scientists from multiple NIOSH diviAn expedited clearance process exists when NIH pro-

sions, each division must give its approval. If authors from

vides “breaking news” to the public on research find-

other agencies are also involved, the information product

ings with immediate health implications prior to peer

must undergo cross-clearance, in which each agency ap-

review and publication. Typically, this will be a clinical

plies its own review process.

trial result that could influence the practice of medicine. A system of internal review is in place “to ensure

Scientists noted that some NIOSH information products

that information disseminated to the public summa-

also require approval from the OMB, which sends each

rizes the facts as NIH currently knows them, and that

document to a variety of stakeholders and gives them

appropriate disclaimers are attached, if necessary.”82

an opportunity to comment on anything contained in
the information product. Some scientists spoke of in-

During interviews, scientists provided additional details

stances in which industry lawyers have generated hun-

about clearance processes, including the following:

dreds of questions about information products; since

•

DOD: In a process described by a scientist as “looser
… with fewer requirements than a university,” the
DOD process involves reviews by the IRB and the
Office of Research.

•

VHA: Any research that does not go through an IRB
should be reviewed by a supervisor. Research that
is to be published should be reviewed at the highest
administrative level before its release.

scientists must respond to each external comment in
writing, these long lists of questions resulted in monthslong response processes.
Information products may also be sent to other agencies for review. NIOSH scientists who produce analytical methods for workplace sampling and analysis 83
reported that the review process for these methods
has also become more complex; additional layers of
internal and external review have been added, includ-

•

IHS: Any report containing information about a Na-

ing opportunities for CDC, HHS, and often OMB to pro-

tive American tribe cannot be published without the

vide input.
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warrant publication as official expression,”84 and USGS cri-

REVIEW FOR QUALITY AND
EDITORIAL STANDARDS

teria for approval include “products are well written and ef-

The official policies and guidelines of many agencies in-

fectively presented, and the tone is appropriate for ease of

clude overarching statements about maintaining quality

understanding by the intended audience.”75 At USDA’s Ag-

standards. For example:

ricultural Research Service (ARS), the research leader’s review is in part “to determine that it is in the best form pos-

•

CDC “is committed to ensuring that all information

sible to enhance communication of the research results.”85

products authored by CDC staff members or published by CDC and released for public use are of the

By contrast, CDC’s policy states that clearance officials are

highest quality and are scientifically sound, technically

not responsible for providing editing comments (such as

accurate, and useful to the intended audience.”

•

comments on grammar and sentence structure), since

74

those issues should be handled at other stages of the proEPA guidelines state that “all Agency communications
products, from concept to publication, are subject to
rigorous review to ensure the highest possible qual-

cess: “Review by a writer/editor may occur during the preclearance preparation and review phase, or during or after
the clearance phase at the discretion of the Center.”74

ity.” Agency administrators are expected to develop
a system of accountability to ensure that a proposed

Likewise, at FDA, CDER policy discourages the clearing

product “is necessary, accurate, consistent with Agency

official from spending extensive time rewriting or com-

policy and that it properly addresses its audience.”

78

EPA also offers these guidelines to authors: Drafts
must “effectively convey appropriate messages to the
target audience(s) … Use an engaging and positive
tone … If the document describes an environmental
problem or issue: describe what EPA has done, is doing

menting on a manuscript, though approval may hinge
on overall quality of the content and writing. “If it is not
of high journalistic quality, it should be returned to the
originator.” The policy also states, “the Clearing Official
may refuse to clear the material if it is not of high journalistic quality.”80

and will do about it [and] clearly explain how the pub… Present current and accurate statistics and explain

ADDITIONAL REQUIREMENTS FOR “INFLUENTIAL
SCIENTIFIC INFORMATION”

statistical models when used.”78

A significant new layer of requirements on the dissemina-

lic can help alleviate the problem or resolve the issue

•

tion of government science was imposed by the OMB on
NIH “expects publications or presentations by NIH
employees to meet high standards of quality, make a
substantial contribution to the field, and contain sufficient information for the informed audience to assess
its validity.”82

all federal agencies under the Information Quality Act of
2001 (also known as the Data Quality Act). The overarching requirement is that information be of high quality,
as defined by its utility, objectivity, and integrity.86 OMB’s
quality guidelines do not apply to opinions or research

Manuscripts that fail to meet an agency’s quality stan-

being published in academic journals, but those publica-

dards may not be cleared. A team leader gave one exam-

tions should include disclaimers stating that their views

ple: NIOSH can refuse to allow a Health Hazard Evaluation

do not necessarily reflect the views of their agencies. 87

paper to be published; the agency “could potentially say
‘we don’t think this is of sufficient quality,’ and it cannot
be submitted to a journal.” The team leader indicated that
while this has occurred, it is not common.

Within this framework, agencies are required to issue
their own information quality guidelines and establish
administrative mechanisms that allow individuals to seek
and obtain corrections for information that does not

Some official policies specifically address tone, clarity, and

comply with the guidelines. Agencies must also report to

the caliber of the editorial presentation. For example, DOI

the OMB director on their compliance with the guidelines

requires that publications be “constructed well enough to

and resolution of complaints. 87
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OMB outlined a peer review mechanism in its 2004 “Final

When the OMB regulations were first developed, many

Information Quality Bulletin for Peer Review,” which “es-

agencies were concerned that they introduced addi-

tablishes that important scientific information shall be

tional, time-consuming layers of review. In addition to the

peer reviewed by qualified specialists before it is dissemi-

bureaucratic requirements, these regulations were po-

88

nated by the federal government.”

tentially a means to challenge or delay findings that had
regulatory implications.

Higher standards are in place for “influential” scientific,
financial, or statistical information, defined as informa-

As required by the legislation, agencies have issued

tion that will have a “clear and substantial impact on

guidelines regarding the quality of information that they

important public policies or important private sector

disseminate; these guidelines are readily available online.

decisions,” and for a newly defined subset of that cat-

The individual agency guidelines describe the mecha-

egory, “highly influential scientific assessments.” A sci-

nisms each agency uses to ensure the quality of its infor-

entific assessment will be considered highly influential

mation and the process by which affected persons can

if the OMB Office of Information and Regulatory Affairs

request correction of disseminated information that does

determines that its “dissemination could have a poten-

not comply with information-quality guidelines. Several

tial impact of more than $500 million in any one year on

agencies provide details about how the OMB guidelines

either the public or private sector or that the dissemina-

apply to their agencies by giving examples of specific

tion is novel, controversial, or precedent-setting, or has

types of information that meet definitions of influential

significant interagency interest.”88

information or scientific assessments, or by explaining

Where influential information is involved:

•

how their agencies adapt the Safe Drinking Water Act
quality principles for their specific types of information.

Agencies must select peer reviewers based on exper-

(In 1996 amendments to the Safe Drinking Water Act, Con-

tise and balance, and must carefully examine their con-

gress specified standards of quality for the use of science

flicts of interest and independence.

in agency decision-making and for the dissemination of
public information about risks of adverse health effects.)

•

In developing an adequate peer-review mechanism,

Some of the agency guidelines refer to existing policies

agencies must consider “the novelty and complexity

or manuals on publication or peer review, which contain

of the science to be reviewed, the relevance of the in-

additional details about quality-assurance processes.

formation to decision making, the extent of prior peer
reviews, and the expected benefits and costs of addi-

•

•

tional review.”

SCIENTISTS’ CONCERNS ABOUT
CLEARANCE PROCESSES

The peer reviewers shall prepare a report describing

In speaking about their agencies’ clearance processes,

their findings and conclusions, post that report online,

scientists voiced several concerns, which included a lack

make it available to the public for comment, and spon-

of clarity and consistency in how policies are presented

sor a public meeting where the relevant scientific is-

and applied. Scientists’ experiences demonstrated a gap

sues can be discussed.

between official policies and scientists’ experiences with
clearance processes.

The agency should consider all the comments made
by peer reviewers, incorporate them where relevant

The overall sense of the review process prior to dissemi-

and valid, and prepare a written response to the peer

nation is that it takes too long, involves too many layers,

review report in which it explains where it agrees and

and sometimes allows reviewers to “just make changes

disagrees, how it will respond, and how its actions will

just for the sake of feeling they’ve made their mark on

satisfy the key concerns in the report.
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88

the document, even though there was no substantive

positive change,” stated a medical officer with experi-

Each one adds its own requirements that take time

ence at multiple agencies.

away from actually generating the data.”

Some government scientists do report more positive

•

A NIOSH research chemist recommended, “Get rid of

experiences with the clearance process, but many say

all these unnecessary layers of review. There is no rea-

it is “challenging,” “unnecessary,” “burdensome,” and/

son that you have to have so many senior scientists in

or “demoralizing.” Regardless of the official policies in

Atlanta and Washington reviewing everything we do

place, review and clearance requirements seem to be en-

that is supposed to be published as a NIOSH docu-

forced differently within the same agency, and sometimes

ment or published on the NIOSH website, it is absurd

within the same department. Two scientists working side

… All these people do is get in the way of getting

by side could have very different experiences, fostering

things done, but is that the goal? It seems to me that

perceptions of lack of continuity, confusion, and some-

[it is a way of ] making it impossible for government to

times favoritism.

get anything done.”

“I find the process burdensome, and it seems kind of ar-

Several interviewees suggested that how one experi-

bitrary because there is not a firm, consistent approach

ences the clearance process depends in part on one’s

across divisions,” said a NIOSH/EPA epidemiologist. An

rank. At NIH, for example, one interviewee pointed out

EPA statistician had a similar assessment. “The biggest

that a bench scientist and a high-level manager will

problem from where I sit is that it is not clear what the

likely understand the necessity and benefits of review

process is … We are not sure what the procedures are.”

very differently.

To some degree, this may reflect differences in subject mat-

Likewise, the experience levels of those conducting re-

ter or the level of potential controversy contained within

search are likely to influence their perspectives. One

the research. Nonetheless, as one interviewee comment-

medical officer suggested that the review process was

ed, “There should still be some sense of continuity for the

useful early in a person’s career, when it could be educa-

sake of morale, and the reputation of the department and

tional, “but as you get more advanced, I think it’s cumber-

the agency.” A senior manager with experience at FDA

some, really lengthy.”

and NIH gave a succinct recommendation: “Whatever the
process is, it should be absolutely clearly known.”

A NIOSH medical officer suggested that MDs and
PhDs “should be able to review their own material. Agency

One common frustration about the clearance process was

review feels a little demeaning at times.” DOD supervisors

the sheer number of people involved. Some scientists feel

apparently came to the same conclusion, according to

they spend too much of their time dealing with the multi-

one interview, because after being notified that a manu-

ple layers of review, and that meaningful communication

script was ready for publication, they would “many times,

between the different people involved is difficult. They

depending on the scientist’s rank, simply wave it by.”

fear that the end result will be less time for generating
data and accomplishing agency goals.

Some scientists reported that their agencies require
that information products be sent to external reviewers

•

•

A senior manager from FDA commented, “It would

for comment prior to dissemination. In cases where the

be helpful if people knew exactly how we get things

product was a manuscript destined to go through a sci-

published … I think that if you wrote it down on paper

entific journal’s peer-review process, scientists often felt

it might actually change it and make it better … and

the agency’s requirement for external review was unnec-

people would see how incredibly burdensome it is.”

essarily duplicative.

An EPA scientist said, “I think all the layers are now mak-

“I personally don’t think there is a lot of added value to

ing it harder and harder to communicate effectively.

having government agency review on top of the peer
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review process in journals,” said a HUD manager. “My ex-

scientists’ comments suggest that actual reviews often

perience with publications in scientific journals is that the

fall far short of these goals.

peer review process is generally pretty rigorous … it is not
easy to get published, and that is a good sign. For agencies
to also add their own peer review on top of that seems to
me to be unnecessary and also creates the possibility of
political interference and holding up of key studies.”

Policies regarding clearance timelines may only apply to a
portion of the entire clearance process that any single information product must undergo. The CDER timeline appears to cover the bulk of the process, while DOI and NIH
provide timelines only for the agency-level approval that

Another concern about the many layers of review is the

follows approval at the bureau level (for DOI) or the insti-

potential for breaches of confidentiality. A number of sci-

tute or center level (at NIH). Likewise, EPA products are re-

entists stated that comments from their reviewers made it

viewed at two levels (by a product review officer and the

clear they had spoken with people who had seen an ear-

Office of Public Affairs (OPA)), but timelines are provided

lier version of their manuscript. There were also incidents

only for the OPA comments. These agencies’ policies in-

in which people outside the approved review process

clude the following:

were gaining access to unpublished work. One scientist
gave an example: The spouse of one of the reviewers, who

•

CDC: The CDC calls for consistent clearance procedures to ensure that the highest-quality reviews are

was employed at another federal agency, commented

performed in a reasonable amount of time. The dead-

in a public setting about research that had not yet been

lines established for routine review and approval will

cleared for publication.

vary by the length and complexity of the information

At NIOSH, external reviews were a particular trouble

product and by the other responsibilities of the clear-

spot. “It gets to be quite burdensome if you are a pro-

ing official (for example, a branch chief may take lon-

lific writer,” said an epidemiologist. “I had seven papers

ger than a center director). However, the full clearance

last year, and I feel as if I am burdening my academic

process is generally expected to take one month or

colleagues,” who are repeatedly asked to serve as ex-

less (although the need for author revisions may ex-

ternal reviewers. One NIOSH scientist reported having

tend the deadlines).74

13 unions, eight companies, and half-a-dozen academ-

The CDC recommends that centers “give serious con-

ics review a paper, and receiving 149 comments from

sideration to shortening the overall timeline as much

just one company.

as possible,” especially for the shortest, simplest infor-

In some instances, the complexity or timeframe of the

mation products and for those prepared in response

review process discourages researchers sufficiently for

to a public health emergency, a news event, or other

them to set their work aside. “Sometimes, people get so

time-sensitive issues. To ensure that routine clearance

dispirited when they get comments from peer review-

occurs efficiently, the policy also recommends estab-

ers that they give up on the manuscript or just procras-

lishing procedures for missed deadlines, designating

tinate,” said a NIOSH team leader. In particular, the com-

alternative staff if a clearing official is not available, and

plexity of revisions in analytic method review has resulted

each office should “monitor and evaluate its clearance

in some NIOSH scientists refusing to pursue publication,

process to ensure timeliness.”74

according to one interviewee.

•

FDA/CDER: CDER instructs authors to submit materials and a clearance request form to the appropriate

TIMELINES

clearing official at least two weeks before the sched-

Agencies are not blind to the problem of lengthy review

uled presentation or publisher’s deadline for submis-

processes that delay dissemination of important infor-

sion.80 Although the clearance timelines at FDA are not

mation to the public. In their written policies, some agen-

currently specified, the FDA Amendments Act of 2007

cies call for time limits on clearance processes. However,

requires a policy that gives reviewing officials 30 days
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to provide written clearance (or “written clearance

for scientific integrity and editing, followed by five or

on the condition of specified changes having been

six additional levels of review until it reaches the exec-

made”). In the absence of clearance, authors may “sub-

utive director. This scientist noted, “There did not seem

mit the article for publication or presentation with an

to be a timeframe in which any one person in the chain

79

appropriate disclaimer.”

•

of review had to respond and pass forward the report;
things could just sit and sit.”

DOI: Assistant secretaries are to notify the Executive
Secretariat two weeks before the anticipated release

•

NIH: Agency scientists say a multi-tiered review pro-

of a major report, and to indicate whether it is likely

cess can take up to six months to complete. “If you are

to require departmental review. If it does, it must be

finally given the chance to do a project and it takes six

submitted to the Executive Secretariat at least a week

months just to get through all the committees, that is

before the release date, accompanied by transmittal

rather discouraging,” said a senior advisor.

letters and a draft press release, if required. The document may be the subject of briefing meetings with the

•

NIOSH: A medical officer involved with health hazard
evaluations of workplaces commented, “There has

secretary, or others as appropriate.90

been some trouble getting the information out in a

•

EPA: After preparing a draft, the author enters it into

timely manner. Reviewers go on vacation, so things get

the agency’s communications-product database,

backed up, or they have different points of view about

where it must be approved first by the product review

how things should be written, so there is a delay in

officer (no timeline is stated). It goes then to the Of-

hashing this out.” On the other hand, the situation has

fice of Public Affairs, which provides comments within

improved somewhat in recent years: “The agency used

10 working days. Authors are required to modify their

to have one person review at a time, but now there can

work in response to those comments. No timeline is

be multiple reviews occurring at the same time.”

given for the subsequent rounds of editing and commenting that may precede final approval.78

The review process may be less onerous to a scientist who
has learned how to navigate it successfully. A senior epi-

•

NIH: Once an information product is approved with-

demiologist stated, “You learn, as a supervisor, to change

in the institute or center, it is sent to the Office of

what you have to change to get things through … If there

Communications and Public Liaison in the Office of

is something that is really, really worth fighting for, you

the Director, which forwards it to the Office of the

have to know when to pick your battles and try to do it in

Assistant Secretary for Public Affairs in DHHS. The

a way that is going to succeed.”

manuscript is to be reviewed and returned to the
author within seven to ten days, with any requested
changes clearly marked.81

SCIENTIFIC INFORMATION INVOLVING POLICY
OR SENSITIVE SUBJECTS

Regardless of official policy, the timeframe for review and

Delays are more likely when an information product has

clearance actually varies considerably by agency, the sub-

policy implications or addresses a sensitive topic. Re-

ject matter, and even the personnel who are in the office

search that has policy implications warrants particularly

at the time, interview subjects explained. In some agen-

careful review at many agencies, with reviewers focusing

cies, scientists say it might typically take three to four

on whether agency policies are represented accurately

weeks, while in others, three to four months is often more

and whether the new research supports or contradicts

typical. In some instances, delays of a year or even two

existing policy. Official statements related to research

have been reported. Frustrations about delayed reviews

with policy implications include the following:

are common across agencies. For example:

•

•

ARS: The area director provides the research leader

CPSC: A statistician reported that the agency review

with a current list of sensitive subjects, and the re-

process involved a review by an immediate supervisor

search leader then “reviews manuscripts for sensitive
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•

•

subjects” and ensures that if a manuscript addresses

The picture that emerged from interviews was that sci-

one of these subjects it is designated as “sensitive” on

entists understood the rationale for policy reviews, and

the agency’s “Request to Submit Manuscript for Publi-

many of them felt that their information products would

cation” form.85

be cleared as long as they made clear distinctions between the research’s conclusion and the agency’s policy.

CDC: The number and qualifications of clearance officials are influenced by the “topic’s level of sensitiv-

A CDC branch chief acknowledged that the Centers “ex-

ity” and “potential to impact CDC recommendations,

cise everything which is considered to be a policy state-

policies, or programs.” However, CDC policies state

ment … There are very definitely marching orders.” But

that “clearance is not a forum for extensive peer review

this, the branch chief felt, “was a good idea because I think

or for policy debate. Such discussions belong in the

if there are policy statements then they would be written

pre-clearance phase.”74

in Atlanta [agency headquarters].” At EPA, a project direc-

CDER: The CDER clearing official may refuse to clear
material that “does not accurately reflect current
policies.”80

•

DOI: Approving officials must determine that “the
ed by the Department and that it is not merely the
expression of an individual’s or group’s projected
or desired program that does not reflect the official
Department stance.”84

that’s really inappropriate on policy. It’s not the science
conclusions that cross over into policy.”
Of concern to some was the lack of consensus about
what constitutes policy. “It seems to be up to the agency
to determine what they consider to be a policy statement,
and sometimes they can be quite broad,” said a CDC
manager. “The interpretation can be pretty draconian at

USGS requires that authors whose products are

times.” Some scientists felt that the goal of review was

of a sensitive nature—which include those with

not to achieve accuracy and clarity about policy, but to

current or future policy implications—consult ap-

avoid disseminating information that might call agency

propriate bureau and departmental officials. USGS

policy decisions into question. A number of scientists felt

specifically mentions land and resource manage-

their agencies only wanted results that supported their

ment decisions or those “that involve matters of

predetermined policies. “There are a number of people

national interest, security or potential commercial

who have had their research killed because the people at

gain” as potentially sensitive.

•

make sure an information product “doesn’t say anything
but whether it’s extending from the science and drawing

paper is descriptive of a policy position fully adopt-

•

tor said that the intent of the policy-related review is to

75

the top don’t think it would benefit their message,” said a
CPSC statistician. This seemed to be of particular concern

EPA: Agency guidelines state that officials must es-

to FDA scientists:

tablish procedures to ensure that proposed products
are “consistent with agency policy,” and top manage-

•

sions didn’t come out the way people wanted them to,

trators) must “determine whether proposed products

they would never be presented.” The scientist contin-

require review by the Office of Public Affairs for policy

ued, “The point of research was to make sure that you
were supporting FDA policy. ” Where findings seemed

78

or other issues.”

•

An FDA senior manager stated, “If the research conclu-

ment officials (such as assistant or regional adminis-

to suggest a flaw in agency policy, “the response is
NIH: The Office of the Director must approve informa-

usually that the research has been done incorrectly.”

tion that “includes any discussion of Federal policy, has
policy implications, or makes public health practice
82

recommendations.”
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•

FDA scientists said that if their research was leading towards a possible conflict with agency policy, they were

required to bring it to the attention of the Program

•

•

A scientist at CPSC reported that the 2003 annual re-

Office. General Counsel was included in subsequent

port on the safety of all-terrain vehicles was delayed

discussions, and “they would generally say to stop the

because the agency’s general counsel had a “hands-

research if it was going to come out that way.”

off” attitude towards the industry of which he had recently been a part. The report was released a year late,

An FDA economist reported being told by a center

and the scientist had at one point been led to believe

deputy director, “I literally cannot understand why you

the general counsel would never approve its release.

cannot write regulatory impact analyses that always
support our position. I just don’t get that.”

•

he would never be able to publish data on sexually

To some, this was a violation of core research princi-

transmitted infections rates among Marines stationed

ples. “My belief is that science is a search for truth, and if

in Southeast Asia. “He told an audience of 150 military

you are a researcher working within the FDA who comes

personnel that he could never get this past the chain

up with something that points to a flaw in your own poli-

of command, and everybody giggled and nodded

cy, that research should be published,” said a senior man-

their heads.”

ager at the FDA.
Nonetheless, this scientist noted that it was possible for

A physician with the DOD said a colleague was told

•

That DOD physician also reported that his commanding officer discouraged him from publishing a story

researchers to influence policy at the margin: “ ‘Our over-

about a contractor’s use of toxic pesticides in embassy

all policy is good but here is a little tweak you could make

housing in the country where he was stationed, which

to improve it.’ That kind of thing you could probably get
through, but nothing that would say ‘this whole policy is

was associated with an employee’s death, because the

ridiculous.’ The FDA doesn’t necessarily want to publish

commanding officer felt it could be embarrassing to

anything that may cause them to change a regulation, or

the embassy.

to change any policy.”

•

A CDC scientist reported that the agency’s then-director refused to allow publication of a paper on bio-

THE IMPACT OF ANTICIPATED REACTIONS
ON CLEARANCE DECISIONS

terrorism in food in Oregon, because the director had

Agencies have their own methods (explicit or not) of clas-

waves” for them. The paper was never published.

come from the industry and did not want to “make

sifying information products as sensitive. From interviews,
it became clear that some clearing officials are reluctant
to approve dissemination of information products that
may upset a particular industry or the public.

A scientist with experience at multiple agencies stated, “The agency will find all types of trivial things that
need to be ‘fixed’ to delay publication.” The interviewee
continued, “There is no avenue to complain because it

Some scientists also suggested that media attention on a

is made to look as if this is just part of the process.” In

particular topic was enough to earn it the label of “sensi-

some instances, self-censorship has also been reported

tive.” CDC scientists reported that their agency was often

because scientists were convinced they could never get

wary of publishing information that might arouse fear

their work approved.

in the general public—even though such publications
might contain important public-health information.

REVIEWERS’ CREDENTIALS

Several scientists reported instances in which clearing

Scientists throughout the federal government repeat-

officials delayed or refused approval for an information

edly stressed that scientific review should be conduct-

product that would harm an industry or agency’s image

ed by scientists. Many interviewees expressed concern

or raise an issue related to sexual activity:

that their work was being reviewed by administrative
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personnel who lacked scientific training, expertise in the

BENEFITS OF THE PROCESS

subject matter, or familiarity with the structure and for-

Despite the frequent characterizations of the review pro-

mat of scientific writing. Scientists stated that feedback

cess as burdensome or onerous, a number of scientists

from knowledgeable reviewers would be helpful, but the

commented on ways that it could improve quality and

review process as currently practiced yields few useful

help the agency reach consensus. “The clearance process

comments. Examples include:

can be an effective tool to shape things in one way or an-

•

other,” said one scientist.

An industrial hygienist at NIOSH said,“I’m not so sure that
I find our own branch and section management review

Several NIOSH scientists found value in their agency’s re-

so helpful. They’re often not subject-matter experts …

view process:

Sometimes there is a danger with this much review.”

•

•

•

The multiple layers of review have “forced studies to

“Often times a case is made in scientific terms, and it’s a

be designed to avoid the criticisms on inadequate

little weird to have the non-scientists who are reading

methodologies … It forces more discipline because

you make your case in scientific terms,” said a NIOSH

everyone knows that there is a certain standard for

senior scientist.

agency research.”

“You may be a nutritionist and find that an economist

•

“They want to ensure the science is correct, what is

is reviewing your work for appropriateness,” com-

being said is based upon what was found, and make

mented an FDA senior manager.

sure that the information is palatable to a wide audience—industry, labor, scientists, and the general

In one FDA unit, a scientist reported, research was re-

public—and that things are worded so that they are

viewed first by the FDA branch chief, then by the associ-

not inflammatory.”

ate director of the division, and then by the office director,
who was an attorney reviewing its legal implications. This
might have been more acceptable to scientists if the at-

•

“The process can make things more concise and create
an overall better product.”

torneys reviewing the research had received some training regarding the subject matters they were to review.

Several EPA scientists also spoke favorably about the process, and indicated they were able to publish without sig-

An FDA senior manager called these kinds of review “op-

nificant constraints:

pressive” and “inappropriate for the [scientific] environment,” and attributed his decision to retire in part to the

•

“I think that the process is reasonable and that the

office director’s insistence that “you just have to live with

people who complain probably don’t understand

whatever change the attorneys make.”

why certain checks and balances are needed,” said an
EPA project director, who also acknowledged that it

Personal bias towards certain branches of science also

was “cumbersome … Some of this depends on man-

seemed to influence decision-making at the FDA. In some

agement’s ability to recognize important factors that

instances, reviewers did not consider certain special-

will need additional review, and having those reviewed

ties to be strong science—a typical clash was between

early to avoid a delay in publication.”

the “hard” laboratory sciences such as physics, chemistry,
or biology and “soft” social sciences, such as sociology,

•

An EPA statistician said, “Sometimes the review comments seem to be off the mark and it is an extra hurdle

economics, or psychology.

to go through, but it also gives us some protection to
Such feelings about the review process were not uniform

have the evidence go through that process.”

across agencies, however. According to a DOD medical
doctor, “there was always a … review and it was based
on science.”
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•

“By the time a paper reached the administrator for
signature, everyone would presumably be on board,

although it was a fairly involved process to bring that

the use of professional qualifications readily identified

about,” stated a senior science advisor with experience

with CDC employment … This work includes service

at the EPA and DOD.

on boards or committees that may write or publish information products … Approval may not be granted

THE USE OF DISCLAIMERS

if the work is determined to be compensated and re-

Most agencies allow their employees to publish their re-

lated to the employee’s official duties.”74

search in journals or other outside publications, or to make

Once the work is approved, an employee may use the

presentations in scientific forums and other external set-

CDC affiliation in connection with outside informa-

tings, provided they use a disclaimer. The goal is generally

tion products as “one of several biographical details …

to ensure that the distinction between the conclusions of

provided the title is given no more prominence than

an individual and a scientific agency is clear. According to

other significant biographical details.” CDC employees

an interviewee, FDA attorneys have created a boilerplate

may also allow their titles to be used if the following

disclaimer to be used in every speech and publication; its
use was “highly encouraged by management,” but it was

disclaimer appears on the information product: “This

not clear that everyone complied. “Disclaimers are very

(article, book, etc.) was (written, edited) by (employee’s

appropriate,” said an FDA division director. “A scientist

name) in (his, her) private capacity. No official support

does not speak for the agency.”

or endorsement by the Centers for Disease Control
and Prevention, Department of Health and Human

Typically, disclaimers will state that a researcher is publish-

Services is intended, nor should be inferred.”74

ing work “in a private capacity” or that the conclusions do
not necessarily reflect the views of the employer agency.

•

CPSC: A disclaimer is required on articles submitted

Some agencies also have rules about the nature of the

for publication unless the text is approved, or the Of-

biographical information a government scientist may in-

fice of General Counsel determines it is not necessary.

clude in externally disseminated documents.

Even if the information product does not relate to
CPSC policies, objectives, or operations, it must con-

Disclaimers are often required when scientists are do-

tain a disclaimer if the authors identify themselves

ing work on their own time, which may or may not be

as Commission employees. The disclaimer must

related to their agency scientific work. A VHA manager

state “that the views expressed are not necessarily

explained, “When I do courses, I don’t speak for the

the views of the Commission. Articles not concerning

agency. I speak for the work I’ve done, which doesn’t
necessarily represent agency policy. That’s the dis-

the CPSC are still subject to regulation on employee

claimer we put on everything.”

standards of conduct.”76

Disclaimers may be required even if the research has

•

DOI: DOI limits the extent to which employees may

been reviewed and cleared by agency officials. Intervie-

use their official title in outside teaching, speaking,

wees reported that NIOSH and EPA’s National Center for

or writing. As at the CDC, agency policy says that an

Environmental Assessment require that all publications

employee’s title or position may be “one of several

and presentations have a disclaimer, while the EPA’s Office

biographical details,” provided that the title or posi-

of Drinking Water requires either that the agency not be

tion is “given no more prominence than other sig-

mentioned at all, or that the information product include

nificant biographical details.” The employee’s title

a disclaimer.

may be used in an article published in a scientific or

These are official policies relating to disclaimers:

•

professional journal provided it is accompanied by a
disclaimer “satisfactory to the agency stating that the

CDC: Employees must receive advance approval for

views expressed in the article do not necessarily repre-

work conducted outside of CDC, if the work “requires

sent the views of the agency or the United States.”91
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•

FDA/CDER: “Personal activities,” which are specifically

AUTHORSHIP

defined by CDER, are not subject to clearance, “regard-

CDC, NIH, and USGS spell out requirements for authorship,

less of whether they deal with topics bearing on the

with each one requiring that a person listed as an author

work of CDER or the Agency.” However, if the personal

must have made a “substantial” or “significant” contribu-

activity pertains to FDA programs or policy, CDER

tion to both the research and the resulting publication.

officials may require a disclaimer that reads as fol-

Both CDC and NIH base their authorship criteria on the

lows: “This [article, book, speech, etc.] was [written, ed-

Uniform Requirements for Manuscripts Submitted to Bio-

ited, prepared] by [employee’s name] in his/her private

medical Journals, developed by the International Com-

capacity. No official support or endorsement by the

mittee of Medical Journal Editors.

Food and Drug Administration is intended or should
be inferred.”80

These are the official policies:

As noted earlier, the FDA Amendments Act states that

•

CDC: Authorship credit is to be based on three conditions, all of which must be met:

if an article or presentation has not been cleared within
30 days after submission for review, the employee “may

•

submit the article for publication or presentation with
an appropriate disclaimer as specified in the policy.”79

•

Substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data.

NIH: The NIH policy states that the clearance process

•

normally eliminates the need for a disclaimer, but one

Drafting the information product or revising it critically for important intellectual content.

may still be required to make clear that the work does
not necessarily represent the NIH view. (The policy

•

Final approval of the version to be published.92

does not elaborate further regarding circumstances
under which such a disclaimer may still be necessary.)

The CDC policy also states that “all persons designated

Investigators may also need disclaimers to identify

as authors should qualify for authorship, and all those

data that is preliminary or incomplete, or to describe

who qualify should be listed. Each author should have
participated sufficiently in the work to take public re-

82

potential sources of error.

sponsibility for appropriate portions of the content. At
Scientists differed in their views about the utility of dis-

least one author, usually the first, should take respon-

claimers. Some saw disclaimer requirements as appropri-

sibility for the integrity of the work as a whole, from

ate, while others questioned why an agency would seek

inception to publication/distribution.” 92

to distance itself from work produced by its scientists. For
some, disclaimer requirements made them feel unsup-

Any disputes about author designation or author order

ported and isolated from their agencies. A senior manag-

that cannot be resolved at the division or office level

er with experience at FDA and NIOSH recalled, “I got to be

should be resolved by the center’s associate director

so frustrated at one point, I gave a talk and said ‘the views

for science, if possible. If it cannot be resolved at the

expressed here do not reflect any views or positions of

center level, it goes to the Office of the Chief Science

FDA, and in fact don’t even reflect my own views.’”

Officer for “final arbitration and ruling.” 92

Disclaimer policies seem more likely to frustrate scientists

•

NIH: The NIH states that the “privilege of authorship

when they require disclaimers in addition to, rather than

should be based on a significant contribution to the

in place of, official agency clearance. “We are still arguing

conceptualization, design, execution, and/or interpre-

about disclaimers,” a CDC branch chief said. “If they’re say-

tation of the research study, as well as on drafting or

ing we don’t speak for the agency, why can’t we just say

substantively reviewing or revising the research arti-

anything we want? Instead, it still has to be cleared.”

cle, and a willingness to assume responsibility for the
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study.” Individuals who do not meet these criteria but

According to a CDC branch chief, the agency does not “re-

provide advice, financial resources, “occasional analy-

gard papers as written by the authors. Although that

ses,” or other kinds of support should be acknowl-

might sound strange, they regard them as written by the

edged in the text, but not listed as authors.93

agency … I would separate those … I write the paper, I

A variety of practices among disciplines makes it impossible to formulate universal standards, but NIH policy advises each research group, laboratory, or branch
to “discuss and resolve questions of authorship, includ-

publish it, my name is on it, and if it gets grief and it’s all
wrong, I take the heat.”

Communicating with the Public

USGS: “Authorship should be restricted to those who

A

contributed substantially not only to the investiga-

feel an obligation to communicate with the public about

tion, providing original data and interpretation of

their work. At the same time, agencies seek to ensure the

that data, but also to the content of the information

correctness and consistency of their communications,

product. Senior authorship is normally assigned to the

and often require scientists to follow specific procedures

ing the order of authors, before and during the course

s scientists noted when speaking about disseminating information products, government science

93

of a study.”

is funded by taxpayers, and taxpayers have a right

•

person who was responsible for the most substantive

to learn from agencies’ scientific work. Many scientists

when communicating publicly.

interpretations of the information product and had
the principal role in preparing the information prod-

For most of the scientists interviewed, the main way

uct. Authors should be listed in a sequence reflecting

they communicated with the public was by speak-

their role in the study.” Individuals with administrative

ing with the news media. Scientists may also speak

or supervisory responsibilities, or those who provide

at meetings that are open to the public and press, or

relatively routine technical assistance, are not to be in-

communicate with academic researchers or other in-

94

cluded as authors.

terested individuals.

In interviews, one NIOSH scientist confirmed the concept
contained in these policies, stating, “The person who does
the most work is the lead author.”

A GOVERNMENT-WIDE POLICY
OF SCIENTIFIC OPENNESS
Promoting “a culture of scientific openness” is official fed-

Another commented on the relationship between the

eral government policy, according to the OSTP.22

lead author and the co-authors. “Once a draft is approved
by co-authors, then the co-authors do not have any more

The OSTP’s “Core Principle for Communication of the Re-

say in the work. Some lead authors will keep their co-

sults of Scientific Research Conducted by Scientists Em-

authors abreast of any changes that occur throughout

ployed by Federal Civilian Agencies” is designed to foster

the review process so that there are no surprises once

such a culture. Part of a set of principles issued in 2008 to

the manuscript has been published. Not all scientists are

guide the release of scientific research results and to com-

courteous about this.”

ply with the America COMPETES Act of 2007, this principle
reads, in part:

Several scientists also discussed situations in which authors had chosen to have their names removed from pa-

Robust and open communication of scientific infor-

pers. In some instances, that reflected disagreement on

mation is critical not only for advancing science, but

how the data were interpreted, or what conclusions were

also for ensuring that society is informed and provided

reached. In others, particularly where the authors came

with objective and factual information to make sound

from several different agencies, a challenging review pro-

decisions. Accordingly, the Federal government is

cess seemed likely to hold up publication of the work un-

committed to a culture of scientific openness that fos-

less they withdrew.

ters and protects the open exchange of ideas, data and
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information to the scientific community, policymakers,
22

not yet developed consistent and clearly articulated strategies in line with the principle that agency employees

and the public.

should share their scientific work with the media, the genTwo supporting principles—one focused on communi-

eral public, and one another.

cating with the media and one on open exchanges of research data—follow from this core principle, OSTP states:

•

Communicating with news and information me-

COMMUNICATING WITH THE MEDIA:
OFFICIAL AGENCY POLICIES

dia: “Agencies should provide for the widest practi-

Where formal policies are in place to govern the interactions

cable and appropriate dissemination of factual infor-

between government scientists and the media, they tend to

mation concerning agency scientific activities and

require, or strongly encourage, employees to seek prior ap-

their results,” and should develop and update policies

proval before being interviewed. However, many agencies

regarding employee interactions with the public and

appear to offer little or no guidance on the subject.

the press.

22

An explicitly restrictive policy at USDA’s FSIS states that
Agency policies should be designed to ensure

only executive management staff and staff from the Con-

that “employees may freely and openly discuss with

gressional and Public Affairs Office are authorized to com-

the public, subject to classification restrictions and

municate with the media. Media requests received else-

consistent with existing laws and regulations, scientific

where in the agency are to be put in writing and routed to

and technical ideas, approaches, findings, and conclu-

the Congressional and Public Affairs Office. 96

sions based on their official work.”

22

That office coordinates the agency’s official responses,

•

Open exchange of research data and results: “Re-

including determining the focus of the news story, iden-

search data produced by scientists working within

tifying the agency representative to whom the reporter

Federal agencies should, to the maximum extent pos-

should speak, and coordinating with that individual “on

sible and consistent with existing Federal law, regula-

information available for public release.”96

tions, and Presidential directives and orders, be made
publicly available consistent with established practices

NIH policy allows employees to “respond orally to questions and requests for information” from the news media

in the relevant fields of research.” 22

or to “appear as a member of a discussion panel or semiAgencies are to develop and update “clear guidelines

nar and on radio or television broadcasts without prior

regarding processes for sharing research data and re-

approval,” so long as the appearance does not require

sults generated by Federal scientists,” consistent with

written text and is not specifically disallowed by an insti-

the Information Quality Act. Research data does not

tute, center, or department policy. Speakers are advised

include trade secrets, confidential information, and in-

to limit their comments to subjects within their field of

dividually identifiable medical information.

22

A memorandum accompanying these principles instruct-

experience and to present only official DHHS and NIH positions in discussions of policy.82

ed federal agencies to update OSTP about their prog-

For news media interviews, responses, or appearances,

ress toward finalizing communication and data-sharing

employees are encouraged to seek advice from the rel-

policies by July 31, 2008. A year after the deadline, not all

evant institute or center communications office, or for

agencies had responded, and information about those

Office of the Director employees, from the NIH Office of

that had communicated with OSTP was not publicly avail-

Communications and Public Liaison.82

able at press time.95
Some agencies distinguish between media inquiries
Online searches of agency policies and the interviews

made to their headquarters and those that come in to re-

with federal scientists suggest that most agencies have

gional offices.
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•

CPSC policy requires that inquiries to CPSC head-

responses to media inquires, OEA “will accompany

quarters be referred to the Office of Information and

staff during interviews” as it deems appropriate.97

Public Affairs (EXPA), which will either respond directly
or coordinate a response from a staff person with appropriate expertise (such as a project manager, analyst,
economist, or attorney).76

•

By contrast, EPA Region 8 emphasizes that EPA’s policy
is “to operate with the maximum degree possible of
public openness, disclosure and responsiveness,” and
notes that “news outlets are a legitimate extension

•

There are a number of exceptions to this policy. Inqui-

of the public and are dealt with as such. Employees

ries made directly to the offices of commissioners do

are authorized to deal with the public and the media

not need to be referred to EXPA. As well, the executive

and are responsible and accountable for those con-

director and the general counsel may respond directly

tacts.” The policy also states that “program staff may

to press inquiries they believe to be within their “spe-

respond within their area of expertise to day-to-day

cial area of expertise,” and the Commission secretary

inquiries from news outlets and are responsible for

may respond to scheduling inquiries.76

the content of those contacts, for knowing if a com-

Media inquiries to CPSC regional offices are left to the
discretion of regional directors, although they are ad-

munication strategy is in place, or if a spokesperson is
appointed for a given issue.”98

vised to “refer media inquiries relating to matters of

Employees are required to complete a Record of Com-

potential national exposure of high-level Commission

munication form after any media contact and to sub-

policymaking” (such as the agency budget, Congres-

mit it to their supervisors, the communications office,

sional testimony, and certain matters of policy) to EXPA.

and the Congressional liaison.98

According to the policy, “If the Director of EXPA determines that any such matter requires notification to any

CDC, FDA, and NIOSH do not appear to have formal, agen-

Commissioner (including the Chairman), then the Di-

cy-wide policies about employee interactions with the

rector will notify all Commissioners immediately.”76

media publicly available online.

Field-level media contacts that fall within the juris-

COMMUNICATING WITH THE MEDIA:
WHAT SCIENTISTS SAY

diction of regional directors include sharing product
safety information (such as press releases, fact sheets,
project hazard updates, injury data, consumer alerts,
and educational material), responding to inquires with
publicly available information about hazards, and initiating meetings and briefings to discuss upcoming
CPSC programs and provide background information
for immediate or future use.76
The EPA does not have an agency-wide media policy
at all, instead allowing regional and other offices to set
their own policies, according to the agency’s response
to a Union of Concerned Scientists Freedom of Information Act request. These policies vary considerably.
For example:

Most of the scientists interviewed, regardless of their
agency, position, or rank, acknowledged the complexity
of interacting with the media. Scientists working on potentially controversial topics were particularly concerned
about saying the wrong thing in a media interaction.
While agency protocols obviously influence each scientist’s perspective on contacts with the media, personality
differences may also play a role. Overall, a majority of
scientists spoke in somewhat negative terms about the
agency press or public affairs officials who have authority to decide who speaks to the media and what they
can say. However, some scientists felt comfortable with
the current approach at their agencies, and appreciated

•

EPA Region 4 requires that all media calls be transferred

having the assistance of a media person. Others felt they

immediately to the Office of External Affairs (OEA),

should have unrestricted access to the media without

which “is responsible for coordinating and overseeing

a “minder,” while still others preferred not to speak with

all contacts with the media.” Along with coordinating

the media at all.
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A senior manager with experience at USDA and NIOSH

•

DOD: Protocol dictates that all media requests be

suggested that agencies’ approaches to media communi-

routed to the DOD public affairs office, which tries to

cation are shifting as agencies better understand the im-

determine what questions will be asked and helps pre-

portance of communication and the need for communi-

pare agency scientists for upcoming interviews.

cation training. “There has been a slow evolution to where
there is starting to be a realization that the communica-

•

FDA: At the FDA, “there are fairly strict guidelines” for
media interviews, according to a senior manager. Any-

tion stuff is really a different skill set than the science.”

one contacted by the media is to immediately notify
A Broad Pre-approval Requirement

the press office, which then sets up a telephone or

Whether or not an agency has a formal policy in place,

in-person interview, and generally listens in on the

the perception among scientists at most agencies is that

conversation. “It was clear that when you spoke to the

some sort of pre-approval is required to speak with the

media you were now speaking for FDA and you were

media. For example, despite a written policy that seems

not giving your own thoughts, you were giving FDA

to suggest otherwise, a majority of the NIH scientists said

thoughts.”

that media contacts must be pre-approved by public af-

Despite standard operating procedures dictating that

fairs officials, according to a Union of Concerned Scientists

fairly high-ranking personnel at FDA could speak with

survey.99 According to interviewees working at CDC, some

the media, this scientist indicated that permission was

scientists have experienced having to seek clearance up

not always granted, even at that level.

the ranks of DHHS for the talking points they prepare for
interviews on high-profile topics.
There is a sense among scientists at many agencies
that approval requirements have grown more stringent in recent years. For example, a senior epidemiologist with NIOSH would in the past routinely set up an
interview, and simply inform the agency media office
of what was likely to transpire. “I would call the media
office and would say ‘this is what they are going to ask
me, this is basically what I’m going to say,’ and that was

•

NIOSH: NIOSH procedures require that any scientist
contacted by the national media inform a press relations person, describe what the interview will be
about, and seek approval to participate, according to
a team leader. If the topic is considered controversial,
media personnel may offer help in creating talking
points in advance of the interview. Those who are less
experienced in working with the media may be given
more “hand-holding.”

fine.” Now, by contrast, “they want a lot more detail,

One NIOSH epidemiologist felt that procedures gener-

they want everything pre-approved, they want a pre-

ally worked well, but added, “I also know what I’m al-

pared statement, and they don’t want open interviews

lowed to say, and not, from years of doing this … they

directly with scientists.”

usually just say ‘okay’ … They want a heads-up, and
they certainly have an expectation that I know what

Some scientists noted that a shift had taken place

the rules are.”

under the Bush administration, especially during the
2004 election year. “Suddenly when people called us

The overarching requirement is to be careful not to

and asked for information, we were told not to give it

speak for the agency itself, but to confine comments to

out,” said a CPSC scientist. “I was like, ‘Whoa, we are be-

research findings, according to the epidemiologist. “I

ing funded by taxpayer dollars here, why aren’t we talk-

can’t talk about NIOSH policy, can’t say ‘NIOSH says,’

ing to the taxpayers?’”

‘NIOSH does’ … I can talk a little bit about my personal
opinion of research findings, but I have to be careful

Federal agencies at which scientists said they are expect-

that it doesn’t come across as an endorsement.”

ed to seek pre-approval for media contacts include CDC,
DOD, FDA, HUD, NIOSH, USDA, and VHA. Scientists gave

After an interview, according to a team leader, the pro-

the following examples of agency approaches:

cess is to “summarize the questions that were asked
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and your responses and then send it to the press of-

LITTLE AWARENESS OF FORMAL POLICIES

ficers, your division chief, and your branch chief. They

Many of the scientists interviewed stated that they were

wanted to be sure they weren’t caught off guard.” If

not aware of formal agency policies governing scien-

they were not quite comfortable with an answer, man-

tists’ interactions with members of the media. Scientists

agement “could call the reporter back and say ‘we want

who held supervisory positions seemed to have a bet-

to revise X, Y, and Z answers.’”

ter sense of agency expectations for media interactions

A senior scientist was less sanguine about NIOSH policies, indicating that they had changed substantially
since 2001. Historically, “you would field a reporter’s
questions, ask them to send you what they write so
you can check it for errors, send it to the institute press
officer, and inform your management chain … It is to-

than more junior scientists did, but their knowledge often came from experience rather than from explicit policies or training. Scientists who reported an absence of
formal policies or training generally did not consider this
absence to be a problem.

•

An environmental health officer at IHS said that he in-

tally changed now. Nowadays, we are not allowed to

formed his supervisor about an upcoming interview

even talk to the press. You refer all inquiries to the OD

and was told “something along the lines of ‘don’t say

[Office of the Director] of NIOSH.”

anything stupid.’ There is no formal protocol, and I
think that is a good policy.”

Several scientists noted that while their agencies expected
media requests to be directed to a press or public affairs

•

An OSHA manager summed up his agency’s approach

office, they were flexible about giving the “go-ahead” for

as “[there were] no written policies, I just had to be very

an interview to take place. In some agencies, approval ap-

careful with what I said.”

peared to be almost pro forma. For example:

•

•

According to a senior manager at NIOSH, employees

A DOD employee who worked in medical science said

were not aware of written policies, but “everybody

that while 95% of the agency’s media requests were

knew as soon as you got out of the Center, you didn’t

submitted to public affairs, “once we had an ongoing

talk off the reservation.”

relationship, public affairs would say ‘don’t worry about
it, just go ahead and tell them whatever they need to

•

ence: “No one ever handed me a set of written poli-

know.’ There was some flexibility on certain topics.”

•

A division director from CDC had a similar expericies. It is expected, if it is a high-profile activity, that

“I don’t recall a time that I was not allowed to speak

you will speak with senior science people and pol-

to the press,” said a HUD manager. “The protocol was

icy people. If it is specifically scientific, there are no

that if I did get a call, I contacted the public affairs

guidelines really.”

office. They would decide, based on the nature of the
story, whether they wanted to listen in or not.”

•

For a medical scientist with DOD, there were some very
clear, informal guidelines to follow: “Be truthful, be fac-

A CPSC scientist reported that the press office’s reach
extended beyond members of the media to academic

tual, don’t say if you don’t know, and try to speak in a
clear, concise manner.”

researchers. “I was prevented from talking to academic researchers who were researching the same things I was re-

Some scientists noted that agency protocols were en-

searching because the political appointees did not want

forced inconsistently. An EPA medical officer said, “I

me to say anything that didn’t coincide with the mes-

was actually pretty free to interact with the me-

sage they wanted to get out. They wanted total control

dia,” while an EPA environmental engineer said the

of the message. The only people allowed to talk to people

policy was “don’t talk to them. If a reporter calls you,

on the outside, including academic researchers, was the

immediately report it to public affairs.” One scientist

press office.”

stated that instructions on media inquiries depended
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on both the department in which a scientist worked

and somebody else says, ‘I’ll respond to that.’ … That’s the

and the subject matter involved.

prerogative of the people higher up in management.”

The decision to allow DOD staffers to speak openly to

Having more senior people speak with the media does

the press also seemed to depend in part on where they

not always help reporters understand the science and

were stationed and what they were working on. One

can create confusion. However, according to an epide-

DOD scientist said, “I was once told not to talk to the me-

miologist, “NIOSH is scared to death of lawsuits,” and will

dia, where I have had colleagues who were encouraged

choose whomever they deem most trustworthy to be in-

to talk to the media.”

terviewed. Several scientists emphasized the importance
of scientific rigor in describing their work to the media:

Determining Who Gets Interviewed
Once a media request is forwarded to the appropriate me-

•

“I would prefer to provide the information to the me-

dia or public affairs office, a question as to who will actual-

dia,” said a health systems specialist with the VHA.“Oth-

ly be interviewed may arise. Requests for information can

erwise information gets lost in translation.”

sometimes be dealt with at an administrative level. “Some
questions would go through administration officers to be

•

office’s young aides in the Secretary’s office are quali-

answered routinely in a certain consistent way, based on

fied to determine how to translate scientific evidence

agency policy,” said a DOD medical officer.

into what they think is understandable,” said a HUD
manager. “They are not scientists.”

Often, however, greater subject knowledge and communication skills are needed to translate scientific information accurately, and to communicate effectively with the

•

“I think our concern is that things we say can be misrepresented, or they may be edited in terms of empha-

media or the public. Some media requests are directed

sis in such a way that … the main point of what we’re

to scientists involved in the research, often with guid-

trying to say gets lost,” said a senior behavioral scien-

ance from the public affairs or press office. On sensitive or

tist who had worked at both CDC and NIH.

high-profile issues, especially those with significant policy
implications, more-senior people or political appointees

“In my experience, I do not think that the public affairs

•

“The science matters, so the idea that you simply turn

may be asked to step in to represent the agency. Under

this over to the press office and have them create

some circumstances, according to an EPA scientist, a presi-

whatever they want out of it is not my idea of being a

dential appointee may initially be asked to take a media

responsible scientist,” said a scientist who had worked

call on a high-profile issue, but then defer to a subject

at several federal agencies. “It is your work.”

matter expert who was “deemed responsible.”
A certain resentment was apparent among some sciMany scientists questioned the appropriateness of turn-

entists when higher-ranked personnel were brought in

ing over an interview to a manager or political appoin-

as agency spokespeople, even though they knew little

tee with less expertise. “Sometimes I was upset because

about the subject:

I probably know more about it than the person being
asked to speak,” said a senior manager at FDA. “But on the
other side, it was nice to be able to take those calls and
just refer them to another office to handle. It also makes
for a consistent response from the agency.”

•

“I have to say, honestly, I was mad about it,” said a
NIOSH team leader. “They were coming to me because I was a recognized expert in this area … It
might have been best to let a scientist represent the
agency as a subject matter expert, but the politics

A chemist understood the frustration of scientists who

trumped that.” In this instance, the scientist who had

have expertise but are not permitted to speak to the

initially been approached by the media had to create

media. “You spend two years on a project and you’re the

talking points for the agency director who was actu-

authority, and then somebody comes and asks about it

ally interviewed.
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•

•

“Only very high people give responses [to the media].

Some agencies provide fairly rigorous training in dealing

I feel like a child,” said a NIOSH senior scientist. “It has

with the media. An EPA medical officer said, “I thought

kept me from wanting to go through the hassle.”

that both CDC and EPA were sophisticated in their training. They had a lot of public communication, written com-

“We are not considered subject matter experts where
I work anymore,” said a CDC branch chief. “We’re not
‘experts’, so the media has a very hard time being allowed to talk to us.”

“I know that conveying information accurately to the media is not something I’m used to doing, and there could
be ramifications for everybody if it isn’t done accurately,” added a NIOSH industrial hygienist. “So I’m comfortable with someone who’s experienced in working with
the media conveying information.”
Preparing for an Interview
A media interview can be an intimidating experience, especially for scientists who have not been asked often to
participate in one. “Civil servants are very, very petrified
of the press,” said an FDA senior manager. Scientists engaged in sensitive research are especially likely to be leery.

munication, and media courses … they put folks in front
of a camera to talk about how to interact, how to do public health messaging.”
NIOSH scientists reported that their agency provides
training, with an emphasis on translating science into
something accessible to the public and developing a “single overriding communication objective.” The goal is to
stick with prepared talking points, regardless of what the
reporter asks. A CDC branch chief also mentioned spending significant time preparing talking points.
A medical scientist with DOD stated, “As a mid-level scientist and science manager … I was sent to specifically study
Congress, how the judicial system operated, and how the
federal government operated.” The scientist considered it
an excellent experience that would not have been available in either the private sector or academia.

A NIOSH team leader said they “fear repercussions” and
feel they have to be very careful about expressing an

On the other hand, training was not always perceived

opinion that could be picked up by the national media.

as adequate. “I thought that there probably should

An FDA scientist said he would always ask that a media

have been more media training. We did have some,

contact send him questions in advance so that he could

but it was sort of random, ad hoc training,” said an FDA

prepare a response.

senior manager. This individual took it upon himself
to guide younger, less experienced scientists through

Some scientists thus found press officers valuable gate-

their media sessions.

keepers who could help them hone their focus in advance
of interviews and develop talking points:

•

One scientist, who has worked at both NIH and FDA,
said, “It’s helpful because they are on your side, they
coach you.”

•

•

Public Affairs Office Participation
Once an interview is scheduled, scientists at many agencies—including CDC, DOD, FDA, HUD, and the VHA—said
that a press or public affairs person sometimes listened
in person, or on the telephone. Several agency staff said

A CDC medical epidemiologist praised the communi-

that press office representatives were present primarily to

cations office for helping to guide the interaction and

see what happened and what was said, and did not inter-

identifying parts of a project that are of greatest inter-

fere. “We don’t do anything without someone from public

est to the media.

affairs in the room,” said a VHA scientist. “[But] there is no
censorship there.”

“Public affairs would help to translate what I had to say
into something that was perhaps understandable to

Nonetheless, it can have a “chilling effect,” according to

the reporters,” said a HUD manager. “It is always a chal-

a CDC branch chief, who said a press officer was on the

lenge to translate science into something that can be

line during every media interview. “Press officers usually

absorbed by the public.”

don’t say anything while on the line, they are there more
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as a reminder to keep on track with the talking points. You

chief said that the press office would “tell reporters that

know they are there.”

you’re out of town when you’re not.” Another CDC scientist said, “You have to get clearance to speak with the

VARYING ATTITUDES TOWARD
AGENCY OVERSIGHT
An environmental engineer at EPA captured the overall

media, and you cannot tell the media that you must have
clearance to speak with them … It keeps media and scientists from speaking with one another.”

ambivalence some scientists have towards approval re-

One scientist indicated that her agency would “do almost

quirements. “On the one hand, as the agency you need to

anything to keep reporters from interviewing me. They

speak as one voice, you cannot have people undermin-

would say things to the reporters such as ‘oh, you have

ing that. On the other hand, we’re a public agency and we

the wrong person, she really doesn’t know anything about

work for the taxpayers, and I think we should be as open

this’ or ‘she’s shy and she won’t give interviews.’” Even

as possible.”

when questions were being asked about a specific pa-

Tension between scientists and agency media offices
sometimes ran high. In a Union of Concerned Scientists
survey, CDC scientists reported difficulties speaking freely

per she had published, the press office told her, “We don’t
think you’re the one who can answer these questions, this
is really an issue for another office.”

with reporters.99 This was confirmed by a CDC branch

Others felt more comfortable with a process they saw as

chief who said that speaking to the media had become

designed primarily to have the agency speak with a single

much more controlled in recent years. “There is much

voice. According to an OSHA manager, “It would certainly

more oversight now when you speak to the media … It is

have been my preference, as a manager, that any requests

a very, very difficult area.” This individual said that report-

from the media go through the agency’s press office and

ers had to formulate their questions “in some way that the

there would be some kind of attempt to think through

CDC press office will decide that I can answer them.”

what was going to be said to the press before any agency

Some scientists, especially those at senior levels, found

person, including scientists, would get an interview.”

ways to work around certain agency approval require-

An EPA project director agreed. “There needs to be over-

ments. One approach was to speak “off-the-record” with

sight, make sure that the right person is contacted, and

reporters on deadline with whom they had long-standing

that’s what the public affairs office does.”

relationships. Once the agency press office approved the
request, the scientists could then speak in an “on-the-re-

An epidemiologist who has worked at EPA and NIOSH

cord” capacity.

said the media contact process had not been problematic. “We’re encouraged to talk about our work with the

A veterinary medical officer at USDA described another “workaround” strategy. After being told specifically
that “if an issue came up, we should not talk to the me-

media when we’re contacted. We just need to make sure
we involve our press officer and give him the option to either participate with us or to let us handle it on our own.”

dia,” the scientist referred inquiries to the district office.
However, this individual would also talk to a reporter

Along the same lines, a CDC medical epidemiologist said

who called at home. “If a reporter called me at home, on

that it was probably best for CDC to track media inquiries

my personal time, I would deal with it myself.” The scien-

and make sure they are referred to appropriate spokes-

tist indicated that it would definitely be a problem if the

people, rather than be handled randomly. “I’m sure there’s

agency learned of the media contact, but did not expect

some distortion of the message that occurs on some is-

that to happen.

sues, but I can’t say I’ve ever experienced that myself.”

Several scientists also described actions by press officers

Most scientists felt that a certain amount of oversight is

or public affairs representatives that seemed overtly

appropriate when scientists (or other federal employees)

intended to discourage media contacts. A CDC branch

are speaking for agencies, provided that the oversight
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process does not interfere with a scientist’s ability to com-

may believe they have to ownership of data acquired

municate effectively. A CDC epidemiologist described an

or generated using federal funds. Such data are, in fact,

ideal “happy medium between making sure the spokes-

owned by the federal government and thus belong to

person doesn’t say something that is totally at odds with

the citizens of the United States.” 106

where the agency stands [and] being totally in control of
Making data available, according to the CDC policy,

everything, and not having any respect for your staff to be

will improve its quality and consistency and build

able to know what to say.”

trust with outside partners and the public by providing an opportunity for them to openly critique

AGENCY COMMITMENTS TO SHARING DATA

CDC investigations. 106

Another important method for communicating results of
scientific work to the public is federal agencies’ sharing of

•

“Access to government information is essential in or-

data they collect. Many agencies make various databases

der for EPA employees to accomplish EPA’s mission of

available to the public, including the following:

protecting human health and the environment and for
citizens to be informed about their environment.” As

•

CDC’s Web-based Injury Statistics Query and Report-

such, it is EPA policy that the agency’s information

100

ing System

products (regardless of format and with appropriate
exceptions) “will be created, collected, maintained, and

•

EPA’s Integrated Risk Information System101

•

FDA’s Adverse Events Reporting System102

•

NIH’s Major Histocompatibility Complex Database103

•

USDA’s National Nutrient Database104

to disseminate data as broadly as possible with the need

•

USGS’s Real-Time Water Data for USA105

to maintain high standards and protect sensitive informa-

managed in a manner which will promote access.” 107
At the same time, each agency recognizes the importance
of adequate safeguards. The CDC, for example, notes that
the data release and sharing policy “balances the desire

tion … CDC also recognizes the need to maintain high

In its 2008 memo, OSTP called for agencies to adopt “clear

standards for data quality, the need for procedures that

guidelines” for sharing research data and results generat-

ensure that the privacy of individuals who provide person-

ed by government scientists.22 In 2009, publicly available

al information is not jeopardized, and the need to protect

policies on data sharing were found on the websites of

information relevant to national security, criminal investi-

106

CDC,

107

EPA,

108

and USGS.

gations, or misconduct inquiries and investigations.”106

The CDC, EPA, and USGS policies emphasize the impor-

CDC and USGS emphasize the importance of timely data

tance of ensuring data quality and dealing appropriately

sharing in their policies, although only CDC provides a

with confidentiality, privacy, and security. CDC makes each

specific timeframe for releasing information:

of its centers responsible for developing specific procedures to meet these goals.

•

CDC centers should include procedures to release
data “as soon as possible after they are collected, scru-

The value of data sharing is described as follows:

•

tinized for errors, and validated. This release should occur no more than one year after these activities.” 106

“CDC believes that public health and scientific advancement are best served when data are released to,

•

USGS policy states that publication or other methods

or shared with, other public health agencies, academic

of release should occur as promptly as possible. It

researchers, and appropriate private researchers in an

also provides a strategy for early release when there

open, timely, and appropriate way. The interests of the

is an immediate demand for the data and prompt

public—which include timely releases of data for fur-

publication is not possible: “The material should be

ther analysis—transcends whatever claim scientists

released in open-file format, including appropriate
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announcements, and where applicable, the reports

date to the Bush Administration, are cumbersome,

thus released should contain an adequate statement

unworkable, and mostly political in nature. A team

of their preliminary nature and that the information

leader at NIOSH working within these restrictions

may be subject to change.” 108

expressed great frustration, saying, “I feel that it was
politically motivated … They don’t want to have their

Both the CDC and USGS suggest the importance of fair-

data analyzed … and studies done because they are

ness in their policies. CDC “strives to have data release

afraid of what we might conclude or … discover, and

policies that are fair to all users, regardless of their orga-

that we might publish and that would be embarrass-

nizational affiliation.”106 USGS staff are prohibited from

ing for them.”

disclosing information to others “until the information
is made available to all, impartially and simultaneous-

•

VHA scientists suggested that access to information

ly” through publicly released information products ap-

has become more restricted in recent years, even

proved by the Director (“except to the extent that such

though data sharing is still needed to complete certain

release is mandated by law”).108

types of assessments and research. They suggested
that difficulties in data sharing might stem from turf

Inter-agency Data Sharing
and Communication

B

ecause many public health issues involve the work

sensitivities as well as the recent development of incompatible data systems.

•

A statistician at EPA reported that the OMB and the

of multiple agencies, federal scientists often wish

Paperwork Reduction Act make it difficult to obtain

to communicate and share data with colleagues at

data from state agencies. “It has been burdensome

other agencies—but scientists at some agencies find it

and has greatly slowed down our access to environ-

difficult to do so.

mental information.” Without current data, it becomes

Interviews with scientists suggest that they can often face
challenges in gaining access to data generated by other

more difficult for the agency to explain and defend its
proposed rules.

scientists within their own agencies, or elsewhere within

Despite barriers, many federal agencies expect and need

the federal government. The extent and nature of the

to be able to work together on issues of common concern.

challenges depend on the agency and the department.

A HUD manager offered the example of EPA and HUD

For example:

collaborating on environmental health issues related to

•

NIOSH scientists described data-sharing difficulties
due to both bureaucratic and technological constraints. One scientist noted that a poor intranet system makes it difficult to communicate even within the
agency; scientists may be unaware of research their
colleagues are conducting.

housing, and suggested that EPA’s Office of Research and
Development should do more to support this process.
According to this scientist, the problematic lack of coordination between these two agencies was evident in the
aftermath of Hurricane Katrina, when EPA and HUD sent
inconsistent messages to the public about indoor mold,
and the inconsistencies reduced the messages’ effective-

A further challenge noted at NIOSH is the Memo-

ness. A similar problem arose when EPA issued a new rule

randum of Understanding (MOU) between OSHA

on renovation and remodeling, which would have allowed

and NIOSH, which limits NIOSH access to OSHA

for less-effective lead paint remediation procedures that

data. Some interviewees believe the intention be-

HUD prohibited in federally assisted housing because

hind the MOU is to allow OSHA to prevent analyses

they were insufficiently protective. The HUD manager felt

agency management may not like. Scientists could

that because the two agencies had not worked together,

see no scientific rationale for this MOU, and reported

EPA’s rule failed to consider the most up-to-date research

that its restrictions on the use of OSHA data, which

that HUD had conducted.
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On the other hand, the HUD manager described a good

body of researchers, academicians, health care provid-

experience when HUD coordinated with EPA and CDC

ers, environmentalists, children’s advocates, profes-

to develop an evidence-based public health law that de-

sionals, government employees, and members of the

fined a lead-paint hazard. According to this scientist, HUD

public who advise EPA on regulations, research, and

alone would not have been able to develop the legisla-

communication issues relevant to children.”109

tive language and support its passage, thus defining an
evidence-based health standard. The inter-agency collaboration and coordination were essential to the success. A
medical officer spoke to the fact that when agencies work
together, “it’s really hard to politically get around two departments simultaneously.”

Data sharing seems to work most smoothly when the
agencies involved have developed mechanisms designed
to facilitate information exchange. A scientist at the EPA
Office of Ground Water and Drinking Water stated that
internal access to data is relatively straightforward and
that mechanisms are in place to exchange data and docu-

An EPA scientist praised the coordination of agencies ad-

ments with outside agencies, which improves the final

dressing the Libby, Montana Superfund site in EPA Region

product. “Everything is pretty public,” said another EPA

8. He explained that EPA oversaw collaboration between

scientist. “We have a tracking process that tells you where

EPA Region 8 employees, a regional health administration,

[the document] is in the process. We tried to make it as

a regional health administrator for HHS, and a regional

public and transparent as we could.”

health administrator for EPA. “It was very effective because you had so many dedicated people to look across
the spectrum instead of … each little group coming and
doing their thing and getting out of Dodge.”

While some agencies evidently promote informationsharing between agencies, others seem to discourage it.
Concerns about barriers to inter-agency scientific communication arose repeatedly during interviews, and some

In general, interviewees felt that the quality of the sci-

scientists suggested that their agencies are too fearful of

ence tends to improve when agencies share information

problems that might be caused by such contact.

with experts in related areas of the field. Several scientists provided examples of effective data sharing, including the following:

A senior manager at FDA said that scientists were not allowed to contact colleagues in other agencies to discuss
a scientific topic. Although this individual nonetheless did

•

An EPA scientist noted that the American Waterworks

so, “it was completely discouraged. You would get in trou-

Association and the Association of State Drinking Wa-

ble … It was not, in that sense, a scientific atmosphere.”

ter Administrators provide data to the branch of the
EPA that monitors contaminants in the water. This
benefits the EPA because these outside stakeholders
can typically obtain data and perform surveys more
quickly than the federal government can.

The prohibition extended well beyond communications
with scientists. “We were told we should not communicate with anybody outside of the Center without going
through the attorneys,” said an FDA scientist. “You should
never talk to anybody in Health and Human Services, the

•

A HUD manager described a collaborative effort

Office of Management and Budget, and of course you

among scientists, through the President’s Task Force

would never speak with anybody from Congress.” Anyone

on Environmental Health Risks and Safety Risks to

who wanted to have a conversation with staff in those

Children, which was composed of “agency scientists at

offices was required to be accompanied by a member

fairly high levels.” The task force produced interagency

of FDA’s legislative office, who would lead the conversa-

reports on lead and asthma, and initiated the National

tion. “You couldn’t say anything unless the attorney more

Children’s Study, which is investigating environmental

or less approved it.”

influences on children’s health.
On the other hand, a statistician at EPA said that it was

•

An EPA project director spoke highly of the Children’s

easy to communicate with external experts but that in-

Health Protection Advisory Committee, which is “a

tra-agency dialogue could be problematic. “Sometimes it
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feels like there are barriers between branches and divi-

While some agencies actively encourage their scientists

sions in EPA.” A NIOSH medical officer concurs, stating, “I

to attend outside meetings and conferences, others are

think we don’t share our information as well as we should

reluctant to do so. Scientists’ comments indicate that per-

… with our coworkers, so we don’t have to reinvent the

mission to attend meetings and conferences seems to

wheel every time.”

depend, at least in part, on the agency involved and the
supervisor and/or political appointee under whom a sci-

COMMITTEE PARTICIPATION

entist works.

During interviews, some scientists noted that they had

Formal agency policies on meeting attendance gener-

engaged in communication and data sharing with col-

ally do not appear to be available online. One exception

leagues within and outside of federal agencies by par-

comes from FDA’s CDER, which states, “Participation in an

ticipating on committees, including interagency working

outside meeting represents a substantial effort and cost

groups, international committees, and review panels. Of

for the Agency and Agency resources should be used to

the scientists who stated that they had represented their

maximum effect. In general, the meetings in which CDER

agencies on committees, most considered their commit-

staff participate should be open to the public, not spe-

tee service to have been a positive experience.

cific to one or a few drug companies, and not arranged or

Scientists found that committee participation was a
means of gaining additional information from colleagues
either within or across agencies, as well as aiding in building communication and data sharing with said colleagues.
It appeared that agencies would sometimes place their
scientists on committees with the goal of staying abreast

sponsored by for-profit organizations.” When staff members receive a request to speak on a CDER policy matter,
it must be forwarded to an “Authorizing Official,” who will
decide whether CDER should supply a speaker and, if so,
which employee is best qualified to represent the agency
on the particular subject.110

of new and relevant information. An EPA project director

According to several scientists, participation in pro-

stated, “[I was placed on the committee with] the under-

fessional meetings seems to have been curtailed in

standing that I would bring back information and brief

recent years, in many instances due to funding reduc-

them regularly on the study and how it’s going, and that

tions, but most scientists indicated they could attend

was factored into our planning of [our own research].”

one or two such events a year. Many scientists agree

Some scientists serving on committees reported that
they received training to ensure they followed agency
policies, while others did not. A research chemist from

that attending meetings is essential to their professional development, and should not be viewed merely
as a perk.

NIOSH stated that NIOSH scientists serving on commit-

In interviews, many scientists emphasized the benefits

tees were required to go through ethics training, whereas

of outside meetings and conferences, and some felt

an EPA assistant center director’s experience with training

their agencies did not fully appreciate how much could

was limited to being told to “keep your mouth shut.”

be gained:

Professional Development

•

I

“Those who are viewing the literature see a growing
amount of studies coming out of Asia, from China, Ja-

nteractions with colleagues from scientists’ disciplines

pan, Korea,” said a NIOSH industrial hygienist. “It con-

are crucial for professional development. For many sci-

cerns me that it’s becoming harder and harder for US

entists, attendance at professional meetings is the most

scientists, in the government anyway, to interact with

important way for them to build professional relation-

anyone from other countries.”

ships, receive feedback on projects, and learn about new
developments in their fields. Nonetheless, many scientists

•

“I think that scientists going to scientific meetings is

felt their agencies did not fully appreciate the benefits of

a fantastic way to improve your science, and we just

attending scientific meetings.

need more money dedicated to that,” said an FDA
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senior manager. “Attending meetings is viewed as a

•

FDA, who her whole career she paid for meetings out

perk, which is kind of silly.”

•

“I know one woman, an economic researcher from
of pocket,” said an FDA senior manager. “She couldn’t

A NIOSH research chemist emphasized how much eas-

get the money to go. She felt it was important for her

ier it is to work in person with scientists, rather than by

career, so she paid for it herself, but most people would

conference call or another similar medium. “As far as I

just not go.”

am concerned, there is no substitute for it. You have to
be able to travel, that is absolutely essential, because if

•

you can’t travel you’re isolated and you die as a scien-

portant to me personally,” stated a CDC branch chief. “I

tist. You have got to be able to travel to present your

would take vacation time and attend at my own cost.”

own work, to listen to other people present their work,
to interact with other scientists, to foster future col-

•

“There should be a commitment to professional devel-

•

cation credits,” reported a veterinary medical officer at

a HUD manager. “Managers should recognize that is

USDA. “They never paid for any of that.”

part of their job, to get those resources.”

encouraging participation in professional events but unable to pay for it. CDC sets aside $1,000/year in Individual
Learning Accounts,111 which can be used to pay meeting
registration costs, but not for transportation or lodging.
Scientists at NIOSH noted that their agency’s method for
distributing research funding makes it difficult for scientists to travel because it does not account for the entire
life cycle of a research project. It generally covers the data
collection, analysis, and manuscript writing, but does not
cover the costs of distribution and dissemination of information at conferences. As an industrial hygienist from
NIOSH put it, “You end up with the funding for the study,

“I had a hard time getting [time off work] to go to yearly meetings that I needed to get my continuing edu-

opment … there should be resources to do that,” said

Finances were a significant barrier, with some agencies

“The travel budget at HUD was always inadequate,” recalled a HUD manager. “I had to pay for my own travel.”

laborations, and so on.”

•

“We were not encouraged to participate, but it was im-

•

A senior manager at FDA said, “The government does
not pay for your participation in professional societies, and they cannot give you time off to participate
… it is part of … what Congress decides to pay for. It is
viewed as a perk rather than a necessity. It is thought
that societies may influence you and you may influence societies.”

Complex approval processes may also discourage some
scientists from seeking agency support for travel to meetings. “It is so burdensome to go through our travel requirements that oftentimes it is just easier for me to set
up travel with an NGO [non-governmental organization]
and take a vacation day,” a CDC epidemiologist said.

but then you have nothing to go to meetings on, so you’re

Scientists at higher levels within their agencies seemed

competing for discretionary funds along with all of the

to have more positive experiences. A VHA manger said

other folks in your branch with similar needs.”

that funding for conferences “hasn’t been much of an

In some instances, scientists reported paying their own
way, and even using vacation time, to attend conferences and meetings. One administrator who has worked
at a number of government agencies recalled spending

issue,” but acknowledged that it was easier for those in
higher positions at the agency. Likewise, a CDC branch
chief said, “I give a lot of talks at scientific meetings and
there is basically zero oversight in that.”

$10,000 of personal funds one year to give talks because

The bias toward allowing senior scientists, but not their

information dissemination was necessary but the agency
was under severe financial constraints. Other scientists re-

lower-ranking counterparts, to attend conferences was a
source of frustration to a CPSC statistician. “I was discour-

ported similar situations:

aged from going. There was very little budget, and the
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people who got to go were long-time senior people who

Two scientists reported that if more than 20 employees

were shown to be incredibly loyal and not likely to be

wanted to attend a single event, a memo or letter had to

seen as a ‘loose cannon.’”

be written describing the necessity for the larger number.
Some interviewees believed the restriction was imposed

On the other hand, a DOD medical scientist indicated that

to reduce the potential for scientists to abuse the travel

all researchers were encouraged to develop profession-

privilege, and branch and division management were

ally, to be actively involved with pertinent professional

said to be sympathetic to researchers hampered by the

organizations, and to attend national and international

limitation but unable to do anything about it.

meetings. “We strongly encouraged our junior researchers to present at least two or three international meetings

Likewise, a NIOSH epidemiologist reported that the

a year. Funding was always available for quality papers to

agency had customarily sent approximately 90 people

quality organizations.”

to the industrial hygienists’ annual conference, because
more industrial hygienists are employed at NIOSH than

Some agencies require, or at least strongly prefer, scientists to actually be presenting a paper in order to attend
an event. “If you want to go, then you have to show why
you’re going, and that means you have to present something,” said an assistant center director at the EPA. Such

at any other federal agency, and this is their main conference. But “somebody in CDC just made a blanket determination that only 12 NIOSH people could attend … it
was purely bureaucratic and had no objective correlated
to what was needed.”

requirements can present barriers for scientists working
on multi-year projects, who would welcome colleagues’

Some scientists considered scientific-meeting attendance

input but may not be ready to make a presentation. “You

useful in principle, but had personally decided to reduce

are not allowed to attend and participate at a confer-

or halt their own travel to professional scientific events.

ence unless you have a manuscript ready to go to a

In a few cases, scientists disliked attending meetings or

journal,” said a senior NIOSH epidemiologist. “If you are

felt that they had already been to enough of them. More

doing a 10-year research program, you can imagine the

often, scientists felt their agencies made travel too diffi-

chilling effect.”

cult. With reductions in administrative staff, some scientists are left to arrange travel logistics on their own, and

At some agencies, scientists scheduled to make a presen-

feel unable to spend the necessary time doing so. In other

tation were expected to make the same presentation in

cases, scientists simply find it too difficult to arrange for

advance to colleagues and sometimes supervisors who

time away from the office. According to a CPSC statisti-

offered feedback. A common practice at FDA and NIOSH,

cian, “CPSC didn’t want us to be out of the office … em-

this was generally considered helpful for junior people

ployees were not even allowed to go to our own Com-

but somewhat burdensome for those who are more ex-

mission meetings unless we had a role there … We were

perienced. “It may be more valuable for newer people, but

supposed to be working.”

for experienced scientists, frankly it’s a waste of time,” said
a NIOSH research chemist. At FDA, the intent is to make
sure a presentation “goes out in a certain way,” said a senior manager. “People would go through their slides, give
their talk, and as they were doing it, they were getting
feedback—‘change that slide,’ ‘don’t say this, say that.’”

Influences on Government Science

S

cientists in many federal agencies are subject to
numerous influences. Congressional representatives, agency managers, and political appointees

may exert their influence explicitly, or scientific activity

According to scientists, some agencies impose other re-

may be shaped in more subtle, bureaucratic ways. There

strictions on conference attendance. During the Bush ad-

may also be considerable public- and private-sector in-

ministration, a restriction was placed on the number of

fluence, either exerted directly on an agency, or through

CDC employees who could attend any one conference.

elected officials.
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Most scientists said these influences were a significant

•

“The first time I found out that decisions were made

burden on their work, especially when they were asked

politically, I became indignant,” said the FDA senior

to redirect their work, often quickly, in response to shift-

manager. “Then, after a while you realize that this is the

ing “political whims.” However, some also acknowledged

world you live in.”

that outside influences could bring new ideas and new
voices to the table and help identify issues appropriate

•

remark: “We work for a political agency, and this is just

for agency study. “There is not a lot of interference but

the way it is.”

there is lots of debate,” said a HUD scientist. “This should
be encouraged among staff and outside experts.”

•

A NIOSH team leader said, “I used to think that politics
had nothing to do with what we do here, when I was

Scientists distinguished between what they considered

very new. But the longer I’ve been here and the higher

to be appropriate influences, such as an organization

I’ve gone … I think politics are more important than I

requesting that an agency study a particular topic, and

thought … They influence what’s done … They influ-

attempts to influence science inappropriately, such as

ence what the agency chooses to pursue to research.”

a member of Congress pressuring an agency to slant or
suppress findings that might displease a constituent

A health systems specialist at the VHA made a similar

•

A senior manager at FDA stated, “I always said the FDA

group. They also noted that some forms of influence, such

is a science-led and science-driven agency, but in fact

as requirements imposed by Congress, might be appro-

they are not. It is an agency that executes the laws that

priate but could still cause the agency to direct its ener-

Congress says they should.” When the law and the sci-

gies away from work scientists considered crucial to their

ence do not mesh, “the law trumps the science.”

agencies’ missions.

WIDESPREAD INFLUENCE

CONGRESSIONAL INFLUENCE
ON RESEARCH PRIORITIES

Although some scientists were surprised to discover

When asked about influence on their work, many sci-

the extent to which government science is shaped by

entists identified Congress as a major force in shaping

internal and external forces, many were willing to ac-

their research priorities. Elected officials often push

cept it. One interviewee said that whether they work in

agencies to conduct specific studies that will please

government or the private sector, scientists are never

their constituents, whether or not they are truly ap-

entirely independent.

propriate research topics, or meet needs identified by

Some scientists also indicated that attempts to exert influence come from all political perspectives. “It’s not just

agency scientists. For example:

•

A DOD physician said, “I thought there was way too

the Bush Administration, it is everyone in DC,” said one.

much money being spent by DOD on things like

Likewise, an FDA senior manager said influence is exerted

Howitzers that were appropriate for fighting Soviet

by “both political parties.” A medical officer with experi-

forces.” This individual thought that work was being

ence at multiple agencies explained, “Certain issues were

funded to “give money to some district in Kansas,” de-

elevated and certain ones were lowered based on politi-

spite the opposition of military officers who were say-

cal interests, and monies tend to flow the same way.” This

ing “we don’t need that piece of junk, it’s 15 years past

scientist did not see a pattern of influence based on who

what we need. We need to do more malaria research.”

was in office.

•

According to an EPA scientist, after Congress set aside

Comments from scientists with experience at several

some funds to conduct a long-term study as part of a

agencies illustrate the pervasive nature of influence on

recommendation made by the EPA’s Science Advisory

government science:

Board, a Congressional representative expected that
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•

some of the funds would be used to complete a spe-

Advisory Board. Every year, the board identifies the topics

cific risk assessment on the health effects of trona,

it believes should be researched and submits a report to

a byproduct of a power plant in Alexandria, Virgin-

the Administrator, who “usually nods and smiles and says

ia. “It seemed that the expectation was that the EPA

‘thank you,’” according to one scientist. “But that is some-

would drop everything and look into the issue,” said

times all that happens … If the funds of the agency are al-

the scientist. Some at the EPA saw this as a “political

ready spoken for, how are they to be redistributed based

ploy” to satisfy constituents, not necessarily to meet

upon the report, particularly when everyone is already

scientific needs.

busy working on their projects?”

A NIOSH scientist reported that after residents in En-

Members of Congress may not only require some stud-

dicott, New York raised concerns about high rates of

ies; they can also prohibit others. Examples from scientists

cancer within a community where IBM was located,

included the following:

Congress put pressure on NIOSH to conduct a study,
even though some scientists who had investigated

•

A senior behavioral scientist with experience at CDC
and NIH spoke of Congressional staffers reading

the issue did not see enough evidence to support

through research abstracts to find projects that, as

further research.

they claimed, were “encouraging sex work” or at least

•

A supervisory chemist at FDA sums up the political in-

not discouraging it, or “encourag[ing] sex among gay

fluences on federal scientists’ work: “You’re in Washing-

men or other populations that displeased certain

ton, that’s just the name of the game. If a Congressman

elements of the social conservatives.” This was seen

wants to give $5 million to do research on an issue and

as an attempt to micromanage Congressional fund-

they get it voted on by their colleagues, you either do

ing to agencies.

it or find another job.”

•

•

According to an epidemiologist at CDC, research on

A research chemist from NIOSH expressed frustration

gun violence is strictly off limits. “It’s a Congressional

with Congressional earmarks: “Get the boutique proj-

mandate that says CDC cannot … do any kind of pol-

ects out of there.” This scientist described members of

icy evaluation or intervention that restricts access to

Congress as focusing too exclusively on their districts

guns.” The scientist found this problematic, since “guns

and having an attitude of “it may not have anything to

are the main weapon for homicides and non-fatal inju-

do with improving whatever in the US, but it’s going to

ries” in the US.

help my district.”
Some scientists expressed concern about members of
Regardless of how worthy the research may be, Congress

Congress lacking sufficient scientific understanding to

sometimes mandates studies without considering the

make informed decisions about scientific priorities. A

agency’s capacity to undertake them. For example, a CDC

CDC epidemiologist summed up what many scientists

division director pointed out that if legislation is passed

feel about political involvement in science, saying, “Poli-

requiring the agency to investigate a particular disease or

cymakers are pushed by different kinds of interests, and

chemical exposure, it may have to cut the budget of other

sometimes those interests have nothing to do with evi-

established programs to fund the new work. A medical

dence, but rather personal interests … If we could at least

epidemiologist from CDC stated, “It’s very frustrating to

get them to look at the evidence and factor it into their

people who know that there’s a big public health prob-

decision making, I think that would be a step forward.”

lem out there that we know what to do with, but we can’t
do that because we’re being told to do something else
that is totally pointless.”

Political officials also may not recognize the scientific
complexities of a research question. “A Senator can ask,
‘what are you doing about mold?’ but it’s almost the

Funding seems to be part of the reason the EPA does

wrong question,” said an EPA project director. “It’s only

not always act on the recommendations of its Science

part of a bigger question.”
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CONGRESSIONAL BUDGET THREATS

Some CDC scientists brought up the example of a propos-

During the interviews, several scientists explained that

al by the CDC director appointed by President George W.

agencies angering Congress risk seeing their funding

Bush to add an additional layer of management between

slashed, or even revoked completely. Several NIOSH sci-

the CDC centers and the Office of the Director, which

entists noted that during the days of the “Contract with

would increase review requirements. NIOSH objected, be-

America” (an agenda of the Republican majority in the

lieving that this would slow down the agency’s work, and

104th Congress), their agency was threatened with out-

both Congressional and industry representatives agreed.

right elimination. These scientists agreed that the experi-

NIOSH was ultimately exempted from the additional re-

ence has had a lasting impact on agency personnel.

view, but all of CDC’s other centers were subject to it, and
some scientists feel that the reorganization has indeed

Since then, a NIOSH team leader explained, the agency

hampered the agency’s work.

has been less bold. New initiatives have “been noticeably in non-controversial areas … It just seems to be a

Scientists at other agencies also noted slowdowns linked

strategy, it’s almost like a survival mechanism.” The fear

to leadership changes. “They’ve essentially slowed down

is that if the agency pursues controversial occupational

our research by increasing the bureaucratic responsibili-

health issues, “our head will be put on the chopping

ties for scientists and reducing the amount of administra-

block once again.”

tive support we have,” said a NIOSH epidemiologist. An

During the 104th Congress, OSHA was also a target, and

ting from senior levels, in the agency, is designed to keep

agency personnel speaking in public had to tread care-

a project from moving forward.”

EPA medical officer suggested, “Sometimes priority reset-

fully. An OSHA scientist described commenting in public
that the agency would continue with its rulemaking on

Agency leadership can also interfere with science-based

ergonomics (a still-controversial regulatory issue) unless

regulatory decisions. At FDA, the controversial topic was

told not to. The next day, members of Congress threat-

the emergency contraceptive Plan B. Despite strong rec-

ened to cut OSHA’s budget dramatically—and they fol-

ommendations from relevant advisory committees and

lowed through on the threat.

the professional review staff of CDER, the FDA long delayed
approval to grant Plan B nonprescription drug status.

The OSHA scientist also reported that the agency “ran in
a very defensive mode” for a few years following criticism

In 2005, FDA’s assistant commissioner for women’s health

from leadership from the House of Representatives. “What

and director of its Office of Women’s Health (one of the

happens in that kind of situation is that the political bat-

authors of this report) resigned in protest, and character-

tles are fought at the upper levels of the agency and the

ized the agency leadership as “disregarding the scientific

scientists do their best to hunker down below the radar

and clinical evidence and established review process and

and continue to do their work, hoping that what they are

… taking an action that harms women’s health.” 6 (In 2006,

doing isn’t going to get caught up in the political battle

Plan B was approved for over-the-counter sale to women

… and that at some point the agency will move forward

over the age of 18, despite recommendations that evi-

and do something with their work.”

dence did not indicate a need for age restrictions.)
In 2007 the Washington Post reported that the FDA in-

EXECUTIVE-BRANCH INFLUENCE

tended to redirect 30% of the Office of Women’s Health

Presidentially appointed agency leaders exercise influ-

budget to uses elsewhere in the agency—a move wide-

ence over their agencies’ scientific work in both overt and

ly seen as retaliatory. This move would have effectively

subtle ways. It is expected that agency priorities will shift

halted further operations, since the funds that remained

with each new administration, but agency heads’ man-

would have been required for staff salaries and projects

agement styles and interest-group ties can also change

already underway.112 Congress restored the funding, but

how agencies conduct scientific work.

the message had been sent.
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Other concerns about scientific work being negatively af-

we felt considerably weakened the report. We caved in

fected by non-scientists who are appointed by presidents

because we had no real choice. If you wanted to transmit

or brought in by appointees included the following:

your report, you will give in.”

•

A CPSC statistician said, “I think that the political ap-

The same scientist noted that the same OMB staff are

pointee needs to be removed from the process. The

assigned to work with the same agencies over and over

scientist needs to be able to work in an atmosphere

again. Agency administration “knows they will have to

that is free of fear, of both reprisal and free of fear from

work with them on the next report, so they’re not particu-

what will happen if their results don’t turn out to be

larly interested in getting into a quarrel with them because

what the political appointee wants them to be.”

they know they’ll be back.” While this may accommodate

•

the needs of administrative staff, “it does not work very
“We got an increase in the concentration of attorneys at the top, and attorneys do not think like scientists,” said an FDA senior manager.

•

A NIOSH research chemist suggested, “If there was any
way the research team could be elevated so it doesn’t

well as far as getting high-quality science through such a
review process, because the administrative people are always looking to the next act and the scientists tend to be
thinking about the data they’re trying to see presented.”
Collegial relationships can also influence scientific activi-

have to answer to the policy wonks, that would be a

ties. For example, a CDC scientist suggested agency func-

really good thing. The same applies to agencies where

tions may be affected by ties between senior managers

scientists are subservient to the attorneys and the pol-

who previously worked together in other environments.

icy people.”

An agency may also deal with other government agen-

Some scientists spoke about political appointees influ-

cies differently than it would deal with private industry.

encing scientific work in order to benefit the industries

For instance, if another agency were responsible for pol-

or interest groups to which they had ties. An EPA environ-

luting a site, it would be “harder for our agency to see the

mental engineer spoke about conducting a Superfund

polluting agency as a polluter and not as a government

site evaluation while being supervised by someone who

agency,” one ATSDR scientist noted.

was a past employee of a company responsible for the
site’s contamination. The scientist reported that his super-

PUBLIC-SECTOR INFLUENCE

visor said, “Hey, you know, don’t … don’t upset these guys.

Some federal scientists reported that some organiza-

Do a good study, but don’t go overboard.” The scientist

tions and segments of the public distrust their agencies’

stood up to the supervisor to ensure an honest study was

findings. This seems to be an issue in particular for those

conducted, but felt that his career as an EPA scientist suf-

whose agencies work directly on consumer safety (e.g.,

fered as a result.

CPSC and FDA).

As noted previously, scientists also spoke about agency

A CDC branch chief attributed this distrust to miscon-

appointees halting or delaying release of papers that

ceptions of relationships between industry and the fed-

would have harmed the all-terrain-vehicle and food in-

eral scientists: “There’s a kind of suspicion … which is very

dustries for which the appointees had previously worked.

weird and kind of hard to deal with … because our decisions are based on our own ideas and information and

In addition to being headed by political appointees with

there’s other issues” the public may not be aware of.

a great deal of influence, agencies are affected by the
White House Office of Management and Budget (OMB).

A scientist with experience at both FDA and NIH com-

A scientist with experience at multiple agencies spoke

mented that pressures from public-interest groups tend

about working on a federally mandated report that con-

to focus on issues that the general public can more eas-

tained information to which OMB objected. “They insisted

ily grasp: “I think everybody thinks they are at least an

a huge amount of exposure information come out, which

amateur expert on energy policy or pollution control. But

78 • The Scientists in Government Project

everybody doesn’t think they are even an amateur expert

•

on cancer drugs.”

An EPA branch chief noted, “Sometimes research raises
more questions than it answers … It’s not definitive,
occasionally it’s not even helpful.”

Advocacy groups often promote research on specific
diseases, and they may urge their members of Congress

•

An FDA project manager said, “A lot of research is fo-

to mandate agency research on a particular condition

cused on what’s novel and what’s new, a lot of regu-

or treatment. Although such advocacy efforts have the

lation is focused on what is solid and sustainable …

potential to draw resources from other priorities, some

At the same time, we were required to use validated

scientists welcome them. Several scientists commented

methods—validated and reproducible. Well, there’s a

that advocacy groups can play an important role in di-

tension because what’s new is typically not validated,

recting resources to important issues that might other-

it’s not known if it’s reproducible and valid, otherwise

wise go unaddressed.

you’re wasting everyone’s time.”

An industrial hygienist at NIOSH supports advocacy in-

•

A HUD manager suggested, “There has always been

fluence or support even if the advocates’ statements are

an undercurrent of anti-intellectualism in America, but

not fully accurate. “I can tolerate some inaccuracy in their

that can be overcome … it’s important that we pro-

statements, because they are at least pushing the agenda

duce products that are meaningful to people, so the

in the right direction.”

science should be relevant.”

General Public

Tribal Influence

Several scientists spoke about a more subtle form of in-

Scientists whose agency experiences involved tribal

fluence: the public’s overall view of science and scientists.

groups noted that Native American and Native Alaskan

A public that does not understand how science works or

tribes have historically had little chance of making an

see the importance of various scientific disciplines is likely

impact on the research that is conducted in and around

to undervalue federal scientific work. Scientists comment-

their tribes—whether on their physical environment or

ed on this:

their people and culture. Some federal agencies have

•

made efforts to bring members of the tribes into discusAn epidemiologist with experience at NIOSH and EPA
stated, “In this country we don’t have a great emphasis on prevention, and much of the work that we do

sions that affect them, but these efforts do not overcome
all of the obstacles that tribes face in working with the
federal government.

at NIOSH and CDC is in the area of prevention … We

•

don’t think very foresightedly about what we need in

A scientist with experience at the EPA and DOD ex-

the future, and research is all about deriving informa-

plained, “Tribes frequently have had some difficulty get-

tion and understanding that will help you move into

ting into the process. In some cases, the tribe might have

the future.”

100 people, they are not going to have 10 people in their
Department of the Environment, and 10 people is not a

A NIOSH team leader identified a combination of
media and misunderstanding of science as a cause of
confusion: “People don’t understand epidemiology
… They don’t realize that it’s the weight of evidence,
no one study can really answer the question … So

lot to cover what is going on.” The scientist considered
tribes to have too little influence to ensure that their concerns were addressed. “Generally speaking, they have relationships with their regions and so the regions tend to
express their points of view or come force an issue.”

people get confused when they hear one study and
then the next week or two they hear another study

This scientist reported having a positive experience with

that addressed the same question but came up with

the National EPA Tribal Science Council, which consists

a different answer … They don’t understand what

of one person from each EPA office and one tribal repre-

that means.”

sentative from each region. The Council “was created in
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partnership with tribal representatives to help integrate

for discussions with more technical knowledge and

Agency and tribal interests, specifically with respect to en-

information than advocates for public health. “The

vironmental science issues.”

113

USDA was much more inclined to be very closely
aligned with the industry that they regulated;

According to an IHS medical director, some tribes have

there were strong relationships with the leaders of

exerted a positive influence on research. For example, “in

the industries.”

the past, data has been taken and published without
tribal approval or knowledge (e.g., rates of alcoholism in

•

An FDA scientist said the agency only spent money

a community lead to a reversal of federal funding and in-

on research when it wanted to “explain away toxico-

crease stigmatization). The research genuinely improved

logical problems.”

[with tribal input] because the tribes help put the data
in context.”

•

“I believe that research is underfunded because the
areas where we could gain ground are stifled,” said a

Employee Groups

NIOSH senior epidemiologist. The avenues of research

Some NIOSH scientists spoke about the increasing dif-

that are stifled “are perceived as having negative out-

ficulty of conducting research involving groups of em-

comes or political interests.”

ployees who may be exposed to a workplace hazard. Employees who do not understand the potential benefits of

•

industry meetings I was told to say things I didn’t be-

NIOSH research, or who fear negative consequences from

lieve in, and I decided it was time to look for another

it, are less likely to participate. One scientist suggested

job. There will be a time when your opinion does not

that employers may encourage workers to fear NIOSH re-

jive with the agency.”

search efforts.
Employees can request that NIOSH conduct Health Haz-

•

ence is stronger from industry than from others.”

reported that the number of worker requests for these

One scientist noted that the term “research” can be intimidating to those who have little experience with it, so employees of a factory where NIOSH would like to conduct

A statistician from CPSC stated, “It is commonly accepted that there is influence from industry … the influ-

ard Evaluations at their workplaces, but interviewees
evaluations is declining.

A senior manager at FDA stated, “A couple of times in

Although such influence may come from close relationships between industry groups and agency officials, some scientists noted that industries can also win
favorable outcomes by fighting and criticizing govern-

research might be fearful of what the agency is doing. “I

ment work:

do think it is getting to be more of a problem, because

•

of the economy, jobs leaving the country. We get fewer

A senior epidemiologist from NIOSH stated, “The biggest obstacle to making changes that are better for

requests” for evaluations, a NIOSH medical officer ex-

the environment is the whole antagonistic situation

plained. “[That’s probably because] they just don’t want

between industry and the government and science

to make waves.”

in this country. They would rather fight than cooperate, they would rather pay lawyers than set up pre-

PRIVATE-SECTOR INFLUENCE
Perceptions about the nature and extent of private-sector
influences on government science vary, but many scientists find them disturbing:

ventive programs.”

•

An environmental engineer from EPA believes that “because the results of research will affect some company’s bottom line, [there] is a strong incentive for that

•

A USDA division director stated, “The primary con-

company to criticize the government research. They

cern at USDA is industry, not public health.” This in-

have a strong vested interest in trying to make our re-

dividual also noted that industry came to the table

search results [look like] ‘junk science.’”
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Some scientists also observed that industry concerns

sector partners with CDC scientists to achieve common

did not always prove valid. One scientist who worked

goals,”114 which one scientist described as a mechanism

at both FDA and EPA said that industries had opposed

for obtaining industry funding for agency research.

both FDA’s decision to ban lead-soldered cans in 1995
and the EPA’s 1997 “cluster rule” pertaining to discharg-

While many scientists interviewed expressed concerns

es into the air and water. This scientist noted that in-

about industry influence on agency science, some scien-

dustry had warned that stricter requirements for their

tists felt that industry involvement was appropriate and

manufacturing processes would make their products

could be beneficial:

too expensive for consumers to afford, but that did not

•

happen in either case.

A DOD interviewee noted junior researchers can sometimes be placed with private companies for a year or

Scientists provided examples of private-sector interests

two to gain experience, and that industry had stepped

influencing agency science:

in to develop ideas that originated with government
scientists in the space program.

•

A branch chief at the CDC was told to “back off” releasing data about an air pollutant because “it would

At OSHA, a scientist commented that where out-

inhibit their ability to pass an amendment. They

siders may perceive that undue influence is being

claimed that it would halt the passage of an amend-

exerted on the agency, some internal staff believe

ment and be problematic for the industry.” The scien-

there is balance.

tist was able to publish limited data on the findings,
but was told to “drop the issue. It then drops off the
radar of all other scientists because if CDC dropped it,
it must not be important.”

•

•

•

A HUD manager said the housing industry was “committed to protecting kids” from hazards such as lead
paint but had legitimate concerns that should be factored into agency policies. “My experience with the

A veterinary medical officer working for FSIS to ensure

housing industry is that they just wanted to know

the safety of meat attempted to enforce a regulation

why they had to do something, and what they need-

at a meat processing plant. After the plant manager

ed to do.”

called the scientist’s supervisor, the scientist was told
that there must be a “mistake” in the assessment of en-

NIOSH’s Right of Entry

forcing the regulation and to back off on the terms of

In interviews, several NIOSH scientists voiced concerns

enforcement. The scientist noted that there is even a

that their agency was bowing to industry pressure in fail-

committee where “industry advises FSIS.”

ing to make use of their right of entry. A NIOSH epidemiologist explained:

Some agencies actively seek out partnerships with industry. An epidemiologist with experience at EPA and NIOSH

Historically we were given as a right from Congress

stated that an increase in industry interference has forced

what we call “right of entry.” We actually carry a card

the “involvement of parties that wouldn’t ordinarily be

that says we have the right to enter your premises,

part of … NIOSH day-to-day research … There’s been

we have the right to do this study, and it’s actually

an increased urging of all staff to increase what they call

in the federal law that we have the right to enter a

partnerships with people who are potentially produc-

factory or a workplace. We have a right to interview

ing the hazardous materials that we’re studying … It has

employees in private; we have a right to do biological

great potential for there being conflict of interest.”

measurements. Through the ‘80s and ‘90s this really
went unchallenged.

These partnerships can be financial in nature. For agencies
facing budget challenges, partnerships that bring funds

According to a senior scientist at NIOSH, this changed ear-

to the agency can be attractive. CDC even has a founda-

ly in the Bush administration, when “the NIOSH attorney

tion whose mission is to “unite a wide range of private

and the CDC attorney said ‘we are not going to enforce
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our legal right to entry … we don’t want to get too high

and wrong and not supported by the science.” This re-

on the radar so we’re not going to [use it].’”

flects “a disastrous change in policy” that in his view was
driven more by industry than by science.

NIOSH scientists reported that the agency’s reluctance to
use its right of entry makes it difficult for them to conduct

A NIOSH research chemist shared a similar perspective,

health hazard evaluations regularly and without interfer-

describing the shift toward placing safety responsibili-

ence. They also suggested that NIOSH’s meeker stance

ties on workers, rather than on job sites: “There is this per-

has emboldened employers, so that on the occasions

ception that NIOSH research is not needed … that if you

when the agency does conduct evaluations, they find em-

happen to work in a very hazardous job, then that’s your

ployers to be less cooperative than in the past. A NIOSH

fault, you’re accepting that responsibility, and if you don’t

industrial hygienist explained that corporate lawyers

like it, quit.” That attitude stands in contrast to an agency

know the agency is unlikely to challenge employers who

philosophy that the scientist describes as a “responsibil-

don’t allow NIOSH employees to enter their workplaces,

ity to not just do research, but to communicate it and to

and “they can’t find any real good reasons why [cooperat-

have an impact and to make sure we actually are making

ing] would be good for their company.”

things better.”

Nowadays, NIOSH scientists report that agency per-

Over time, the influences exerted on scientific agencies

sonnel must essentially beg for entry into workplaces,

can alter overall attitudes. An EPA environmental engineer

and provide evidence of potential exposure before

felt that the culture had shifted, growing more autocratic

they can study workplace conditions. However, one

and less idealistic over time. “You don’t see the passion for

scientist explained that where evidence of exposure

the environment or the same commitment to public ser-

does exist, an employer can say “okay, come back in

vice, the same idealism that there used to be.”

a year and we’ll let you do the study.” Then the employer can remedy problems before NIOSH employees return; this can protect the workers’ health going
forward, but does not allow for investigating workers’
past exposures or collecting information that could

Even if an agency’s overall attitude changes, individual
scientists can still promote what they view as the right actions for science and public health. In some cases, taking
these stands can harm scientists’ careers, as these interviewees noted:

benefit other workers in the future.

•

‘to get along you go along,’” said an FDA senior man-

WORKING IN AN ATMOSPHERE OF INFLUENCE

ager. “If you want to be kept on the promotion track,

Some scientists who had worked at an agency for several

you don’t buck things like that. That can harm your ca-

years noted shifts in their agencies’ overall attitudes in the

reer, and believe me, it harmed mine.”

face of constant pressure from Congress, the executive
branch, and the public and private sectors.

•

A NIOSH research chemist said that outspoken scientists may pay a price. “As a scientist, if we came out

Scientists voiced frustrations about agencies failing

and said what we really thought, publicly, it would

to respond to public-health issues—even when data

have been individual punishment as well as institu-

showed a threat to health—because of a lack of politi-

tional punishment.”

cal will. Some also expressed concern about agencies
coming to view limiting health risks as more of an in-

“The truth of the matter is bureaucracy is the culture of

•

A team leader at NIOSH spoke of a report written by a

dividual responsibility, rather than something a federal

colleague that had concluded an association exists be-

agency should address. For instance, a HUD manager

tween a chemical application and illness. The author

was disturbed to note a national-level shift away from

of the report “got pressure from supervisors who were

addressing housing deficiencies and toward “blaming

getting pressure from the governor’s office to change

mothers and blaming the victims, which is inappropriate

the conclusions.” The scientist reported that when the
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author refused, his travel expenses were audited, a $6
error was found, and the scientist was then terminated.
Scientists who take principled stands on scientific matters do not always suffer career damage; in some cases,
they convince their superiors, and in others they conclude

Follow-up Survey Results

A

s noted in the Methodology section, 30 of the
original 37 interviewees participated in an anonymous online follow-up survey. The objective of

this survey was to determine if scientists felt that change,

that agency management has the right and responsibility

either positive or negative, had occurred at their agen-

to make the ultimate decisions. A NIOSH epidemiologist

cies since the initial interviews took place. The survey was

described taking a dispute to upper management and

conducted during July and August 2009, approximately

going several levels above an immediate supervisor, but

six months after the Obama administration began.

still getting a “no” answer. At a certain point, this individual recognized, “I’ve taken this as far as I can and now it’s
the agency’s decision … You have a choice to either say ‘I
can’t accept that ‘no’ answer, I’m leaving,’ or ‘I have to live
with that ‘no’ answer.’”

Of the 30 scientists who responded, 18 were still employed by the federal government at one of the following agencies: VHA, IHS, CDC (including NIOSH and ATSDR), USDA, or EPA. Scientists no longer employed by the
federal government provided various reasons for their
departures: retirement, resigned for another position

THE IMPORTANCE OF
SUPPORTIVE MANAGEMENT

outside of the government, or other. One of the scientists

Whether pervasive influence shifts agency attitudes and

due to an injury.”

who selected “other” reported being “forced out of work

harms scientists’ morale depends in large measure on
the extent to which managers prevent inappropriate
influence from interfering with scientists’ work. Some of
the interviewees who served in managerial roles commented on steps they took to buffer their scientists from
outside pressures. “We felt very committed to try to
protect junior scientists from some of the bureaucratic
problems associated with Congressional committees
and oversight,” said a medical scientist at DOD.

Questions addressed the same areas covered in the interviews: workplace supportiveness, access to data, research review processes, publication clearance processes,
communication with media and the public, ease of attending professional meetings, feedback processes, and
overall work environment. On each topic, respondents
were asked, “How do you feel things have changed, if at
all, since the new administration began?” and given four
options from which to choose:

Other scientists expressed gratitude for supportive managers. According to an OSHA manager, a trade association
sought the firing of a scientist because they did not like

•

Change for the better

•

Change for the worse

•

No change

•

N/A

the findings of a paper the scientist wrote. The scientist’s
manager refused to discipline the scientist “for functioning as a capable scientist operating within standard operating principles of academic publication.”
This scientist also reflected on the overall role of influence

Results appear in Table 8.

on agency work. “One of the things that most impressed

In most of the areas, the majority of respondents did not

me about working for the federal government was the

perceive change. In two areas, responses indicated that

extent to which outside organizations attempt vigorously

a substantial minority perceived improvements. Regard-

to influence the agencies. That seems like a fact of life,

ing scientists’ ability and willingness to provide feedback,

and I don’t think that it is necessarily inappropriate,” he

33% reported improvement. And, according to 30% of re-

said. “How those attempts at influence are handled by the

spondents, the overall work environment has changed for

agencies is what is important.”

the better.
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Table 8: Results of Follow-up Survey
Question: How do you feel things have changed, if at all,

Change for

Change for

since the new administration began in regard to…

the better

the worse

No change

N/A

Providing a supportive workplace?

20%

10%

50%

20%

Access to data?

10%

3%

16%

27%

The research review process?

17%

7%

53%

27%

The publication review/clearance process?

3%

3%

66%

28%

Scientists’ communication with the media and the public?

7%

3%

59%

31%

Scientists’ ability to attend meetings, conferences, etc.?

7%

17%

52%

24%

Scientists’ ability and willingness to provide feedback

33%

7%

37%

23%

30%

13%

33%

23%

on scientific activities and processes?
The overall work environment?
Percentages may not total 100 due to non-responses on some questions

Despite indications that some scientists perceive improve-

that any reorganization will be “transparent” and that

ments at their agencies, comments reflected a belief that

a team approach will be encouraged in the agency. So

change comes slowly, if at all, to federal agencies. Some

it is possible that progressive change will occur at CDC

scientists felt that entrenched managers and civil-service

and ATSDR, but I have a “wait and see” attitude.

leadership would hamper improvements, and several
noted that funding concerns have not abated and may

•

The new administration clearly values science and
has put well-qualified scientists in leadership posi-

worsen further.

tions. The willful anti-intellectualism of the past 8 years
seems (thankfully) past—for now.

LEADERSHIP
Many respondents expressed optimism about the Obama

•

administration addressing some of the problems with

If the new leadership proves itself competent and
transparent, the atmosphere can only get better.

agency environments and processes:

•
•

I hope things will change for the better (i.e., less ad-

Yes, I anticipate it changing, because the agency I

ministrative oversight) once new leadership is estab-

worked for has just received new leadership from the

lished in our institute.

Obama administration. However, that took a long time
after the election, and the effects have not yet been

Comments regarding leadership were not uniformly posi-

felt—the new leadership has only been in place a few

tive, however:

weeks.

•

•

If anything, I expect it to get worse. I don’t think the

Possibly, because we have a new director at CDC who

new director will be happy about science that doesn’t

just started about a month ago. Dr. Frieden has stated

completely support his views.
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•

Not in the immediate future. We have had no change

made many good contacts for developing my project.

in leadership at any level and no change in policies

To only network with other scientists after the research

and programs, including those implemented during

is completed deprives the scientist of the valuable in-

the Bush years.

put that could improve a project during its design,
planning and analysis stages.

In some cases, low expectations for improvement
stemmed not from dissatisfaction with an agency’s lead-

By contrast, other scientists did not report changes in

ership but from a belief that new appointees will find it

their agencies’ management practices, and did not antici-

difficult to change entrenched processes and cultures:

pate any improvements in the near future:

•

•

I do not anticipate it changing. The culture of secrecy
at my former agency is too entrenched, and I don’t

ment with respect of the individual. This still does not

believe that even new leadership from the administra-

exist at my former agency.

tion is capable of changing it.

•

To provide feedback, there must be an open environ-

•

Key people in the upper leadership have been given

The review process is too entrenched at my former

tremendous power in the past 6-8 years and are reluc-

agency, and I don’t believe that the administration has

tant to change anything.

the power to change it. There are people in place who
exert political influence over the content of reports,

•

Change will be slow to come. Middle management remains a barrier to open sharing of ideas and information.

and until/unless they are removed, the review process
will still suffer from political interference (even from

•

the long arm of the previous administration’s bur-

FUNDING

rowed appointees).

While a few scientists expressed optimism about their
agencies benefiting from increased funding in the Obama

Probably no change because the bureaucratic system
in place during the previous administration is now ensconced in our agency.

MANAGEMENT

administration, more respondents were concerned that
the national financial situation would lead to damaging
budget cuts:

•

Only a few scientists identified improvements in manage-

now and I expect that to worsen.

ment at their agencies, and some others expressed hope
that they would see positive changes soon:

•

Much better, more ethical attitude.

•

A more open and rational approach to management

I expect things to get worse with budget cuts—there
are few support staff and inadequate support services

•

I’m very concerned about future funding for science
in light of consideration of the magnitude of the national debt.

will eventually make everyone feel more confident
and less confused.

•

Scarcity of resources has increased unhealthy competition among staff, and reluctance to share information
and resources.

•

Top-down management approach currently prevails;
hopefully more bottom-up ideas will be better received in the near future.

Given that the survey was conducted approximately six
months after the start of the Obama administration, it
does not capture all of the changes that the administra-

•

I work in a Branch that usually requires a manuscript

tion is likely to make. Scientists’ responses indicate a cau-

before attending conferences. Recently, I was able to

tious optimism about agencies’ ability to improve, com-

attend a very small meeting without a paper (I had

bined with concerns about the difficulties of changing

funding from another government agency), and I

policies and practices at federal agencies.
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Recommendations

T

he recommendations below address the issues

who shape and fund research priorities. When lawmakers

around which scientists expressed the most

or interest groups attempt to exert inappropriate influ-

need for change. Addressing scientists’ concerns

ence on scientific work, managers must buffer scientists

can improve morale at federal agencies, which will in

from these attempts and defend scientists’ adherence to

turn improve scientists’ productivity and lead to bet-

scientific principles.

ter government. These recommendations are often restatements of suggestions made by multiple scientists
about how to ensure that their work proceeds efficiently and can be translated quickly into public benefits.
Each recommendation section includes an overarching
principle as well as specific recommendations to address the issues raised.

In interviews, several scientists voiced criticisms about
managers who have insufficient scientific training to understand scientists’ work or empathize with them—or, on
the other end of the spectrum, scientists who have been
promoted to management positions despite lacking
managerial skills. Agencies should choose managers who
have sufficient skills and knowledge to work productively

While the majority of the recommendations apply to

with scientists, and provide sufficient training so they can

agencies, White House offices and OPM also have a role to

carry out their responsibilities effectively.

play in ensuring that the recommended policies are adopted. This leads to the first overarching recommendation
pertaining to all other recommendations in this report.

PRINCIPLE: Agencies should hire and promote managers
who have the training and skills necessary to facilitate scientists’ ability to conduct and disseminate scientific work.

OVERARCHING RECOMMENDATION:
ENSURING POLICY CONSISTENCY AND
CLEAR COMMUNICATION

Recommendation: Agencies should recruit and train

The White House OSTP and OMB should ensure that agen-

tific mission.

cies adopt the policies described in this report’s recommendations, and that the policies are generally consistent
across agencies and appropriate within each agency’s
mission and scope. These policies should be clearly and

managers who will buffer scientists against undue influence and ensure that the agency pursues its scien-

Recommendation: Agencies should hire managers who
have enough scientific training to translate between scientists and upper management and policymakers.

actively communicated to agency leadership, scientific

Recommendation: Agencies should provide manage-

managers, and the federal scientific workforce.

ment training to those who will be managing scientists.

When OPM policies (for instance, those regarding hiring

Recommendation: Agencies should not require scien-

and promotion) conflict with the recommendations in

tists to become managers in order to advance in their

this report, OPM should revise its policies to allow agen-

professional careers.

cies to follow the recommendations.
Recommendation: Agencies should evaluate and ad-

Management

M

dress perceived and real inconsistencies in the treatment
of scientists on different career pathways (e.g., PHS vs. civil

anagers of scientists play a key role in the pro-

servants).

duction and dissemination of science from
federal agencies. They must be able to com-

Recommendation: Agencies should minimize adminis-

municate effectively between scientists who carry out

trative duties that detract from scientists’ ability to con-

research and the upper management and lawmakers

duct their work.
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Feedback

T

he scientists interviewed for this study voiced many

some scientists still considered the process to be excessively burdensome.

insights and suggestions about how their agencies

PRINCIPLE: Agencies should limit the time and effort re-

could improve, but few shared these thoughts with

quired by scientists proposing research to what is neces-

their agencies. Although a few scientists noted instances

sary to ensure that the agency is supporting high-quality

in which agencies solicited and considered suggestions

research.

from scientists, many felt that formal avenues for feedback were either nonexistent or useless. Several scientists

Recommendation: Agencies should streamline intramu-

suggested that anyone providing feedback on agency ac-

ral proposal processes to the extent possible.

tions or policies would risk retaliation, and that employees would only feel comfortable providing feedback if it
could be given anonymously.
PRINCIPLE: Agencies should encourage honest feedback
from scientists, and use it to inform decisions about policies and practices.

Recommendation: Agencies should make the time and
effort required to propose research commensurate with
the amount of funding being sought.
Recommendation: OMB should streamline the process
for approving information collections subject to its oversight, and facilitate the process for the scientists involved.

Recommendation: Provide a formal and anonymous
means by which scientists can provide feedback to rel-

Disseminating Scientific Work

evant colleagues, including upper management, without

A

fear of retaliation.
Recommendation: Provide regular and follow-up training to ensure that all managers and supervisors are properly trained to understand employees’ rights and to comply with the procedures that protect whistleblowers.

lthough the process for clearing research results for publication varies across agencies, information products must often be reviewed by

multiple individuals before being submitted to a journal or otherwise disseminated. Agencies must ensure
that the information products they disseminate are
accurate and of high quality, but they must also avoid

Approving Proposed Research

M

any of the scientists interviewed felt that the

procedures that interfere with the timely communication of scientific information or discourage scientists
from pursuing future publications.

time and effort required to obtain agency approval for research projects is excessive—and

Some scientists suggested that their agencies have

these resources could be better spent on conducting the

used the clearance process to delay or even prevent

research, rather than writing lengthy research proposals.

the publication of findings that could ignite controver-

Scientists from NIOSH were particularly concerned about

sy. Congress addressed this issue at one agency with a

long proposals required for relatively small amounts

provision in the Food and Drug Administration Amend-

of research funding. Although agencies have a duty to

ments Act of 2007: It requires an FDA policy that gives

use taxpayer dollars wisely and support only the most

reviewing officials 30 days to provide written clear-

worthwhile research, they must balance this requirement

ance; if the deadline is not met, authors can submit the

against the toll that extensive application processes take

article for publication with a disclaimer stating that it

on scientists.

does not represent the agency’s viewpoint.

Scientists whose research involves surveys must also

Scientists also expressed concerns about unclear and

have their information collection approved by the OMB.

inconsistently applied agency policies on dissemination;

Although OMB has made some improvements to the pro-

reviewers lacking expertise in the relevant subject mat-

cess by which it evaluates requests to collect information,

ter; and extensive time required to respond to all reviewer
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comments, although not all comments were necessarily

inquiries be routed through the media office, and some

useful or relevant.

specify that someone from the media office must be present (in person or on the phone) during conversations be-

The issue of scientific publications produced on scientists’

tween reporters and scientists.

personal time also arose in some interviews. Even though
such publications usually include a disclaimer stating that

Although some scientists appreciate the involvement of

the work represents only the view of the author and not

the media office, several of those interviewed raised con-

that of the agency where the author is employed, some

cerns. In some cases, political appointees or members of

agencies still require scientists to submit these publica-

upper management are the ones chosen to respond to

tions for agency clearance.

media inquiries, even though they know less about the

PRINCIPLE: Agencies should disseminate scientific work
in a timely fashion, and the clearance process should not
be a tool for slowing down the dissemination of scientific
information that may be deemed unfavorable.
Recommendation: All agencies should have clear policies on review and clearance, and apply them consistently
and in a timely fashion.

subject at hand than the scientists who research it. When
scientists do speak to members of the media, the involvement of media-office personnel may have a chilling effect
on what scientists say. These situations not only frustrate
scientists, but may lead to the public missing important
information.
The National Institutes of Health has a policy that appears to strike a balance: It allows scientists to respond

Recommendation: Agencies assigning reviewers to re-

to oral questions without preapproval, so long as they

view the content of scientific output should ensure that

are limited to the speaker’s field of expertise and policy

the reviewers have expertise in a relevant field.

statements present only official agency policy positions.
However, a survey by the Union of Concerned Scientists

Recommendation: Agencies should encourage expedi-

found that NIH scientists think that media contacts must

tious and focused reviews.

be pre-approved, which suggests that the implementa-

Recommendation: Agencies should have processes for

tion of this policy is uneven.

expedited clearance of time-sensitive materials.

In 2008, the OSTP instructed agencies to develop and

Recommendation: Agencies should allow scientific work

update media policies to ensure that “employees may

conducted on agency time but not approved by the

freely and openly discuss with the public, subject to

agency within a reasonable timeframe to be published

classification restrictions and consistent with existing

with a disclaimer that it represents only the views of the

laws and regulations, scientific and technical ideas, ap-

author(s) rather than the agency.

proaches, findings, and conclusions based on their official work.”22 Agencies do not appear to have developed

Recommendation: Agencies should allow scientists to

such policies yet.

disseminate scientific work done on their own time, provided they attach any necessary disclaimers, without re-

PRINCIPLE: As directed by the OSTP principles, agencies

ceiving agency approval. Scientists should not face retri-

should develop policies that “provide for the widest prac-

bution if they exercise this right.

ticable and appropriate dissemination of factual information concerning agency scientific activities and their re-

Communicating with the Public

sults” and ensure free and open discussion.

A

gency policies governing scientists’ interactions

Recommendation: Agencies should have clear policies

with the media tend to require, or strongly en-

on scientists’ communication with the media and the

courage, employees to seek prior approval before

public, and ensure that they are understood and consis-

being interviewed. Some agencies require that all media
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tently enforced.

Recommendation: Agencies’ default policy should be to
allow scientists to handle media inquiries directly and interact with reporters without the presence of media office
representatives; under certain circumstances (e.g., when
the topic is a policy rather than technical issue) it may be
necessary for the media office to play a more central role.

Professional Development

T

he scientists interviewed agreed on the importance of agency scientists engaging with colleagues within their fields of study. Many scientists

emphasized that attending professional meetings and
conferences was an important component of professional

Recommendation: Agencies should not require scien-

development. Nonetheless, scientists often find it difficult

tists to speak with the media; those who wish to do so

to secure agency support for attending such meetings.

should be offered media training or be allowed to shift
inquiries to the media office.

Agencies have limited travel budgets and must ensure
that sending scientists to meetings will help advance

Inter-agency Data Sharing
and Communication

D

agency goals. It is appropriate to require a certain level of
meeting participation by scientists (such as presenting a
poster or talk), but some agencies take the requirement

uring interviews, some scientists raised concerns
about the difficulty of sharing data or other information with colleagues at other federal agencies.

Incompatible data systems and restrictive Memoranda of
Understanding between agencies were two of the problems raised, but a few scientists also stated that they were
discouraged from contacting colleagues at other agencies directly about topics of common interest.

too far. As an example, NIOSH scientists indicated that
conference participation is not supported until a scientist is ready to submit a full manuscript to a journal. It is
reasonable to require that scientists be delivering a presentation, but not to require that they have a manuscript
ready for submission to a scientific journal. Agencies must
recognize the importance of professional engagement
for their scientists and make every effort to secure and

While agencies do have a responsibility to ensure that

award adequate funds for meeting attendance.

confidential and sensitive data are protected, they should
be able to fulfill this responsibility while allowing for com-

Scientists also expressed frustration about arbitrary limits

munication and data sharing between agencies.

placed on the number of agency employees who could
attend a single conference, and about what some of them

PRINCIPLE: Scientists should be able to communicate

saw as preferential treatment of more-senior scientists

and share data freely and efficiently across federal

seeking to attend meetings.

agencies.
PRINCIPLE: Scientists should be encouraged to mainRecommendation: Agencies should develop and com-

tain their professional standing and pursue profes-

municate clear policies on data sharing.

sional development through engagement with their

Recommendation: Agencies should end explicit or per-

scientific colleagues, to the extent possible given their

ceived prohibitions on inter-agency communications.

agencies’ resources.

Recommendation: Agencies should examine the need

Recommendation: Agencies should ensure that require-

for establishing MOUs with other agencies before data

ments determining which scientists are eligible for sup-

sharing occurs; when MOUs are deemed necessary,

port to attend professional meetings and conferences are

they should be developed quickly and in a straightfor-

flexible, appropriate, and applied consistently.

ward manner.

Recommendation: Agencies should allow all scientists

Recommendation: Agencies should identify ease of

for whom attendance at a particular meeting is appropri-

data sharing as a priority when making decisions about

ate to attend without imposing arbitrary limits on the to-

data systems.

tal number of employee attendees.
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Influence

S

cientists described influences on their work from
members of Congress, appointed agency leadership, the OMB, and the public and private sectors.

They distinguished between what they considered to be

operating at their agencies. In some cases, scientists
reported that senior agency personnel’s ties to certain
industries caused them to suppress or ignore findings
that could have negatively affected those industries’
reputations or profitability.

appropriate influences, such as an organization request-

Allowing for appropriate influence from stakeholders

ing that an agency study a particular topic, and attempts

while protecting the integrity of science from inappro-

to influence science inappropriately, such as a member of

priate pressures requires vigilance and sound judgment.

Congress pressuring an agency to slant or suppress find-

Agencies should ensure their leadership and manage-

ings that might displease a constituent group.

ment are equipped to make these judgments and protect

Scientists also noted that some forms of influence, such
as requirements imposed by Congress, might be appro-

scientists from inappropriate influence that could compromise the integrity of their work.

priate but could still cause the agency to direct its ener-

PRINCIPLE: Agencies should protect scientific work from

gies away from work scientists considered crucial to their

inappropriate influence.

agencies’ missions. Likewise, while scientists recognized
newly appointed agency directors’ right to redirect scien-

Recommendation: Agencies should adopt policies and

tific resources, they often felt frustrated when they were

training programs for both managers and scientists that

told to halt work on research they had been conducting

affirm agency commitment to scientific integrity and help

for several years.

employees distinguish between appropriate and inappropriate influence on scientific work.

In general, scientists saw influence from the private sector as being more problematic than influence from the

Recommendation: Agencies should have policies in place

public sector—although some scientists stated that

to ensure transparency regarding input from political ac-

they did not see inappropriate private-sector influence

tors as well as private- and public-sector stakeholders.
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Conclusion

T

he roles and responsibilities of scientists who

•

Minimizing the bureaucratic maze needed to ini-

work for the federal government in science-based

tiate new research and to allow for publication or

agencies cannot be simplified into a sound bite

other dissemination of research results, with or with-

or single issue. This study and the recommendations

out disclaimers;

that have emerged from it call for ensuring a balance
that will protect the fundamental principles of scientific

•

Providing the opportunity for scientists to communi-

method, integrity, freedom of inquiry, and dissemination

cate with the public, while also providing any support

of results as well as one that will achieve the missions

or training that scientists need to improve their skills in

and goals of the scientific agencies as established by our

public communication;

elected representatives.

•

Promoting engagement with federal scientists at oth-

The commitment and pride of scientists who work in

er agencies and with the larger scientific community,

federal agencies is remarkable. Their dedication to the

including sharing of data and professional opportuni-

public mission of our health and environmental agen-

ties; and

cies was demonstrated repeatedly throughout this
study. Individual scientists within federal agencies, their
managers, agency leaders, the relevant offices at the

•

Minimizing the impact of inappropriate influence
from non-scientific directions, while recognizing the

White House, and Congress all play critical roles in creat-

appropriate roles of elected officials and the public

ing a work environment that promotes the morale and

in shaping the missions, scientific work, and policies

productivity of the scientific workforce that ultimately

of the agencies.

benefits the public.

Concerns about scientific integrity and the politicization

The principles that are outlined in this report start with

of science have been raised across several administra-

valuing the scientific workforce and establishing policies

tions, and peaked during the first decade of the 21st cen-

that are consistent across the federal government while

tury over issues ranging from climate-change research

being tailored appropriately for the mission and scope of

and reproductive-health issues to regulatory standards.

each agency. Transparency, consistency, and accountabil-

It is notable that in follow-up research conducted after

ity must be key elements in these policies.

the 2009 inauguration, several scientists who participated in this research did not anticipate that the change in

The OSTP, along with the OMB, should bring agencies’
leadership together to establish common policy approaches. Specific policies should address

•

administration would significantly alter their agencies’
approach to science. Change in large agencies with hierarchical structures is difficult and takes time. This presents

Improving management training and overall manage-

a challenge to both the new leadership and the existing

ment approaches for scientific projects and staff, in-

career scientists to initiate and maintain new strategies

cluding promoting opportunities for honest feedback

and approaches for improving and sustaining the scien-

without fear of retaliation;

tific workforce.
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Appendix A: Interview Guide
Scientists in Government: An Examination of Their Rights
and Responsibilities in Civil Society

T

hank you for taking the time to speak with us

Probe 3: Specify job titles and scientific

about this topic. The information you will provide

responsibilities.

will be very important for our research on the ef-

Probe 4: Which presidential administrations have

fects of federally-employed (past and present) scientists

you worked under? In which agencies and in

within the U.S. political environment. We are working on

what capacities?

the Scientific Knowledge and Public Policy (SKAPP) project with the School of Public Health and Health Services

6. What are your primary roles and responsibilities as a

(SPHHS) at the George Washington University (GWU), and

scientist in your current and/or previous position(s)

we would like to learn more about the relationship be-

with federal agencies?

tween government scientists (both social and laboratory),

Probe 1: What are the primary differences between

science, and policy making within civil society.

your current position and previous position(s) with
other federal agencies, if any?

All of the information you provide will be kept confidential and private—your name or any other identifying

7. How does your agency (past and present) foster a

information will not be attached to any answers given.

workplace ethic for scientists that is consistent with

Please feel free to share any information, ideas, thoughts,

its mission?

and/or beliefs regarding science and politics—whether

Probe 1: What efforts are made to effectively work

positive or negative.

toward the agency’s mission?
Probe 2: How could the agency improve upon this?

SECTION I: OVERVIEW
SECTION II: RESEARCH

1. Name of organization

1. What is the research results review process? When

2. Title [management/supervisory] OR

does it occur?

[non-supervisory/staff ]

Probe 1: What are the avenues to go through to

3. Demographics

have research results reviewed? Are there standard

a. Male/Female

operating procedures? Where are they?

b. Race: ________________
c. Age Range: 25-35

36-45

Probe 2: At what point in the process is research
46-55

55+

d. Academic background (e.g., MD, PhD, MS,
MPH, etc.): ________________
4. What are your prior experience(s) or affiliation(s) with
federal agencies, other than your current agency?
5. What is the number of years of involvement that
you have with your current agency and/or previous
experience(s) with federal agencies?

reviewed?
Probe 3: What are the layers of review? How many
are there? How easy/difficult are they to navigate?
Probe 4: How are research results utilized to create
internal and external policies?
Probe 5: How are controversial—both political and
scientific—topics handled? Is there efficient support from supervisors?

Probe 1: Specify years with current agency.

Probe 6: What do you think of this process?

Probe 2: Specify years with other agencies and

Probe 7: How could this process be improved, if

name other agencies.

at all?
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Probe 8: What difficulties have you encountered or

Probe 2: What difficulties have you encountered

observed in this process? How were they handled?

or observed? How were they handled?

2. When research is conducted, who receives
authorship?
Probe 1: What, if any, difference is there for internal

7. What is the venue in which scientists can provide
feedback on the processes that exist regarding research?

or external reports/publications?

Probe 1: How often is feedback generally provided?

Probe 2: What do you think of this process? Are

Are there standard operating procedures? Where

there standard operating procedures? Where

are they?

are they?

Probe 2: How does feedback affect existing proto-

Probe 3: How could this process be improved, if
at all?
Probe 4: What difficulties have you encountered or
observed in this process? How were they handled?

cols?
Probe 3: What type of mechanism/tool is used to
gather feedback?
Probe 4: What do you think of this process?
Probe 5: How could this process be improved, if at

3. What kind of influence exists from non-career
personnel, who may or may not be scientists,
upon scientific research?
Probe 1: Under what circumstances would a
non-career personnel interject in a scientific
determination?
Probe 2: What difficulties have you encountered
or observed? How were they handled?
4. What kind of influence exists from members of
Congress upon scientific research?

all?
Probe 6: What difficulties have you encountered or
observed? How were they handled?

SECTION III: PUBLICATION & DISSEMINATION
1. What is the publication process? Are scientists encouraged/discouraged to publish?
Probe 1: What are the requirements to be met prior
to publication? What is this process?
Probe 2: What is the difference in protocol between

Probe 1: Under what circumstances would a

internal and external publications, if any?

member of Congress interject in a scientific

Probe 3: Who has ownership of the research?

determination?

Probe 4: Under what circumstances would a

Probe 2: What difficulties have you encountered

scientist be hindered from publishing research in

or observed? How were they handled?

peer-reviewed scientific journals?
Probe 5: Are you aware of publications being hin-

5. What kind of influence exists from state, tribal, or local

dered? What was the outcome?

government/elected officials upon scientific research?
Probe 1: Under what circumstances would a state,
tribal, or local government/elected official interject
in a scientific determination?
Probe 2: What difficulties have you encountered
or observed? How were they handled?

Probe 6: Under what circumstance would there be
an exclusion or alteration of technical information
from an agency document?
Probe 7: What do you think of this process?
Probe 8: How could this process be improved, if
at all?

6. What kind of influence exists from the private sector
upon scientific research?

Probe 9: What difficulties have you encountered or
observed? How were they handled?

Probe 1: Under what circumstances would the
private sector involve themselves in a scientific
determination?

2. What is the dissemination process, if different than
the publication process?
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Probe 1: Who has access to the data and when?

Probe 1: Under what circumstances would a state,

Probe 2: What are the protocols when releasing

tribal, or local government/elected official inter-

data to the media and the public? Are there stan-

ject in the publication and/or dissemination of

dard operating procedures? Where are they?

research findings?

Probe 3: Under what circumstances would informa-

Probe 2: What difficulties have you encountered

tion be restricted from being disseminated? What,

or observed? How were they handled?

if any, situations have you been privy to this occurring? What was the outcome?
Probe 4: What do you think of this process?

7. What kind of private-sector influence upon the
release of research findings to the public are you
familiar with?

Probe 5: How could this process be improved, if

Probe 1: Under what circumstances would the

at all?

private sector involve themselves in the publica-

Probe 6: What difficulties have you encountered
or observed? How were they handled?

tion and/or dissemination of research findings?
Probe 2: What difficulties have you encountered
or observed? How were they handled?

3. How, if at all, are “minders” used at your agency?
Probe 1: What are the protocols to follow when
speaking with the public/media?

8. What is the venue in which scientists can provide
feedback on the processes that exist regarding publication and dissemination of research findings?

Probe 2: What do you think of this process?

Probe 1: How often is feedback generally provided?

Probe 3: How could this process be improved, if

Probe 2: How does feedback affect existing

at all?

protocols?

Probe 4: What difficulties have you encountered

Probe 3: What type of mechanism/tool is used

or observed? How were they handled?

to gather feedback?

4. What kind of influence exists from non-career person-

Probe 4: What do you think of this process?

nel in regard to the release of research findings to

Probe 5: How could this process be improved, if

the public?

at all?

Probe 1: Under what circumstances would non-

Probe 6: What difficulties have you encountered

career personnel interject in the publication and/

or observed? How were they handled?

or dissemination of research findings?
Probe 2: What difficulties have you encountered
or observed? How were they handled?

SECTION IV: REPRESENTING
A GOVERNMENT AGENCY
1. In what capacity and under what circumstance, if

5. What kind of influence exists from Congress in regard
to the release of research findings to the public?

any, have you represented your agency (past and/or
present) in a public and/or private arena?

Probe 1: Under what circumstances would a mem-

Probe 1: What are the written policies that you had

ber of Congress interject in the publication and/or

to abide by? Where are they?

dissemination of research findings?
Probe 2: What difficulties have you encountered
or observed? How were they handled?
6. What kind of influence exists from state, tribal, or local

2. What are the guidelines to follow when responding to
requests of information from outside the agency?
Probe 1: Are you allowed to respond to such
inquires?

government/elected officials in regard to the release

Probe 2: What do you think of the policies? Are

of research findings to the public?

there written standards of operation?
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Probe 3: How could they be improved, if at all?

Probe 2: What is the process you must adhere to

Probe 4: What difficulties have you encountered

in order to participate in such activities? Are there

or observed? How were they handled?

written standards of operation? Where are they?
Probe 3: What difficulties have you encountered or

3. What policies does your agency abide by when

observed? How were they handled?

you represent the agency either in public or private
arenas?
Probe 1: What do you think of the policies? Are
there written standards of operation?
Probe 2: How could they be improved, if at all?
Probe 3: What difficulties have you encountered

SECTION V. RECOMMENDATIONS
1. What types of managerial skills are best suited for
working with scientists in a political environment?
Why?
Probe 1: How could these skills be instilled?

or observed? How were they handled?
Probe 2: What kinds of training would be beneficial
4. What access does the public and media have to
agency information (e.g., research findings, board
meeting minutes, agency policies, etc.)?
Probe 1: What do you think of this process? Are
there written standards of operation?

for managers to attain such skills?
2. What types of skills do scientists need to work in
government?
Probe 1: How could these skills be instilled?

Probe 2: How could this process be improved, if

Probe 2: What kinds of training would be beneficial

at all?

for scientists to attain such skills?

Probe 3: What difficulties have you encountered or
observed? How were they handled?
5. If there is scientific data that you, as an individual
scientist, feel is necessary/appropriate to disclose to
the public and your agency disagrees, how would you
handle this situation?
Probe 1: Under what circumstances would you feel
able to reveal this opinion?
Probe 2: Would you fear retribution from your
agency and/or colleagues?
Probe 3: To your knowledge, has this happened
before and what was the outcome?
6. In what ways are you encouraged (or not) to participate in scientific professional training, societies, and
organizations?

3. How could scientific protocols, in your agency,
be improved?
Probe 1: What is the method by which scientists
can provide feedback to improve upon the scientific protocols of your agency?
Probe 2: Is this method effective? Why or why not?
4. How could internal and external publication and dissemination protocols be improved, at your agency?
Probe 1: What is the method by which scientists
can provide feedback to improve upon these protocols at your agency?
Probe 2: Is this method effective? Why or why not?
5. Is there anything that we have not yet discussed that
you believe to be pertinent to our research? What?

Probe 1: How is participation in these activities
paid for?

Thank you!
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Appendix B: Synopsis of Institutional Review
Board (IRB) Approved Application
PRINCIPAL OBJECTIVES: The goal of the project is to pro-

DATA COLLECTION: Data will be qualitative in nature. An

voke and shape the public discussion about the rights

interview guide will be used to probe the subjects on the

and responsibilities of government scientists, as part of

questions relating to the study objectives.

the larger effort to ensure that government uses the best
science to protect and promote the health and well-being

INFORMED CONSENT: Informed consent will be obtained

of Americans.

through the use of an informed consent form. The con-

JUSTIFICATION FOR STUDY & CONTRIBUTION: This project

sent form will be offered to the subject to read in front

aims to develop a generally accepted set of principles on

of the interviewer and then the subject will be offered a

the rights and responsibilities of government scientists

copy of an information sheet discussing the study.

that asserts the values of scientific integrity, freedom, and
openness, while affirming the responsibility to support

RESEARCH-SPECIFIC RISKS: There are no physical risks as-

the public mission of the employing agency.

sociated with this study. There is, however, the possible
risk of loss of confidentiality.

SUBJECT RECRUITMENT: As many as 100 subjects may be
asked to participate in the study with the anticipation that
approximately half will be willing and able to participate.
Five sampling strategies in qualitative inquiry will also be
used to determine saturation of data. These strategies are
Snowball or Chain, Criterion, Opportunistic, Combination
or Mixed, and Convenience (Marshall & Rossman, 1999).
Due to the qualitative nature of the study, more or fewer
subjects may be asked to participate to reach saturation.

STEPS TO MINIMIZE RISK: Some of the questions asked
as part of this study may make subjects feel uncomfortable. They are able to refuse to answer any of the
questions, they may take a break at any time during
the study, and they may stop their participation in this
study at any time. Due to the slim chance of a breach of
confidentiality, a request of a waiver has been made for
signed consent forms.

SUBJECT IDENTIFICATION: Subjects will be identified by
investigators in conjunction with the Advisory Board.

ASSURANCE OF CONFIDENTIALITY/ANONYMITY: Every ef-

The Advisory Board’s responsibility and potential con-

fort will be made to keep subjects’ information confiden-

tact with subjects lies only in the recruitment section

tial, however, this cannot be guaranteed. The informed

of the study. The selection criterion is that subjects will

consent form will include language to ensure this. All re-

have been employed (either past and/or present) by a

search materials will be kept in a secure location available

government agency in a scientific capacity. Subjects

only to the research team.

will also be recruited through employment and professional associations.

RESEARCH DATA & MATERIALS: Not all research data and

SUBJECT PARTICIPATION: Subjects will participate in one

materials will be destroyed at the end of the study. Audio

60-90 minute in-person or telephone interview, that will

tapes, hand-written/typed notes, and consent forms will

be audio recorded and hand-written/typed notes taken

be kept in a locked and secure environment where only

during the interview. Subjects may be asked to partici-

the research team has access. The items may be used in

pate in a 15-30 minute in-person or telephone follow-up

the future for verification and clarification of analysis. Sub-

interview for clarification of previously asked or addition-

jects will agree to possible future use of such materials as

al questions.

part of their consent to participate in the study.
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